Skip to main content

6. Diseases as Risk Factors for ADHD

6. Diseases as Risk Factors for ADHD

Last updated:

Author: Ulrich Brennecke
Review (2024): Waldemar Zdero, M.A. in Psychology

Traumatic physical or psychological experiences during childhood can be a contributing factor to ADHD.
This article discusses medical conditions as risk factors for ADHD.

For infants and children:
Exposure to secondhand smoke, air pollution (particularly fine particulate matter and nitrogen oxides), and various pollutants such as lead, manganese, or phthalates is associated with an increased risk of ADHD.
Surgical procedures under anesthesia, atopic dermatitis, bacterial infections, and concussions are risk factors for ADHD, as are stressful childhood psychological experiences such as trauma, chronic stress, or growing up in a children’s home.
A lack of attachment from the mother or parents during childhood, maternal stress during childhood, or the parents’ mental health issues increase the risk of ADHD in children, as do low socioeconomic status, low educational attainment, or parental unemployment.
Starting school earlier and being the youngest child in the class are additional risk factors.

During puberty:
High levels of stress during adolescence are considered a risk factor for ADHD persisting into adulthood.

The percentage values indicate the extent to which the risk of ADHD correlates with the respective factor. These figures do not imply that the respective factor is a causal cause.

6.1. Infections and Infectious Diseases

An infection is the entry of microorganisms (viruses, fungi, bacteria, parasites) into an organism, followed by their colonization and reproduction.
In a broader sense, infectious diseases are also imprecisely referred to as “infections.”1

A higher infection burden may have a cumulative association with psychiatric disorders that goes beyond what has been described for individual infections. Susceptibility to infections is reflected in the infection burden (the number of specific types or sites of infection). An increased infection burden correlates with an increased risk of:2

  • ADHD
  • ASS
  • bipolar disorders
  • Depression
  • Schizophrenia
  • total number of psychiatric diagnoses.
    A modest but significant heritability was found for the infection burden (h2 = 0.0221), as well as a high degree of genetic correlation between it and the overall psychiatric diagnosis (rg = 0.4298). Evidence was also found for a genetic causality of the total infection on the overall psychiatric diagnosis.

6.1.1. Infections during the first year of life (+16% to +77%)

A registry-based cohort study (n = 2,885,662, of whom n = 1,864,660 were full siblings) found a slight 16% increase in the risk of ADHD associated with childhood infections during the first year of life (ASD + 12%, tics + 12%, intellectual disability + 63%), which disappeared when adjusted for ADHD and tics using twins as a control group.3
Severe infections during the first week of life increased the risk of ADHD treated with medication between the ages of 8 and 14 by 12%. Meningitis during the first week of life increased the risk of ADHD, as defined here, by 77% and the risk of ASD by 105%.4

6.1.2. Bacterial infections (up to +593%)

Severe bacterial infectious diseases during childhood or adolescence dramatically increase the risk of serious mental disorders (HR):5

  • ASS: 13.80
  • ADHD: 6.93
    • ADHD medication use: 11.81
  • Tic disorder: 6.19
  • OCD: 3.93
  • Bipolar disorder: 2.50
  • Depressive disorders: 1.93
    • Antidepressant use: 2.96
    • Mood stabilizer intake: 4.51
    • Use of atypical antipsychotics: 4.23
  • Schizophrenia6

Among the bacterial species studied (streptococci, staphylococci, Pseudomonas, Klebsiella, Haemophilus, mycoplasmas, tuberculosis, meningococci, Escherichia, Chlamydia, and scrub typhus), streptococci were associated with the most clinical presentations. ADHD was associated with eight bacterial infections.5

6.1.2.1. Bacterial meningitis (inflammation of the meninges) (+40% to +180%)

The consequences of bacterial meningitis (but not of enteroviral meningitis) were an increased risk of ADHD or of taking ADHD medication:7

  • Meningitis in the first 90 days of life:
    • 2.8-fold increased risk of ADHD (aHR 2.8, +180%)
    • 2.2 times more likely to take ADHD medication
    • 1.9-fold increased risk of ASD
    • Behavioral and emotional disorders (2 categories)
    • Learning and intellectual development disorders: 4.2 times
  • Meningitis between 90 days and 18 years of age:
    • 1.4 times higher risk of ADHD (+40%)
    • ADHD medication use: 1.5 times
    • Learning and intellectual development disorders: 1.5 times

All 21 people with tuberculous meningitis exhibited ADHD symptoms.8 Given a population prevalence of 8%, this would represent a 1,150% increase in risk.
In a recent study of 78 children with tuberculous meningitis, the same authors found that only 13.5% of the children had a clinical Total Problem Score on the CBCL (above 70) and 20.6% had clinical Social Problems Scores. The ADHD score was significantly elevated in the group, although no conclusion was drawn regarding the number of people with ADHD.9

The prevalence of Streptococcus agalactiae (Group B Streptococcus, GBS) infection among infants was 0.07%.
GBS caused:10

  • increased infant mortality (19.41 times higher)
  • Long-term neurological developmental disorders (3.49 times)

GBS meningitis increased the risk of10

  • ADHD
  • cerebral palsy
  • Epilepsy
  • Hearing impairment
  • profound and specific developmental disorders

6.1.2.2. Periodontal Disease

Periodontitis is a bacterial infection of the gums caused by the bacterium P. gingivalis, which secretes toxins. Periodontitis is described as a risk factor for ADHD.11

6.1.2.3. Antibiotics in the first years of life (up to +33%)

In a very large study, antibiotic use during a child’s second year of life increased the risk of ADHD by 20 to 33% and the risk of sleep problems by 24 to 50%.12 An even larger study from Korea found a dose-dependent 10% increase in the risk of ADHD, with prenatal and early childhood administration together further increasing the risk.13
Another very large study found that the risk of ADHD increased all the more as14

  • the earlier the first course of antibiotics was administered (under 2 years old, 2 to 5 years old, 5 to 8 years old) and
  • the longer the course of antibiotics lasted (less than 7 days, 7 to 14 days, more than 14 days):
ADHD prevalence among children who received antibiotics at the following ages / for the following durations: under 2 years 2–5 years 5–8 years
< 7 Days 10.53% 7.33% 5.18%
7–14 days 10.66% 8.80% 7.25%
&gt; 14 days 11.47% 11.11% 8.83%

A small study found more frequent behavioral problems and depressive symptoms in 3 1/2-year-old children who had received antibiotics during their first year of life.15 Two other studies found no increased risk of mental disorders associated with antibiotic use during the first 1 16 to 217 years of life.
One study found no increased risk of ADHD, but did find an increased risk of asthma, food allergies, and allergic rhinitis (hay fever),18 which are known to be associated with an increased risk of ADHD.

Antibiotic use during the first three years of life reduces the diversity, stability, and composition of the microbiome:19

  • reduced frequency of genera
    • Bacteroides
    • Bifidobacterium
    • Lactobacillus
    • Staphylococcus
    • Sediminibacterium
  • increased incidence of
    • Members of the Enterobacteriaceae family
    • of the genus Enterococcus

As the microbiome matures, several processes in the central nervous system—such as synaptogenesis, myelination, and synaptic pruning—take place, and these can be influenced by microbiome-associated metabolites.19

Antibiotic exposure during the first years of life increased the child’s risk of: (meta-analysis, k = 30, n = 7,047,853)20

  • ADHD: +33%
    • not significant in studies that used sibling control groups
  • Depression: +29%
    • not significant in studies that used sibling control groups
  • ASS: +19%

A cohort study found no significant increase in the risk of ADHD or ASD associated with antibiotic use during the first two years of life.21

6.1.3. Viral Infections

The Powassan flavivirus is transmitted by ticks and, in rare cases, causes encephalitis in humans. Six children with Powassan virus encephalitis, who were diagnosed between the ages of 14 months and 11 years, all suffered permanent neurological sequelae, including:22

  • Seizures
  • Movement disorders
  • Behavioral problems
  • ADHD
  • Learning difficulties
  • Anxiety
  • Sleep disorders

6.1.3.1. Enteroviruses in general (up to +182%)

(Non-polio) enteroviruses account for just over half of all cases of aseptic meningitis, making them one of the most significant known causes.23 In addition to encephalitis24, (non-polio) enteroviruses also frequently cause febrile illnesses, hand-foot-and-mouth disease, herpangina, aseptic meningitis, and encephalitis, as well as, on occasion, severe and life-threatening infections such as myocarditis or neonatal sepsis.

Enteroviruses are considered a possible cause of ADHD.25
A study found an increased risk of ADHD associated with mild enterovirus infections (16%) and severe enterovirus infections (182%).26

6.1.3.2. Enterovirus A71 (EV-A71) (+200%)

A longitudinal study of 43 adolescents who had a central nervous system infection with enterovirus A71 (EV-A71) between the ages of 6 and 18 found that 34.9% had ADHD. This indicates that the risk of ADHD is more than tripled. In addition, increased autistic symptoms were observed. There was no increase in other psychiatric diagnoses.2728 Another study found ADHD to be particularly common when the A71 infection was accompanied by cardiopulmonary failure.29
EV-A71 often causes weakness, limb atrophy, seizures, hand, foot, and mouth disease, encephalitis, and reduced intelligence.

6.1.3.3. HIV (+150% to +1,000%)

A study of children and adolescents with HIV who were in stable health found ADHD symptoms in 20% of them.30
A 2007 study of 100 African children aged 5 and older with HIV found ADHD symptoms in 88% of the participants: 26% had ADHD-I, 38% had ADHD-HI, and 24% had ADHD-C. In addition, the prevalence of ODD ranged from 9.5% (teacher assessment) to 12% (parent assessment). Sixty percent of the caregivers were themselves infected with HIV.31
Assuming a population prevalence of 8%, this would result in a +150% to +1,000% increase in ADHD prevalence.

6.1.3.4. Herpes zoster encephalitis

In one isolated case, ADHD was mentioned in connection with zoster encephalitis.32

6.1.3.5. Human Endogenous Retroviruses (HERV)

The Topic Human Endogenous Retroviruses (HERV) and ADHD Is discussed in the chapter “ ” due to its high heritability Origin in the article Genetic and Epigenetic Causes of ADHD – Introduction

6.1.4. Parasitic Infections

A study of 100 children with ADHD and 100 healthy children found a correlation between ADHD and:33

  • Toxoplasma
  • Toxocara
  • Cryptosporidium parvum
  • Giardia lamblia
  • Entamoeba histolytica
    No difference was found with regard to Schistosoma (coccidian parasites).

6.2. Traumatic Brain Injuries (up to +529%)

Traumatic brain injuries (TBI) are estimated internationally at 349 per 100,000 person-years. One in two people will suffer a traumatic brain injury at some point in their lives. Traumatic brain injuries have the highest incidence and prevalence of all common neurological disorders and have been linked in studies to consequences such as neurodegenerative diseases, cognitive impairments, stroke, psychiatric disorders, and increased mortality.34

Traumatic brain injuries can trigger secondary ADHD.35
The severity of brain injuries correlates with significantly higher ADHD symptoms. Changes in the morphometry of the default mode network (DMN) caused by brain injuries predict higher ADHD symptoms 12 months after the injury, whereas the morphometry of the Salience Network (SN) and the Central Executive Network (CEN) did not constitute significant independent predictors.36

A systematic review of k = 24 meta-analyses found a correlation between the risk of ADHD and previous traumatic brain injuries:34

  • mild traumatic brain injury: +18%, not statistically significant, n = 4,098 participants
  • moderate traumatic brain injury: +266%, not statistically significant, n = 117
  • Severe traumatic brain injury: +529%, statistically significant, n = 5,092

It remains unclear to what extent traumatic brain injuries in ADHD are the consequences of the increased likelihood of accidents and injuries associated with ADHD.
In one study, 30% of boys and 15% of girls with traumatic brain injury had previously been diagnosed with ADHD.37 This study also suggests incorporating physical activity and providing resources to help girls cope with school-related stress into their rehabilitation programs. For boys, cognitive support and strategies for managing ADHD may be more effective.

ADHD was associated with an increased incidence of traumatic brain injuries3839 40 and otolaryngological trauma.41
A study examined mild (concussion) and severe traumatic brain injuries occurring before the age of 10. The incidence was 1,156 per 100,000 person-years. At age 19, the risk of ADHD was 68% higher, and the risk of a learning disability was 29% higher.42
In cases of more severe traumatic brain injury, the association was not statistically significant. In an analysis of cases with possible traumatic brain injury (corresponding to a concussion), the result was significant (105% increased risk of ADHD, 42% increased risk of learning disabilities). The risk in adulthood was particularly elevated among children with the least severe injuries.
In purely correlational studies, however, it remains unclear to what extent traumatic brain injuries are a consequence of ADHD (increased risk of accidents) or whether ADHD is a consequence of traumatic brain injuries (secondary ADHD).

Among 1,709 ice hockey players aged 11 to 17, the rate of concussions correlated with higher self-reported and parent-reported scores for attention problems. Only self-reported hyperactivity—not parent-reported hyperactivity—was also significantly correlated with concussions. A T-score ≥ 60, which combines scores for attention problems and hyperactivity (an estimate of probable ADHD), was not significantly associated with the frequency of injuries or concussions.43

A Finnish nationwide retrospective cohort study (1998 to 2018) of patients with pediatric traumatic brain injury (n > 126,000) found a significant association between pediatric traumatic brain injury and post-traumatic use of ADHD medications during a 20-year follow-up period, with the association being particularly pronounced after 4 years.44
The proposed mechanism of action was neurodegeneration resulting from traumatic brain injury, followed by neuroinflammation and oxidative stress, which could impair brain development and neurotransmitter function and increase the risk of neurodevelopmental disorders.45

6.3. Craniosynostosis (+500%)

Craniosynostosis is the premature fusion of the skull sutures. In one study, the majority of children with craniosynostosis also exhibited ADHD symptoms. Maternal smoking during pregnancy significantly increased the risk of craniosynostosis.46
Approximately one in two children who underwent surgery for metopic synostosis (trigonocephaly or metopic craniosynostosis) at 9.5 (± 7.9) months of age showed at least borderline levels of hyperactivity and inattention at 10.3 (± 3.5) years, at least borderline levels of hyperactivity and inattention.47 A higher age at the time of surgery was associated with poorer executive functions.
A study found that 42.6% of those who had undergone surgery for craniosynostosis as children had high scores on the CAARS-2 ADHD Index at age 16 and older.48
Craniosynostosis is associated with a significantly increased risk of ADHD symptoms.49

6.4. Epilepsy (up to +470%)

Epilepsy is a physical neurological disorder,
One study found a 5.7-fold increased risk of ADHD in children with epilepsy (41.5% vs. 7.3%). In most of these children, ADHD was diagnosed after their epilepsy had subsided and they had stopped taking epilepsy medication.50 Another study found that 43.3% of children with epilepsy had ADHD or a learning disability.51 One study reported a prevalence of 11.2% for ADHD and 19.1% for ASD among children with epilepsy aged 7 years.52

Among children with infection-related epilepsy (FIRES), 33.3% exhibited symptoms of inattention, 53.3% exhibited aggression, and 20% exhibited mood problems.53

For West syndrome (infantile spasms, BNS epilepsy), which occurs in infants, the prevalence of ADHD has been reported to be 15%.54

6.5. Phenylketonuria (PKU) (+375%)

See the section below on Monogenic Causes of ADHD.

6.6. Sleep-Related Breathing Disorders (SBAS, SDB, SRBD) (up to +350%)

Other names: Sleep-disordered breathing (SDB), Sleep-related breathing disorder (SRBD).55

Sleep-related breathing disorders (SBAS), as an umbrella term, include, among other things,

  • primary snoring (snoring alone, without other sleep-related breathing disorders)
  • Upper Airway Resistance Syndrome56
  • Obstructive sleep apnea (OSA)5758
  • central sleep apnea (CSA)
  • Sleep-Related Gas Exchange Disorders (SAGEA)

SBAS is most common between the ages of 2 and 8, presumably due to the relative size of the lymphatic tissue compared to the diameter of the airways.59

6.6.1. Sleep-Related Breathing Disorders in General

6.6.1.1. Prevalence of Sleep-Related Breathing Disorders

The prevalence of sleep-related breathing disorders (SBAS) was found to be

  • Children:
    • 12%60
    • 10% (study of n = 227 children aged 4 to 2 years)59
  • Children and adolescents (ages 6 to 17)
  • Children and adolescents (ages 5 to 16) undergoing orthodontic treatment:58
    • SBAS: 10.8% vs. 5% in healthy controls
    • Snoring: 13.3%
    • Drowsiness: 17.9%
  • Teens
    • 7%62
      • male: 5.8%
      • female: 8%
      • weekly: 6%62
    • 5.8% without obesity62
      • 12.8% with obesity
  • Population
    • Ages 30 to 60, AHI of 5 or higher63
      • 9% among women
      • 24% among men
    • 20%64
    • 23.4% among women65
      • 3- to 4-fold increase in postmenopausal women compared with premenopausal women66
    • Average age 59 years, AHI 15 or higher65
      • 49.7% among men
      • The median AHI for the general population was 6.9/h for women and 14.9/h for men65
    • ages 30 to 69 (meta-analysis, k = 17)67
      • Germany
        • 60.1% AHI of 5 or higher
        • AHI of 32.9% or higher starting at age 15
      • France
        • 72.1% AHI of 5 or higher
        • AHI of 36.3% or higher starting at age 15
      • Austria
        • 48.7% AHI of 5 or higher
        • AHI of 28.4% or higher starting at age 15
      • Switzerland
        • 72.4% AHI of 5 or higher
        • AHI of 36.6% or higher starting at age 15
      • Denmark
        • 48.9% AHI of 5 or higher
        • AHI of 28.5% or higher starting at age 15
      • Sweden
        • 17.0% AHI from 5 onward
        • AHI of 12.7% or higher starting at age 15
      • United States
        • AHI of 33.2% or higher
        • 14.5% AHI at age 15 and older
  • inpatients in psychiatric care
  • Prevalence of SBAS (apnea-hypopnea index (AHI), respiratory disturbance index (RDI), or oxygen desaturation index (ODI) of 5 or more per hour):66
    • 24.0% to 83.8% among men
    • 9.0% to 76.6% among women
  • Prevalence of moderate-to-severe SBAS (AHI, RDI, or ODI of 15 or more per hour)66
    • 7.2% to 67.2% among men
    • 4.0% to 50.9% among women

SBD is associated with hearing problems.
44.8% of children who habitually snored had recurrent middle ear infections69
Middle ear infection is associated with SBD and the resulting hypoxia.70 Children with middle ear infection and effusion are more likely to have significant OSA symptoms.71
Middle ear infections are exacerbated by a lack of oxygen.7273747576

Mild SBAS that went untreated resolved on its own:

  • among 70.8% of children and adolescents aged 6 to 1761
  • in 65% of children aged 5 to 9 with mild OSA77
  • Among 52.9% of children with an AHI of 2 or higher, the condition persists into adolescence78
  • 100% of children with an AHI of 5 or higher through adolescence; below that,78
    • 50% partial remission for an AHI of 2 to 4
    • 50% achieved a reduction in AHI to below 2

In cases of moderate or severe OSAS (AHI ≥ 5), spontaneous remission is less common. Obesity, a high BMI, persistent tonsillar hypertrophy, male gender, or African American ethnicity are unfavorable predictors of spontaneous remission of OSAS.79

6.6.1.2. Oxygen Supply for SBAS

TOI: mean nocturnal tissue oxygen index

Unlike in adults, the TOI during sleep in children with SBAS does not appear to differ from that of healthy controls.80
In cases of apnea and hypopnea, the decrease in TOI is preceded by peripheral and systemic desaturation.
TOI Falls More Sharply

  • in cases of apnea as well as hypopnea
  • during REM sleep than during other sleep stages
  • in younger children than in older children
  • in children with a high AHI rather than a low AHI

A study of 65 children with SBAS examined 540 obstructive and mixed apneas, 172 central apneas, and 393 obstructive hypopneas.81

  • SpO2 decreased by an average of 4.1% (± 3.1%)
  • TOI decreased by an average of 3.4% (± 2.8%)
  • TOI declined more sharply
    • in cases of apnea (cessation of breathing) compared to obstructive hypopnea (reduced depth of breathing, shallower breathing)
    • in cases of moderate to severe SBAS compared to mild SBAS
    • in children up to 6 years of age compared to older children
      • Explanatory models: lower residual functional capacity, higher oxygen consumption, and immaturity of cerebral autoregulation in children80
  • Decreases in TOI correlated significantly with, regardless of the type of event,
    • Decreases in SpO2
    • Duration of the event
    • Age

A study of 60 children with SBAS analyzed 493 central and 399 obstructive events:82

  • Central oxygenation and heart rate changed more significantly during central events (apneas) than during obstructive events
  • The changes were greater during NREM sleep than during REM sleep
  • TOI changed more significantly among 3- to 6-year-olds than among 7- to 12-year-olds
  • Heart rate fluctuated more among 7- to 12-year-olds than among 3- to 6-year-olds

Two studies found different results:

  • Cerebral oxygenation did not correlate with the severity of SBAS. Primary snoring was associated with significantly poorer cerebral oxygenation than mild or severe OSA. Sleep disturbances, male gender, arousal index, and NREM sleep correlate with reduced cerebral oxygenation. An increase in mean arterial blood pressure, older age, higher blood oxygen saturation, and REM sleep were associated with higher cerebral oxygenation.83
  • SBAS in children aged 7 to 12 was associated with a significant increase (in cases of primary snoring, AHI ≤ 1) or a tendency toward an increase (in cases of mild and severe OSA) in cerebral oxygenation (TOI). This could possibly be a compensatory response to reduced arterial oxygen saturation during an apnea (cerebral autoregulation). In children aged 3 to 6 years, cerebral oxygen levels remained unchanged, regardless of the severity of SBAS. Cerebral oxygen levels did not correlate with cognitive deficits but did correlate with behavioral problems in children aged 7 to 12 years. In contrast to cerebral oxygenation, the oxygen extraction rate (O2-ER or FTOE, which measures tissue oxygen consumption) was lower in all SBAS groups during all sleep stages compared to controls. The SpO2 value was the same across all groups.84

In adults, obstructive respiratory events (particularly during REM sleep and in relation to the duration of the event) were associated with80

  • Decrease in O2Hb
  • TOI Acceptance
  • Increase in HHb
  • Increase in tHb

In adults, cerebral oxygen supply changed85

  • more pronounced during obstructive apneas than during obstructive hypopneas
  • more severe in cases of severe OSA than in cases of mild or moderate OSA

Repeated drops in oxygen levels during sleep can damage the brainstem’s respiratory control centers, particularly during critical developmental stages, which can lead to long-term problems such as unstable breathing, cardiovascular strain, or neurological issues.86

Hyperactivity was correlated with reduced blood oxygen saturation.87

Hypoxia is a relevant developmental pathway for ADHD.88

Neural inflammation may be another common pathway in the development of ADHD and SBAS.8990

CO2 and Oxygen

Hypocapnia is a decreased partial pressure of CO2 in arterial blood. Hypocapnia can occur, for example, during hyperventilation due to increased exhalation of CO2.
Hypocapnia causes the blood vessels in the brain to constrict (cerebral vasoconstriction), which reduces the oxygen supply to the brain despite adequate O₂ saturation in the blood. A reduced blood CO₂ level thus leads to a lack of oxygen in the brain, which is independent of the blood’s O₂ saturation. Since CO₂ dilates blood vessels, a lack of CO₂ leads to constriction of the blood vessels and thus to reduced blood flow and, consequently, reduced oxygen supply.
Hemoglobin binds oxygen in the lungs and transports it to the body’s cells.
Hypocapnia (low CO2 levels) increases the oxygen affinity of hemoglobin, causing it to bind more oxygen and making it harder for it to release oxygen into the tissues.
Hypercapnia (high CO₂ levels) reduces the oxygen affinity of hemoglobin (Bohr effect), which promotes oxygen delivery to the tissues.
In cases of carbon monoxide (CO) poisoning, CO displaces CO2 from the blood and, through hypocapnia, indirectly causes a lack of oxygen in the brain.

6.6.1.3. ADHD in SBAS

One review reports a 50% correlation between ADHD and SBAS.89
SBAS shows a moderate correlation with ADHD symptoms (Hedges’ g = 0.57, 95% confidence interval: 0.36–0.78; p = 0.000001). A high AHI was associated with lower effect sizes. (Meta-analysis, k = 18, n = 2,518)91 Adenotonsillectomy was associated with a reduction in ADHD symptoms 2–13 months after surgery (Hedges’ g = 0.43; SMD; 95% confidence interval = 0.30–0.55; p < 0.001; n = 529).

The risk of ADHD is increased in SBAS:92

  • by 1,106% for moderate and severe sleep problems93
  • by 759% (31.8% vs. 3.8% among children and adolescents aged 5 to 16) in orthodontic treatment:58
    • Nocturnal enuresis: 13.6% vs. 0%
    • Overweight: 18.2% vs. 2.7%
  • by 393% for mild sleep problems93
  • by 150% to 200%94
  • by more than 100%95
  • in children with SBAS
    • Hyperactivity9697 98 99
      • increased by 150%100
      • increased by 57%101
      • The cutoff on the BASC-2 PRF scale for hyperactivity was exceeded 6.82 times more often in children with persistent SBD compared to those who never had SBD (+582%)102
    • Inattention10296 99
      • increased by 110%100
      • increased by 89%101
      • Elevated levels of103 in NEPSY
    • Hyperactivity and inattention improved significantly following an adenotonsillectomy.
  • Impaired executive functions
    • for 5-year-old children104
    • on NEPSY103
  • Impaired memory functions
    • for 5-year-old children104
  • impaired general intellectual abilities
    • for 5-year-old children104
  • externalizing symptoms96
    • for children ages 7 to 12 (CBCL and BRIEF)105
    • The cutoff on the BASC-2 PRF scale for externalizing problems was exceeded 3.29 times more often in cases of persistent SBD compared to those who never had SBD (+229%)102#
  • Aggressiveness10296
    • increased by 110%100
  • reduced social skills102
  • impaired communication skills102
  • reduced adaptability102
  • Behavioral symptoms99
    • (but no cognitive symptoms) in children aged 3 to 5106
    • for children ages 7 to 12 (CBCL and BRIEF)105
  • internalizing symptoms96
    • for children ages 7 to 12 (CBCL and BRIEF)105

Children with Robin sequence (Pierre Robin sequence, PRS) suffer from a congenital combination of malformations:

  • Underdeveloped lower jaw (micrognathia)
  • tongue that falls backward (glossoptosis)
  • resulting breathing difficulties caused by a blockage of the upper airways
  • often accompanied by a cleft palate, which exacerbates breathing and feeding problems
  • ADHD symptoms as a possible consequence of breathing difficulties107
  • PRS is a common feature of Stickler syndrome, a genetic disorder that causes underdevelopment of the midface

ADHD symptoms resulting from SBD are also referred to as “ADHD-like,” “acquired ADHD,” “secondary ADHD,” or “atypical ADHD108, since the ADHD symptoms in this case do not result from a neurodevelopmental disorder.

Opinion by Ulrich Brennecke, ADxS.org:

Although the name ADHD suggests that it is a disorder, ADHD is actually a syndrome defined solely by its symptoms. ADHD symptoms can be triggered by many different causes. Since ADHD has so far been treated primarily symptomatically (typical ADHD medications target the symptoms), distinguishing between “true/primary” ADHD and “false/secondary” ADHD offers, on the one hand, the opportunity to measuring the necessity and success of treating the causes of “secondary” ADHD against the ADHD symptoms themselves, and, on the other hand, the risk of considering established ADHD treatment methods to be unsuitable or inappropriate for treating “secondary” ADHD. The latter, however, would be disastrous.
Even though the DSM now classifies ADHD as a neurodevelopmental disorder, it is unclear to what extent this classification stems from the mere necessity of fitting it into the DSM’s two-dimensional, linear organizational structure, and to what extent it is intended to define the nature of ADHD. A two-dimensional framework such as the DSM, which does not allow for multiple listings, is forced to classify an item in the most likely or most essential category; however, this does not imply that this must be the only correct category. In its rationale for ADHD, the DSM-5-TR is quite contradictory.109
Not only do a variety of environmental factors contribute to ADHD, but even within neurological development, there are likely many different pathways that lead to ADHD. Furthermore, it is not possible to clearly distinguish between primary ADHD and the resulting increased risk of comorbidities on the one hand, and the causes of secondary ADHD on the other. Often enough, an existing (subclinical) primary ADHD likely only reaches a clinical level when additional environmental factors (including illnesses) come into play. There are no studies that clearly define how many people with “secondary” ADHD already had subclinical ADHD symptoms (in the sense of a predisposition to ADHD) before the onset of the secondary cause (such as traumatic brain injury, encephalitis, SBAS) already had subclinical ADHD symptoms (in the sense of a predisposition to ADHD). This question is relevant because not all people with ADHD also develop secondary ADHD symptoms. It also remains unclear in how many people with ADHD—for whom successful treatment of the secondary cause improves ADHD symptoms—these “secondary” ADHD symptoms are completely eliminated or merely reduced to a subclinical level, where they are still present and can certainly have a negative impact on quality of life, but are no longer severe enough to meet the diagnostic criteria.
Studies on the prevalence of ADHD in the general population do not distinguish between the causes of diagnosed ADHD and ADHD diagnoses made in the (still prevailing) absence of knowledge about the cause.
Given this context, it would likely make more sense to continue referring to ADHD as ADHD and to distinguish between different conditions within the ADHD spectrum based on their various causes and contributing factors.

Among children aged 4 to 12 who visited a dental clinic, SBAS was associated with a more than 7.35-fold increased risk of ADHD medication, a 40% increased risk of asthma medication, and a 12.5-fold increased risk of other medications.59

  • SBAS continued to correlate with:59
    • Allergies: 4.9 times
    • Developmental disorders: 4.94 times
    • Behavioral disorders: 3.94 times
    • Difficulty sleeping through the night: 3 to 6 times
    • Mouth breathing: 4.7 to 5 times
    • Snoring: 3 times
      • 70% of children with SBAS snore frequently110
    • fewer complications experienced during their own childbirth
    • 83.3% of parents reported that they snore, compared with 52.2% of parents of children without SBAS
  • The use of ADHD medication was found to have a low-to-moderate correlation with mouth breathing (Phi = 0.216)
  • Mouth breathing was moderately to strongly correlated with snoring (Phi = 0.386, p < 0.001).

Polysomnography studies found a correlation between ADHD and sleep-related disorders only in terms of increased nighttime movements.111112 Polysomnography is a sleep laboratory examination that measures brain waves (EEG), eye movements (EOG), heart activity (ECG), respiration, oxygen saturation, muscle activity (EMG), and body position.

A study reports increased snoring and breathing pauses in children with Down syndrome.113 Down syndrome is associated with a 50% prevalence of ADHD. For more information, see Monogenic Causes of ADHD.

A genomic correlation was found between ADHD and insomnia, daytime napping, daytime sleepiness, snoring, and short and long sleep duration. Insomnia, daytime sleepiness, and snoring shared genes with ADHD that are involved in neurobiological functions and regulatory signaling pathways.114

The upper quartile for the SBAS apnea-hypopnea index (AHI greater than 20.6/h) correlated (independently in each case) with65

  • metabolic syndrome (OR 2.80)
  • Diabetes (OR 2.00)
  • Depression (OR 1.92)
  • High blood pressure (OR 1.60)

Children with ADHD are more likely to exhibit SBAS symptoms.115

6.6.1.4. Adenotonsillectomy for SBAS and Changes in ADHD Symptoms

Children aged 6 to 12 with SBAS showed a correlation between the lowest blood oxygen saturation levels and performance on the Modified Wisconsin Card Sorting Test. An adenotonsillectomy significantly improved the apnea-hypopnea index (AHI) and improved the mean scores on most neurocognitive and behavioral measures, although residual deficits persisted even after 6 months. However, nearly half of the children continued to suffer from SBAS. A baseline AHI > 5/h and complete resolution of SBAS (postoperative AHI < 1/h) correlated with improvement in more subscales than a baseline AHI < 5/h or incomplete resolution of SBAS. The impairment of neurocognitive performance in SBAS appears to be attributable more to hypoxemia than to the frequency of SBAS events.116
Children with SBAS who had undergone an adenotonsillectomy117

  • showed, prior to surgery, compared to those not affected
    • common ADHD (DSM-IV)
    • frequent hyperactivity
    • increased inattention on cognitive tests
    • increased sleepiness in the Multiple Sleep Latency Test; more sleepy
  • showed significant improvements in all measures after surgery and no longer differed from those without the condition
  • The improvements could not be predicted by polysomnographic measurements prior to surgery

Among 64 children with SBAS (ages 3 to 12), there was a significant improvement in quality of life 4 years after adenotonsillectomy, but no improvement in behavior as measured by the CBCL.118
Among 20 children with OSA (ages 3 to 13), a significant improvement in ADHD symptoms, behavior, and snoring was observed 4.5 years after an adenotonsillectomy.119

Among 54 children with sleep-related gas exchange disorders (SAGEA), surgical tonsillectomy and adenoidectomy resulted in a statistically significant improvement in school performance, whereas performance remained unchanged in children who did not undergo surgery.120

Children with mild (Apnea-Hypopnea Index (AHI) below 6 or Apnea Index (AI) below 1) SBAS (mean AHI of 3.1) and children with OSA (AHI of 5 or higher or AI of 1 or higher) (average AHI 25.3; range 10 to 48) showed no differences in BASC scores prior to adenotonsillectomy. After surgery, both groups showed a significant improvement in the behavioral symptom index, as well as in the BASC scales for atypicality, depression, hyperactivity, and somatization.121

Differences in Observation: Symptom Perception vs. Polysomnographic Measurement

Several studies have found that the severity of symptoms reported by parents or teachers correlates only to a limited extent with the results of polysomnographic measurements.

SBAS in children aged 5 to 17 showed the following results for the five domains of executive function (meta-analysis: k = 14, n = 1,697)122

  • during polysomnographic testing
    • 0.43 Generativity (SMD)
    • the other four areas of executive functions (vigilance, inhibition, working memory, and task switching) were not significantly
  • for questionnaire surveys
    • significant for all three measured domains of executive functions, ranging from SMD 0.64 to 1.06
      • 0.64 Inhibition (SMD in the parent report)
      • 1.06 Working Memory (SMD as reported by parents)
      • 0.86 task switches (SMD in the parent report)
  • The severity of SBAS did not affect executive functions

Children aged 7 to 12 years, who were divided based on nocturnal polysomnography into a control group (N = 34); primary snoring (PS: N = 55), mild obstructive sleep apnea (mild OSA: N = 22), and moderate-to-severe OSA (MS OSA: n = 16) showed deficits in working memory on the Behavior Rating Inventory of Executive Function (BRIEF) across all severity levels of SBAS. While a computer-based test (playing card recognition, CogHealth) found no difference between SBAS and controls, the mild OSA group performed significantly worse than the primary snoring group. Parents of children with primary snoring, however, reported more severe working memory deficits than those indicated by the objective measurement.123

Among children aged 5 to 9 years with adenotonsillar hypertrophy and diagnosed sleep apnea, 42% no longer met the diagnostic criteria for sleep apnea after 7 months without surgery. This remission was statistically significantly more common among children with a lower AHI, better oxygen saturation, smaller waist circumference, a higher-positioned soft palate, smaller neck circumference, and non-black skin color. However, of the 167 children with baseline PSQ scores ≥ 0.33, only 15% achieved symptomatic remission. Symptomatic remission was predicted by low PSQ and PSQ snoring subscale scores, the absence of habitual snoring, loud snoring, observed apneas, or smokers in the household, a higher quality of life, fewer ADHD symptoms, and female gender. Only lower PSQ and snoring scores were independent predictors.
In summary, while a “wait-and-see” approach to polysomnography is often associated with the OSAS diagnosis being dropped, it is rarely associated with a significant improvement in symptoms.124

Children aged 3 to 5 with SBD showed the following in a follow-up examination 3 years later:125

  • 60% of the children treated showed a resolution of SBAS
  • 40% of the untreated children showed a resolution of SBAS
  • “Cured” was defined as: a maximum OAHI of 1 per hour, no snoring observed during polysomnography, and no report of habitual snoring by the parents
  • No cognitive differences between the “recovered,” “unrecovered,” and “control group”
  • Behavioral functions were significantly worse in children with an initial diagnosis of SBAS compared to controls, regardless of whether they had recovered
  • Changes in OAHI did not predict cognitive or behavioral outcomes
  • A reduction in nighttime arousal, regardless of whether a complete recovery occurred, was associated with improved attention and reduced aggression

6.6.1.5. Risk Factors for Sleep-Related Breathing Disorders

Risk factors for sleep-related breathing disorders, particularly sleep apnea, include126

  • Sleep Mask (Standard Treatment)
  • Alcohol
  • Obesity
    • elongated soft palate
    • Retraction of the lower jaw
    • Fat deposits in the tongue and lateral pharyngeal wall

6.6.2. Snoring (up to +350%)

Primary snoring (snoring without OSA) differs from obstructive sleep apnea in terms of the number of hypopneas per hour.
Primary snoring is defined as an AHI of 1 or less, while OSA is defined as an AHI greater than 1.

6.6.2.1. Prevalence of Snoring

  • Children ages 4 to 6127
    • 24.9% occasional snoring
    • 15.2% habitual snoring
  • Children ages 5 to 7
    • 7.7% of children reported to snore by their parents128
  • Children ages 2 to 8: 10%129
  • Children ages 6 to 12: 5.7%130
    • Boys 7.5%
    • Girls 3.8%
    • higher for ages 6 to 9 than for ages 10 to 12
  • Children ages 7 to 13131
    • 38.9%
    • Habitual snoring 3.5%
    • most commonly between the ages of 7 and 8
  • Children ages 2 to 14 who had a hospital appointment
    • 16% habitual snoring132
  • Children aged 14:
    • 23.2%133
    • 19% (sometimes or often)134
    • Nightmares: 27.88%133
    • Sleepwalking/talking in one’s sleep: 27.7%133
    • Difficulty falling asleep: 40.6%133
  • Children and teens ages 2 to 18: 10%135
  • Adolescents 9.7%62
    • male: 10.4%62
    • Female: 9.1%62
    • with obesity: 18.2%62
    • without obesity: 7.8%62
    • a few nights per month: 20%95
    • every night: 6%95
    • continuously: 1.5 to 6%136

Habitual snoring in elementary school children (ages 4 to 6) was correlated with127

  • Secondhand smoke (odds ratio (OR) = 1.77, +77%),
  • Pets at home (OR = 0.58, 42% decrease)
  • Nitrogen dioxide (NO₂) pollution in winter increases the risk of snoring compared to lower levels of pollution (<30 micrograms/m³)
    • 2.5 times (+150%) at moderate (30–60 µg/m³) NO₂ exposure
    • 4.5 times (+350%) at high exposure levels (>60 µg/m³)

6.6.2.2. Snoring and ADHD Symptoms

Habitual snoring predicted hyperactivity in children 4 years later (+340%, OR 4.4), as did loud snoring (+350%, OR 4.5). The top 25% of snorers had a 5.3-fold increased risk of hyperactivity 4 years later (+430%). Sleepiness was associated with a 3-fold increased risk (+200%), and sleep-related breathing disorders with a 4-fold increased risk (+300%) of hyperactivity 4 years later.137

Among children who snored occasionally or frequently, the prevalence of ADHD was doubled (+100%).134

In contrast, a study of n = 512 snoring children and adolescents (70% of whom were overweight or obese and 35% of whom had an elevated obstructive AHI of more than 3/h) found that among the snoring children138

  • 36% exhibited hyperactivity/impulsivity
  • 24% exhibited emotional dysregulation
  • Surprisingly, it was not the reduced oxygen supply caused by sleep apnea that correlated with hyperactivity/impulsivity or emotional dysregulation, but rather the volume of the snoring

In a large study of children aged 6 to 12, various forms of snoring were associated with a 30% increase in scores for inattention, hyperactivity, and ADHD overall, as measured by the Korean ADHD-RS:139

  • Snoring more than half the time
  • Always snores
  • Loud snoring
  • Heavy or loud breathing

Among children aged 5 to 7 who had not been diagnosed with ADHD and did not exhibit hyperactivity, frequent snoring was associated with140

  • Attention problems
  • Social problems
  • Symptoms of anxiety
  • Symptoms of depression
  • Lower cognitive scores

Children aged 6 to 10 years with habitual snoring who underwent polysomnography (PSG) showed elevated levels of, compared to controls,141

  • Hyperactivity (ADHD Rating Scale)
  • Inattention (ADHD Rating Scale)

ADHD symptoms in children aged 6 to 12 depended on the severity of their snoring:130

  • Children who snore frequently
    • 31.3% attention deficit
    • 18.2% hyperactivity/impulsivity
  • children who occasionally snore
    • 16.2% attention deficit
    • 9.9% hyperactivity/impulsivity
  • children who don’t snore
    • 13.9% attention deficit
    • 8.8% hyperactivity/impulsivity

Children aged 2 to 14 who had a hospital appointment showed:132

  • Hyperactivity: 22% among habitual snorers vs. 12% among non-snorers

The severity of snoring—but not the AHI—correlated in children aged 4 to 10 with142

  • Hyperactivity (CPRS-R)
  • Inattention (CPRS-R)
  • Cognitive abilities (NEPSY, DAS)
  • Internalizing symptoms (CBCL)
  • Externalizing symptoms (CBCL)
  • Understanding instructions (NEPSY)
  • The correlation between snoring and AHI was weak (rs = 0.24).

Among snoring children aged 5 to 7, an AHI of 5 or higher in the NEPSY study was associated with poorer scores in terms of143

  • Inattention
  • Executive function problems

Habitual snoring in children and adolescents was associated with hyperactivity.131144

A study of n = 405 children aged 4 to 9 years found clinically significant hyperactivity in 15.5% of the participants, compared with 5.3% of the controls (+188%). In addition, 11.1% were found to have a high probability of hyperactivity, compared with 4.1% in the control group (+170%).

A study found that children who snored had 43% higher rates of hyperactivity and 25% higher rates of inattention. Both measures improved significantly following an adenotonsillectomy.101

Habitual snoring among elementary school children was associated with:

  • Hyperactivity increases145 by 180%146 by 140% 147
  • Inattention increases145 by 340%146 by 300%147
  • Increased defiant behavior145
  • Behavioral problems are 180% more common 147
  • Emotional problems are 450% more common147
  • Problems with peers are 870% more common 147
  • Daytime sleepiness is 970% more common146
  • UARS/OSA at 25%146
  • poorer academic performance146
    • Mathematics + 160%
    • Natural Sciences + 230%
    • Spelling + 150%

The changes occurred 140% more frequently, regardless of intermittent hypoxia.147 The behavioral problems improved when the snoring stopped.

Among adolescents, frequent snoring was associated with a 130% increased risk of ADHD.148

A study using Mendelian randomization found no statistically significant association between sleep apnea or snoring and ADHD. ADHD was significantly correlated with shorter sleep duration.149

Children with ADHD snored more frequently than those without the condition.150151152

  • 77.8% of children aged 6 to 14 with ADHD who underwent polysomnography snored heavily. Obstructive sleep apnea syndrome (OSAS) was found in 50.0% of them.153
  • 40% of children with ADHD sometimes snored louder than 60 dB, compared with 28% of the control group.154
  • 33% of children with ADHD (DSM-IV) snored, compared with 9% to 11% of those without the condition135
  • According to155, 26.7% of children aged 5 to 13 with hyperkinetic syndrome snored
  • 21% of all children with ADHD (average age 8.9 years) snored.156

Adolescents who had been diagnosed with ADHD (DSM-IV) as children,157

  • and whose ADHD persisted into adolescence, 57.9% snored. Snoring was thus 3.5 times as common as among those without ADHD (+250%)
  • and whose ADHD did not fully persist into adolescence (subclinical ADHD), 43.4% of them snored—2.0 times as often as those without ADHD (+100%)
  • Snoring was thus 80% more common in cases of persistent ADHD than in cases of subclinical ADHD.
  • 28.3% of the inspections that were not affected were suspended

ADHD at age 5 was associated with a 32% higher risk of snoring at age 14.158
Among adolescents aged 10 to 17, 50.7% of people with ADHD-I and ADHD-C snored, compared to 33.2% of people without ADHD159 In contrast, a small study found an increased prevalence of snoring only among people with ADHD-HI.160

Even occasional snoring in children was associated with increased ADHD symptoms.161

After 6 months, methylphenidate improved snoring and bruxism in patients with ADHD-I.162

6.6.2.3. Adenotonsillectomy for Snoring and Changes in ADHD Symptoms

In children who snore, an adenotonsillectomy improved:

  • Attention/concentration by 42%163
  • verbal fluency by 92%163
  • Learning/memory by 38%163
  • executive functions by 52%163
  • general intellectual abilities by 33%163
  • Inattention by 21%163
  • Hyperactivity by 21%163
  • neurocognitive performance does not164

See also under Differential Diagnosis: Primary Organic Disorders

6.6.3. Nasal turbinate constriction (+300%)

Hypertrophy of the inferior turbinate can cause sleep-related breathing disorders (SRBD) and ADHD symptoms.
The inferior turbinates account for up to 50% of the total resistance in the nasal airways.165 Up to 20% of the population suffers from chronic nasal congestion due to turbinate hypertrophy.166
Chronic hypertrophy of the turbinates—often caused by allergic rhinitis (hay fever) or chronic rhinosinusitis—can significantly impair nasal breathing even in the absence of adenotonsillar pathology.167

A retrospective cohort study of n = 326 children aged 3 to 17 years (mean age 9 years, 65% boys) who underwent inferior turbinate reduction (ITR) between December 2020 and May 2023 (either as a standalone procedure or in combination with an adenotonsillectomy, septoplasty, or functional endoscopic sinus surgery) found that 32.5% of the participants exhibited ADHD-like symptoms prior to surgery. Twelve months after surgery, parents of these children reported:167

  • 89.6% improvement in nasal breathing
  • 84.0% resolution of SBAS symptoms
  • A 48.1% improvement in ADHD symptoms, which correlated significantly with an improvement in nasal breathing

Assuming an ADHD prevalence of 8% among children and assuming that ADHD symptoms are equivalent to an ADHD diagnosis, a figure of 32.5% would indicate a 300% increased risk of ADHD.

A study found a significant improvement in sleep quality, but no improvement in ADHD symptoms, following nasal septum surgery (straightening of a deviated nasal septum).168

6.6.4. Enlarged pharyngeal and palatine tonsils (adenotonsillar hypertrophy) (up to +275%)

**Adenotonsillectomy: Surgical removal of the palatine tonsils and pharyngeal adenoids, often due to recurrent infections or enlargement that leads to breathing problems such as obstructive sleep apnea. A common standard treatment for children with moderate to severe sleep apnea syndromes. It can improve breathing problems, behavioral issues, and daytime sleepiness.
**Adenotomy: Surgical removal of only the pharyngeal tonsils (adenoids, childhood polyps)
**Tonsillectomy: Surgical removal of only the palatine tonsils (tonsils, throat tonsils)

Adenotonsillar hypertrophy is the most common cause of SBAS in children.57169
Chronic adenotonsillar hypertrophy can lead to various types of sleep-related breathing disorders, ranging from loud snoring to severe obstructive sleep apnea. Chronic adenotonsillar hypertrophy can disrupt sleep architecture, e.g., through increased arousal during sleep, increased REM sleep latency, reduced REM sleep, and decreased sleep efficiency.
or reduced sleep duration.170171
Enlarged tonsils usually occur especially during the first few years of life and typically—though not necessarily—reduce in size during late childhood.
The loss of nasal function during breathing can contribute to chronic inflammation of the upper respiratory tract.

6.6.4.1. Prevalence of Adenotonsillar Hypertrophy

The prevalence of adenoid hypertrophy in the general population was

  • in children
  • in children and adolescents
    • 49.7% (meta-analysis, k = 17, n = 5,248)173
      • 42.2% Grade 1
      • 70.0% Grade 2
      • 34.5% Grade 3
    • 34.5% in a randomized, representative group173
  • in adults
    • 26.28%, regardless of gender174
      • 14.6% Grade 1
      • 8.2% Grade 2
      • 3.6% Grade 3
  • Tonsillar/adenoid hypertrophy was found in children with ADHD (ages 6 to 12) at175
    • 30.2% of those with sleep disorders
    • 13.8% of those without sleep disorders
6.6.4.2. Adenotonsillar Hypertrophy and ADHD Symptoms

The prevalence of ADHD among children with adenotonsillar hypertrophy was (compared to an estimated prevalence of 8%)

  • 30% (+275%)176
  • 30% (+275%)177
  • 27.1% (+238%)178
  • 26.8% (+235%)179

In a group of n = 35 children aged 5 to 12 years with adenotonsillar hypertrophy and ADHD (DSM-IV), an adenotonsillectomy** Resulted in the following six months after surgery:180

  • 57.8% reduction in ADHD-C (22.9% after surgery compared to 54.3% before surgery).
  • Significantly reduced inattention
  • Hyperactivity significantly reduced
  • significantly reduced combined ADHD symptoms

Children with ADHD aged 6 to 12 had a 2.71-fold increased risk of adenotonsillar hypertrophy.175

Impaired cognitive function and behavior in children aged 6 to 12 correlated with snoring, sleep efficiency, sleep latency, and ethnicity, but not with tonsil size. Snoring correlated more strongly with these deficits than the number of apnea and hypopnea episodes per hour of sleep.181

6.6.4.3. Adenotonsillectomy for Adenotonsillar Hypertrophy

Adenotonsillectomy in Children with ADHD and Adenotonsillar Hypertrophy

  • ADHD was resolved in 50% of patients 6 months after surgery. ODD remained unchanged.176
  • resolved ADHD in 70% of patients 6 months after adenotonsillectomy182
  • reduced (even more pronounced after 6 months than after 3 months):183
    • Oppositional behavior
    • Inattention / cognitive symptoms
    • Hyperactivity
    • Overall ADHD symptoms
  • showed improvement in children with ADHD, as well as in children without ADHD.184
    • Oppositional behavior
    • Inattention / cognitive symptoms
    • Hyperactivity
    • Overall ADHD symptoms
    • In a long-term follow-up, the scores did not worsen 2.4 to 3.6 years after surgery and remained—with the exception of the ADHD total score—significantly better than the scores before surgery.185
  • improved ADHD symptoms to a greater extent than treatment with MPH alone without surgery, with symptoms dropping to nearly the same level as those of people without ADHD after the surgery186
  • significantly improved the scores of children and adolescents with SBAS and ADHD (according to DSM-IV) in 187188179189190
    • Hyperactivity
    • Inattention
    • Total ADHD score

Similarly, 54% of children with enuresis no longer experienced it after the surgery.188

Among 26.3% of children (ages 3 to 7) who underwent an adenotonsillectomy, sleep apnea (AHI greater than 2) was still present one year later.191

6.6.5. Breathing pauses during sleep (sleep apnea, OSA, OSAS) (+100%)

Sleep apnea (obstructive sleep apnea syndrome, OSA, OSAS) is measured using the apnea-hypopnea index (AHI). This index indicates the number of complete breathing pauses (apneas) and partial breathing disturbances (hypopneas) per hour of sleep. An AHI below 5 is considered normal; 5 to 14 indicates mild sleep apnea; 15 to 30 indicates moderate sleep apnea; and an AHI of more than 30 indicates severe sleep apnea.192

6.6.5.1. Prevalence of OSA

The prevalence of sleep apnea in the general population has been estimated at

  • 2 to 4%
  • Children
    • 1.2 to 5.7%193
    • 10%134
    • Maximum between the ages of 2 and 8, which corresponds to the age at which tonsil and adenoid hypertrophy peaks194
  • Adolescents: 2.5 to 6.1%62
    • Ages 30 to 60, SHI of 5 or higher, and daytime hypersomnolence63
      • 2% among women
      • 4% among men
  • average age: 4 to 5%64
  • in some recent studies, 13% among men and 6% among women
  • in people with type 2 diabetes
    • 65% (AHI 5 or higher), 26% with moderate (AHI 15 or higher) or severe OSA195
  • in cases of Down syndrome
    • 66.4%; 30% with an AHI of 10 or higher; 75.7% among children with Down syndrome who snored, but more severe OSA was found in children who did not snore196
    • OSA with an AHI of 1.5 or higher in individuals with Down syndrome was associated with an additional loss of 9 IQ points197

OSA in children with ADHD (ages 6 to 12):175

  • 46.6% of children with ADHD were suspected of having OSA based on a PSQ score greater than 7 (Pediatric Sleep Questionnaire)
  • 23.4% of children with ADHD aged 6 to 12 showed signs of OSA on respiratory polygraphy
    • Compared to an assumed OSA prevalence of 8% in the pediatric population, this represents a 200% increase in OSA risk
  • 93.5% reported clinically significant sleep problems according to the Children’s Sleep Habits Questionnaire (CSHQ)

OSA is associated with hypoxia, arousal episodes during sleep, and negative fluctuations in intrathoracic pressure. The consequences may include e79

  • Strain on the cardiovascular system.
    • peripheral vasoconstriction
    • intermittent increases in blood pressure (increased blood pressure variability)
    • increased heart rate
    • reduced heart rate variability
    • Treatment of OSA improves cardiovascular factors.79
  • Activation of the sympathetic nervous system
    • elevated urinary catecholamine levels
  • increased oxidative stress
  • systemic inflammation
  • endothelial dysfunction
  • reduced nocturnal baroreflex gain
    • with consequences of increased fluctuations in blood pressure
  • subclinical abnormalities in heart structure and function that are detectable only by ECG
  • Enuresis
    • improved through OSA treatment
  • Growth restriction
    • Size and Weight
    • improved through OSA treatment
  • Excessive daytime sleepiness
    • improved through OSA treatment
  • Reduced quality of life
    • improved through OSA treatment
  • ADHD (see below)
    • Hyperactivity
    • Inattention
    • cognitive limitations
    • impaired executive functions
    • improved through OSA treatment

The prevalence of insomnia in OSA ranges from 39% to 55%.195

6.6.5.2. ADHD Symptoms in OSA

Sleep-related breathing pauses in children can cause symptoms that resemble ADHD.198
It remains unclear whether sleep apnea can cause enough stress to contribute to ADHD through epigenetic changes, or whether it merely causes symptoms that resemble those of ADHD. In the latter case, people who did not previously have ADHD and who developed ADHD-like symptoms due to sleep apnea would have to see those symptoms disappear completely once the sleep apnea is resolved. To date, we are not aware of any studies on this topic.

Among children with OSA, the prevalence of ADHD was doubled (+100%).134

Children aged 6 to 10 with OSA who had undergone polysomnography (PSG) showed elevated levels of199

  • Hyperactivity (ADHD Rating Scale)
  • Inattention (ADHD Rating Scale)

Among 110 boys aged 6, SBAS was correlated with hyperactivity but not with inattention.200

Children aged 4 to 12 years with mild or moderate OSAHS diagnosed by polysomnography showed, compared to healthy controls,201

  • FIQ, VIQ, and performance IQ (PIQ) scores did not correlate with AHI, OAHI, and the lowest nocturnal SO2 value
  • under 6 years old
    • significantly lower scores on the full-scale IQ (FIQ), verbal IQ (VIQ), comprehension test, and visual analysis test
    • The cumulative time with SO2 levels below 90% (p = 0.046) and the percentage of cumulative time with SO2 levels below 90% during total sleep time (p = 0.034) were significantly negatively correlated with the PIQ
  • Starting at age 6, significantly lower IQ and classification test scores in children with OSAHS

Children with ADHD have a significantly higher AHI (apnea-hypopnea index). (METASTUDY, k = 16, n = 1,360)202 A case study of three adults with ADHD and OSA drew attention to this issue early on.203

Children with ADHD but without OSA, aged 6 to 13, showed normal sleep patterns on polysomnography.204

Compared to children with OSA but without ADHD, children with both OSA and ADHD showed:205

  • Elevated AHI values
  • Increased blood oxygen saturation
  • Increased IL-4
  • Increased IL-12
  • Elevated IL-13
  • transforming growth factor (TGF)-β significantly lower
  • Elevated dopamine levels (presumably peripheral)
  • Norepinephrine levels significantly lower (presumably peripheral)
  • Elevated serum leptin levels
  • Adiponectin decreases
  • Reduces resistin

6.6.5.3. Adenotonsillectomy for OSA and Changes in ADHD Symptoms

Children with OSA due to grade 3 and 4 adenotonsillar hypertrophy exhibited cognitive impairment (lower NESPY score). An adenotonsillectomy improved these outcomes and reduced serum cytokine levels of tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and IL-1β. Lifestyle interventions were effective in cases of mild OSAS and minimal cognitive impairment and improved the outcomes of adenoidectomy prior to surgery. Among the participants, 33.5% were overweight and an additional 55.8% were obese. Tonsillar hypertrophy was grade 4 in 27.7%, grade 3 in 44.2%, grade 2 in 27.2%, and grade 1 in 0.9%. Adenoid hypertrophy was grade 0 in 5.4%, grade 1 in 5.7%, grade 2 in 41.1%, grade 3 in 36.2%, and grade 4 in 11.5%. Neither tonsillar hypertrophy nor adenoid hypertrophy correlated statistically significantly with the OSA AHI score. Severe OSA was associated with a tendency toward increased adenoid hypertrophy.206 Of the 181 patients with grade 3 or 4 adenotonsillar hypertrophy, 19 underwent adenoidectomy, 76 underwent tonsillectomy, and 86 underwent adenotonsillectomy. A tonsillectomy or adenotonsillectomy was required significantly more often in cases of severe OSA. Cognitive performance (NEPSY score) was significantly worse before treatment in patients with severe OSA than in those with mild OSA. At follow-up, cognitive performance improved in 76.7% of patients with mild OSA, 84.1% with moderate OSA, and 87.8% with severe OSA.
The reduced serum levels of inflammatory cytokines suggest that OSA plays a role in inflammatory processes.

In children aged 5 to 9 years with an OAI (apneas per hour of sleep) of 1 to 20 or an AHI (apneas or hypopneas per hour of sleep) of 2 to 30, adenotonsillectomy was associated with slight improvements (SMD Cohen’s d, 0.20 to 0.24) with respect to207

  • nonverbal thinking
  • Fine motor skills
  • selective attention

A study of children with OSA without prolonged desaturation of blood oxygen levels found that early adenotonsillectomy, compared with a watch-and-wait approach with supportive treatment, resulted in a trend toward (SMD 0.15), but not statistically significant improvement in attention and executive function scores on the Developmental Neuropsychological Assessment. However, compared to a watch-and-wait approach, early adenotonsillectomy correlated with significantly greater improvements in:77

  • Behavior
  • Quality of life
  • polysomnographic findings (79% normalization compared to 46%)
  • ADHD symptoms (SMD 0.28 on the parent rating and SMD 0.29 on the teacher rating of the Conners Rating Scale)

Children with OSA showed

  • Before an adenotonsillectomy

    • Significantly poorer cognitive performance compared to the control group; postoperatively, there was no longer any difference in the scores.208
  • After an adenotonsillectomy

    • A statistically insignificant trend toward higher scores on the Homework Performance Questionnaire (HPQ-P).209
    • Moderate improvement in executive functions210
    • Attention moderately improved210
    • Moderate improvement in motor skills210
    • Moderate improvement in internalizing behaviors (parent report)210
    • moderate improvement in externalizing behaviors (parent report)210

Among 52 children with OSA (age 7.1; 2.5–14.9 years) (AHI 16.2; 5.0–88.0), mean BASC-t scores for all behavioral scales and composites exceeded 50 prior to adenoidectomy and tonsillectomy. Following the procedure, significant improvements were observed for:211

  • Aggression
  • Atypicality
  • Depression
  • Hyperactivity
  • Somatization

Elevated levels of IL-6, IL-8, IL-17, IL-18, MIF, Hs-CRP, TNF-α, PAI-1, and leptin were found to correlate with OSA; of these, only IL-18 did not also correlate with BMI, whereas IL-23 additionally correlated with BMI.212

Children aged 6 to 12 with a low AHI (1 to 4) showed no statistically significant impairments in neuropsychological functions (intelligence, verbal and nonverbal reasoning, attention, executive functions, memory, processing speed, and visuomotor skills).213

6.6.5.4. Risk Factors for OSA

The STOP-BANG questionnaire provides a rough risk assessment for obstructive sleep apnea.

  1. Do you snore loudly (louder than when you speak, or loud enough to be heard through a closed door)?
  2. Do you often feel tired or sleepy during the day?
  3. Has anyone ever noticed that you stop breathing while you sleep?
  4. Are you currently being treated for high blood pressure, or have you been treated for it in the past?
  5. BMI greater than 35 kg/m² (BMI = weight in kg / (height in m) x (height in m))
  6. Are you over 50?
  7. Neck circumference greater than
    • 40 cm for women
    • 43 cm for men
  8. Gender: Male

If you answer “yes” to 3 of these questions, you have a 50% risk of OSA.126
The more “yes” answers you give, the more strongly we recommend undergoing a polygraph test (using a home testing device).
Polysomnography (sleep lab) is performed only in the second step.

6.6.5.5. Treatment Options for OSA

There are various treatment options for OSA:126

  • Sleep Mask (Standard Treatment)
    • After 3 years, half of OSA patients stop using a sleep mask.
  • Nighttime mandibular advancement splint (covered by insurance only if the mouthguard does not work)
    • Pushes the lower jaw forward
  • Tongue pacemaker (not covered by insurance, expensive)
  • Position sensors that prevent the patient from lying on their back
    • It seems to be just as effective as a sleep mask
  • Medications (currently only in research; not yet in clinical use)
  • Weight Loss
    • GIP/GLP-1 receptor agonist: 20% weight loss after 52 weeks + AHI reduced by 25 to 30214

6.6.6. Upper Airway Resistance Syndrome (UARS)

While OSA is characterized by apneas (breathing pauses) and hypopneas (reduced breathing depth) that last more than 10 seconds (2 to 3 breaths) and are often accompanied by a drop in blood oxygen levels and an increase in CO2, upper airway resistance syndrome (UARS) is associated with shorter breathing pauses.56

Boys are affected more often because testosterone leads to muscle growth. While the craniofacial skeleton develops in early childhood, testosterone-induced muscle growth—including that of the tongue and throat muscles—does not begin until puberty, within a spatial structure that has already been defined by the bone structure.
In addition to a genetic predisposition, increased nasal resistance is influenced by various environmental factors:56

  • Allergies
  • Infections
  • abnormal enlargement of the nasal lymphatic tissue (which, in turn, is exacerbated by allergies and infections of the respiratory tract or ears)

In newborns, the following symptoms appear:56

  • increased respiratory effort, lasting longer than four breaths, as measured by the rate of exhalation
  • a sudden increase in respiratory effort accompanied by a negative peak end-expiratory effort, immediately followed by a cessation of diaphragmatic movement for two or more breaths. These are not central apneas, but rather a response to the sudden increase in respiratory effort
  • an abrupt increase in respiratory rate of 4 or more breaths without an increase in respiratory effort. The increase in respiratory rate serves to compensate for the decrease in
    Tidal volume
  • These events occur without a significant decrease in oxygen saturation (pulse oximeter) or oxygen tension (transcutaneous P o 2 electrode)

In infants, the following symptoms appear:56

  • more pronounced nighttime symptoms
  • Possible difficulty sleeping through the night; crying upon waking at night
  • Thumb-sucking can promote a change in tongue position; the combination of pressure and suction can reduce the initial resistance to inhalation, especially
    when breathing through the mouth
  • less commonly, talking in one’s sleep
  • Restless sleep
  • Night sweats, the severity of which correlates with fluctuations in nasal resistance
  • The head may be hyperextended
  • Sleeps on her stomach more often, sometimes every night with her knees tucked under her stomach and her bottom raised
  • breathing through the mouth, at least some of the time
  • occasional snoring
  • Enuresis is possible
  • A long head with a narrow jaw favors UARS

Often accompanied by:

  • more frequent earaches
  • frequent respiratory infections
  • Respiratory allergies

Behavioral problems can be a consequence of this age:56

  • Attention problems
  • Hyperactivity
  • rebellious behavior
  • unexplained aggression toward peers
  • significant shyness
  • Anxiety

In school-age children and teenagers, the following symptoms appear:56

  • common:
    • Hyperactivity
    • Attention Disorders
    • Poor academic performance
    • occasional daydreaming (teacher’s report)
    • Daytime sleepiness
    • Normal weight to underweight
  • possible:
    • Drowsiness
    • Difficulties with peers
    • Aggressiveness
    • mild autonomic dysfunction
      • cold hands and/or feet
      • Dizziness or lightheadedness when bending over or standing up suddenly

.

  • Sleep patterns:
    • frequent snoring
    • continuous movements
    • Difficulty getting up in the morning
      • Teenagers are often hard to wake up in the morning
        • late for school / for training
        • shifted circadian rhythm (eveningness)
        • Daytime sleepiness
        • Exhaustion at the end of the day
        • Anxiety during the day
    • night sweats
    • morning headaches
    • Enuresis
    • Conversations in Sleep
    • Sleepwalking
      • especially among teenagers
      • sometimes accompanied by nightmares or sleep disturbances
    • Teeth grinding

Treatment options for children:
- Tonsillectomy
- adenoidectomy, if necessary
- Orthodontic treatment, if necessary:
- slow maxillary distraction
- maxillary and/or mandibular expansion
- Braces
- Removing wisdom teeth in cases of a narrow jaw

6.7. Gastroesophageal Reflux (+248%)

Gastroesophageal reflux disease (GERD) increased the risk of ADHD between the ages of 3 and 5 (HR = 3.48) (registry study, n = 631,695).215
ADHD increases the risk of GERD.216

It is not clear from the abstract whether the study actually deals with GERD in the children themselves. We have not yet been able to access the full text of the study.

6.8. Anorectal malformations (+200%)

Anorectal malformations are congenital abnormalities of the anal canal and are associated with an increased risk of ADHD, depression, and anxiety disorders.217

  • A threefold increased risk of ADHD and ASD218
  • ADHD medications are prescribed 2.26 times as often218

6.9. Febrile seizures (+168%)

According to clinical and animal studies, febrile seizures have harmful effects on neurodevelopment, which can lead to ADHD, increased susceptibility to epilepsy, hippocampal sclerosis, and cognitive decline in adulthood.219
Febrile seizures in children increased the risk of ADHD by

  • 168% (91% unadjusted) (meta-analysis, k = 12, n = 958,082)220
  • 66%221
  • 28%222

6.10. D-3 deficiency (+157%)

A meta-analysis of 10,334 children and adolescents found a 2.57-fold increased risk of ADHD in cases of vitamin D3 deficiency (between 10 and 30 mg/nl in blood plasma).223

Comprehensive information on vitamin D3 at Vitamin D In the article Vitamins for ADHD in the section Vitamins, Minerals, and Dietary Supplements for ADHD in the chapter Treatment

6.11. (Untreated) Type 1 diabetes (+145% to +719%)

People with type 1 diabetes were found to have an increased risk of ADHD:224

  • 8.19-fold increased risk of ADHD (HR = 8.19)225
  • A 2.45-fold increased risk of ADHD among untreated participants in a study of people with ADHD, both those treated with and those not treated with an insulin pump, in which ADHD was considered a risk factor for inconsistent diabetes management226
  • 1.68 times the risk of ADHD (4.2% vs. 2.5%)227
  • Among people with type 1 diabetes, 15.9% had a prior ADHD diagnosis, and an additional 31.9% met the ADHD criteria of the ASRS.228 Assuming an ADHD prevalence of 8%, this would represent a doubling (+100%). However, the participants were those who had responded to the ASRS that was sent to them, so a bias toward an inflated ADHD rate is to be expected here.
  • Children with diabetes have a higher prevalence of ADHD, ASD, seizures, and depression, as well as a tendency toward lower IQ scores and poorer academic performance229

A study found no evidence of a causal link between autoimmune diseases such as type 1 diabetes and ADHD.230

In addition to regulating blood sugar levels, insulin also plays a role in the brain:229

  • acts on the IR in brain astrocytes, which affects dopaminergic signaling and can thus modulate cognition and mood
  • increases the number of NMDAR channels in the cell membrane through regulated exocytosis
    • NMDARs regulate the influx of calcium ions into the cell and trigger long-term potentiation (LTP), which is associated with learning and memory processes
  • affects the activity of AMPA receptors in the hippocampus
    • This leads to LTD in the CA1 region, which downregulates the receptor—a process that is important for memory consolidation and flexibility
  • affects brain development
    • regulates the proliferation, differentiation, and growth of neurites231
  • responsible for memory consolidation
  • increases GABA receptors in the hippocampus
  • Insulin deficiency leads to diabetic neurological complications in older adults and children
  • Insulin activates phosphatidylinositol (PI)-3-kinase, which increases the externalization of DAT to the membrane surface. Chronic hypoinsulinemia, such as that seen in diabetes, appears to reduce the amount of DAT available on the cell surface.232 This increases extracellular dopamine and, to the best of our understanding, is likely to reduce phasic dopamine, since less dopamine enters the cell to be stored in vesicles and released in response to signals.

6.12. Premenstrual Syndrome (PMS) / Premenstrual Dysphoric Disorder (PMDD) (+143%)

A study of 290 women with severe PMD/PMDD found increased risks for:233

  • ADHD: 2.43 times (+143%)
  • AuDSH: 3.27 times (+227%)

The risk of ASD without ADHD remained unchanged.

6.13. Dystrophinopathy (muscular dystrophy, muscle weakness) (+130%)

See the section below on Monogenic Causes of ADHD.

6.14. Atopic disorders (excess immunoglobulin E)

Atopy is a genetic predisposition to have hypersensitive (allergic) reactions to environmental substances that are otherwise harmless.

In children with low birth weight, a history of type 2 inflammatory diseases such as asthma and atopic dermatitis increased the risk of:234

  • ADHD by 81%
  • Learning disability by 74%
  • ASS by 47%
  • intellectual disability of 35%

Atopic disorders were associated not only with an increased risk of ADHD but also with the severity of ASDHS symptoms.235

6.14.1. Respiratory allergies (+83% to 108%)

For the percentages in the headline, the lowest and highest results were omitted because there were a sufficient number of studies.

Children with an allergy to respiratory medications had an ADHD prevalence of 12.16% compared with 7.63% among children without such an allergy. After adjusting for covariates, the increased risk was +50%.236

Allergic rhinitis increased the risk of ADHD

  • 3.96 times higher (+296%, OR 3.96). (Meta-analysis, k = 2, n = 132,561)237
  • 2.08 times (+108%)238
  • 1.83 times higher (+83%; meta-analysis, k = 18, n = 4,289,444)239
    • Women are 1.86 times more likely than men (+86%)
    • Children up to age 8 are 1.75 times more likely to be affected than older children (+75%)
    • ASS: 1.90-fold risk (+90%)

ADHD increased the risk of allergic rhinitis

  • 1.85 times higher (+85%, OR 1.84) (meta-analysis, k = 10, n = 397,799)237
  • a 1.38-fold increase across all studies (+38%; meta-analysis, k = 18, n = 4,289,444)239
    • Women compared to men: an additional +86% (meta-analysis, k = 18, n = 4,289,444)239
    • Children up to age 8 compared to older children: an additional +75% (meta-analysis, k = 18, n = 4,289,444)239
    • a 1.90-fold increase in a cohort study (+90%; meta-analysis, k = 18, n = 4,289,444)239
  • a 1.27-fold increase (+27%) in a genetic association study240
  • Allergic rhinitis was found in children with ADHD (ages 6 to 12) at175
    • 26.6% of those with sleep disorders
    • 13.8% of those without sleep disorders

A systematic review (k = 21 meta-analyses, n = 348,405,029) found, with highly suggestive evidence (Class II), that allergic rhinitis (hay fever) increased the risk of:241
- for tic disorders, by 161% (OR 2.61)
- for sleep disorders, by 171% (OR 2.17)

6.14.2. Food allergies (+72%)

A food intolerance is a reaction of the digestive system, whereas a food allergy is a reaction of the immune system.
Food allergies are part of the atopic spectrum.242

Children with a food allergy had an ADHD prevalence of 12.66% compared with 7.99% among children without such an allergy. After adjusting for covariates, the increased risk was +72%.236

Food allergies may mediate behavioral abnormalities via the microbiota-gut-brain axis (MGBA), specifically through the gut microbiota and amino acid metabolites.243 People with food allergies exhibit different microbiome profiles compared to those without food allergies. Microbial interventions can support the restoration of gut microbiome structure, e.g.:244

  • Nutrition
  • Probiotics (live microorganisms such as bacteria and yeasts)
  • Prebiotics (indigestible dietary fiber)
  • Synbiotics (a combination of probiotics and prebiotics)
  • Fecal transplant245246

6.14.3. Atopic eczema (+72%)

Eczema increased the risk of ADHD by a factor of 1.72 (+72%).238

6.14.4. Skin allergies (+65%)

Children with a skin allergy had an ADHD prevalence of 11.46% compared with 7.83% among children without such an allergy. After adjusting for covariates, the increased risk was +65%.236

6.14.5. Asthma (+34% to +62%)

While respiratory allergies affect the upper respiratory tract, allergic asthma affects the lungs.

A systematic review (k = 21 meta-analyses, n = 348,405,029) found that asthma increases the risk of ADHD by 34% (OR 1.34), based on convincing evidence (Evidence Class I).241
Based on highly suggestive evidence (Class II), asthma increased the risk of

  • Depression by 64% (OR 1.64)
  • Anxiety by 95% (OR 1.95)
  • tic disorders by 90% (OR 1.90),
  • Suicidal thoughts: 52% (OR 1.52)
  • Suicide attempts: 60% (OR 1.60)
  • Asthma was found in children with ADHD (ages 6 to 12) at175
    • 10.7% of those with sleep disorders
    • 5.3% of those without sleep disorders

A large study found an association between ADHD and asthma in children of +79% before and +62% after adjusting for all covariates. ADHD causally increased the risk of asthma in children by 27%.247
Children with bronchial asthma are more likely to have ADHD (SMD 0.29; meta-analysis, k = 7, n = 104,975).248

A genetic association study found no causal increase in the risk of ADHD due to asthma.240

6.14.6. Neurodermatitis / atopic dermatitis (+11.6% to +28%)

The highest and lowest values were excluded when calculating the figures in the headline.

Neurodermatitis / atopic eczema / atopic dermatitis in childhood is associated with an increased risk of ADHD.249

A systematic review (k = 21 meta-analyses, n = 348,405,029) found, with highly suggestive evidence (Class II), an increased risk in patients with atopic dermatitis241

  • for ADHD, by 28% (OR 1.28)
  • for depression, by 60% (OR 1.60)
  • for anxiety by 62% (OR 1.62)
  • for suicidal thoughts, by 44% (OR 1.44)

A study conducted in Saudi Arabia among people with atopic dermatitis found a prevalence of ADHD of 20.9% among children and 18.9% among adults. Atopic dermatitis was not correlated with the severity of ADHD symptoms.250

A study found evidence that a predisposition to atopic dermatitis causally increases the risk of ADHD (+11.6%) and ASD (+13.1%). Conversely, a predisposition to ADHD (+11.2%) and anorexia nervosa (+10%) was associated with an increased risk of atopic dermatitis. Only the causal relationship between AD and ASD was independent of bias caused by the reverse effect.251
In cases of urticaria, the risk of ADHD increased by 9%.252

People with ADHD had a 45% increased risk of atopic dermatitis (OR = 1.45).
People with atopic dermatitis had a 34% to 42% increased risk of ADHD (OR = 1.34; HRs = 1.42); in cases of severe atopic dermatitis, the risk of ADHD was 162% higher (OR = 2.62); by 189% in cases of multiple allergic conditions (OR = 2.89), and by 143% in cases of atopic dermatitis with concurrent sleep disorders (ORs = 2.43). (Meta-analysis, k = 49)253

In contrast, a cohort study found no significant (+2%) increase in the risk of ADHD among children with atopic dermatitis.254
A cohort study of n = 69,732,807 people found an increased risk of learning difficulties (OR = 1.77) and memory problems (OR = 1.69) among individuals with atopic dermatitis.
The increase in risk was unevenly distributed: Among children with neurodevelopmental disorders such as ADHD, the risk of memory or learning difficulties was 2 to 3 times higher. In contrast, among children without neurodevelopmental disorders, atopic dermatitis did not alter the risk of learning or memory difficulties.255

6.15. Hyperthyroidism / Overactive Thyroid (+70%)

A study found that the prevalence of ADHD was 1.7 times higher among children with hyperthyroidism.256
Children with ADHD showed

  • significantly higher T4 levels (total thyroxine).257
  • Significantly reduced FT4 (free thyroxine) and TT3 (total triiodothyronine) levels (meta-analysis, k = 12, n = 11,836)258, Children with ASD showed reduced FT4 and unchanged TT3.

Hyperthyroidism can cause ADHD-like symptoms, including anxiety, nervousness, irritability, and physical hyperactivity. One study found a correlation between elevated TSH levels and hyperactivity in ADHD.259

Hyperthyroidism can cause inattention and hyperarousal, among other cognitive deficits. Depending on the severity of hypothyroidism, the cognitive effects can range from mild impairments in memory and attention to full-blown dementia.260261

The THRA gene encodes the thyroid receptor alpha (TRα1), while the TRHB gene encodes the thyroid receptor isoforms TRβ1 and TRβ2.
The pituitary hormone TSH (thyroid-stimulating hormone) stimulates the thyroid gland to produce thyroxine (T4; prohormone) and subsequently triiodothyronine (T3). The thyroid hormones (T3 and T4) in the blood, in turn, regulate the pituitary release of TSH within the hypothalamic-pituitary-thyroid axis, which is mediated by the receptor isoform TRβ2.
In cases of (rare, genetically determined) resistance to thyroid hormone β, this negative feedback loop—which stabilizes TH levels in the blood—is disrupted. This leads to elevated TH levels and unsuppressed—i.e., normal—TSH levels.262

One cause of hyperthyroidism is Graves’ disease. The prevalence of Graves’ disease in the United States was reported in 1972 to be between 0.02% and 0.4%, with children accounting for 5% of cases.263 Today, in countries with adequate iodine intake, the prevalence is estimated to be 2% to 3% among women and 0.2% among men. Most cases occur between the ages of 30 and 60. Other sources report that the highest incidence occurs between the ages of 11 and 15.264
There is evidence of an increased risk of ADHD in patients with Graves’ disease.265266 267 A small study reports a twofold increase in ADHD prevalence.268 A medical practice reports hyperactivity in 85% of the people with ADHD (n = 21), which subsided in 20 of them following treatment for hyperthyroidism.263

For information on the effects of abnormal thyroid hormone levels during pregnancy, see Prenatal Stressors as Environmental Causes of ADHD

6.16. Nutrition and Food Intolerances

6.16.1. High-sugar diet (+41%)

A diet high in refined sugar and saturated fats during childhood increased the risk of ADHD by 41%, while a healthy diet reduced the risk of ADHD by 35%. (Meta-analysis, k = 14 studies)269 Compared to a healthy diet, an unhealthy diet therefore increases the risk by 117%.

A study found a correlation between sugar intake at 30 months and the risk of ADHD, sleep disorders, and anxiety. No correlation was found at 12 months of age.270
In an Egyptian study, a child’s daily consumption of sweets was associated with a 6.82-fold increased risk of ADHD (+582%).271 It remains unclear whether this represents a causal relationship or a consequence of altered food preferences resulting from a predisposition to the disorder.

6.16.2. Highly processed foods (up to +25%)

A high percentage of highly processed foods in children aged 3 to 4 increased the risk of ADHD at ages 12 to 13 by 25% (RR 1.25).272

6.16.3. Commercially packaged pasta

Children who consumed commercially packaged pasta three times or more per week were found to have a 57-fold increased risk of ADHD.271
It remains unclear whether this is related to the ingredients in commercially packaged pasta in Egypt, to food preferences resulting from ADHD, or to the family’s low socioeconomic status.

6.16.4. Unpackaged flour

According to an Egyptian study, the use of unpackaged flour in cooking was associated with a 44-fold increased risk of ADHD.271

6.16.5. Food Intolerances

A food intolerance is a reaction of the digestive system, whereas a food allergy is a reaction of the immune system.

It has been established that ADHD is not caused by any single, specific food, phosphates, or additives.

However, individual food intolerances or allergies are just as much stressors as illnesses, toxins, or psychological stress, and can therefore exacerbate the stress experienced by people with ADHD to the point that symptoms develop. This is not an observation specific to ADHD. For example, in a group of children with schizophrenia-related issues, dietary treatment of an existing gluten intolerance eliminated the schizophrenia symptoms in the affected children.273274 The same was observed in people with ADHD.275

Food additives (in this case: Sun Yellow, Carmoisine, Tartrazine, Ponceau 4R; Quinoline Yellow, Allura Red, sodium benzoate) can cause the release of histamine from circulating basophils. This process is not allergic in nature, i.e., it does not depend on immunoglobulin E. The increased release of histamine can—in individuals who carry certain gene variants encoding histamine-degrading enzymes—exacerbate ADHD symptoms.276

An elimination diet can be helpful in identifying rare food intolerances (which, unlike allergies, cannot be detected through blood tests). However, such a diet is very difficult to implement and adhere to, and is barely possible to follow for younger children. In particular, any potential benefits must be weighed against the sometimes serious social consequences.

In other cases, such a diet can help alleviate symptoms in people with existing food intolerances.

When assessing the effectiveness of diets (and other “desirable” treatment approaches), parents’ evaluations often far exceed what tests or teacher evaluations can confirm.

A systematic review (k = 21 meta-analyses, n = 348,405,029) found, with highly suggestive evidence (evidence class II), an increased risk of ASS by 179% in cases of food allergies (OR 2.79).241

For more information, visit Nutrition and Diet for ADHD.

6.17. Precocious puberty (Pubertas praecox) (+40%)

Among girls with precocious puberty (the onset of sexual maturation before age 8 in girls and before age 9 in boys), the prevalence of ADHD was 13.5%.277

6.18. Surgical procedures under general anesthesia (+25 to 39%)

Anesthesia in childhood is associated with an increased risk of ADHD.278
Children who underwent a single surgical procedure under anesthesia before the age of 5 were 37% more likely to take ADHD medication in later years.279 A Korean cohort study found a 41% increased risk of ADHD as a consequence of general anesthesia in early childhood. In addition, the duration of general anesthesia was correlated with an increased risk of ADHD.280
A study found a 37% increase in the risk of ADHD following a single instance of anesthesia during surgery before the age of 5, and a 75% increase following multiple instances.281
A cohort study of n = 15,072 children, half of whom had received anesthetics between the ages of 0 and 3, found a 39% increased risk of ADHD.The frequency of anesthetic exposure, the duration of exposure, male gender, and surgeries involving the central nervous system were significant risk factors for future ADHD.282
Other studies have reached similar conclusions.283284
A meta-analysis found that general anesthesia in childhood was associated with a 25% increase in the risk of developing ADHD later in life (RR = 1.26).285

  • 38% (RR = 1.38) due to a single general anesthesia lasting no more than 60 minutes during childhood
  • 55% (RR = 1.55) due to a single general anesthesia lasting a maximum of 61 to 120 minutes or more than 120 minutes during childhood
  • 61% (RR = 1.61) after multiple general anesthesias

In contrast, a cohort study in Taiwan found no increased risk of ADHD associated with anesthetics during the first 3 years of life.286

It remains unclear to what extent the likelihood of undergoing surgery under anesthesia is already influenced by the increased risk of accidents among people with ADHD. For more on this, see Consequences of ADHD.

However, there is evidence that general anesthesia using fentanyl and sevoflurane in newborn mice can cause ADHD symptoms—such as ADHD-like behaviors, cognitive impairments, and fine motor skill disorders—as well as disrupt neurogenesis and alter gene expression. These effects could be reduced by prior administration of vitamin K2. Administration of K2 prior to general anesthesia led to significantly different changes in gene expression.287

6.19. Selective immunoglobulin A deficiency (+30%)

Selective immunoglobulin A deficiency was associated with a 30% higher risk of ADHD (OR 1.30) as well as an increased incidence of respiratory and gastrointestinal infections.288.

6.20. Inflammatory Bowel Disease (IBD) (+20%)

Inflammatory bowel disease (IBD) is associated with an increased risk of ADHD and higher use of stimulants.289
People whose IBD began in childhood had an increased risk of290

  • ADHD: +20%
  • ASS: +40%
  • Psychiatric disorders overall: +60%
  • Anxiety disorders: +90%
  • Affective disorders: +60%
  • Eating disorders: +60%
  • Personality disorders: +40%
  • Suicide attempts: +40%

A study found no significant increase in ADHD associated with IBD overall, but did find an increase associated with Crohn’s disease (CD) (+6.5%) and ulcerative colitis (UC) (+5%).291

A study of individuals with childhood-onset IBD found a 25% reduced risk of MPH use. Ulcerative colitis was associated with a 37% reduced risk of MPH use and—although not statistically significant—a reduced risk of an ADHD diagnosis. The risk of depression was 50% higher in people with IBD and 73% higher in people with both IBD subtypes (Crohn’s disease and ulcerative colitis).292

Some studies suggest that IBD in the mother during pregnancy can cause inflammation in the central nervous system, which increases the risk of ADHD in her children.293

6.21. Antihistamines in Early Childhood

A large cohort study found that taking antihistamines (especially first-generation antihistamines) during the first years of life significantly increased the risk of developing ADHD later on. A disorder of REM sleep was cited as a possible cause, which in turn impairs brain maturation.294

6.22. Lack of sleep

Short sleep duration was associated with an increased risk of anxiety, attention-deficit/hyperactivity disorder, and emotional and psychological conditions that limit daily functioning, after adjusting for ethnicity, deprivation, age, and gender.295
Ethnicity and socioeconomic disadvantage in the neighborhood were independently associated with short sleep duration and snoring or noisy breathing during sleep.
Long sleep duration was independently associated with an increased risk of depression.

6.23. Acne vulgaris

A study found moderately elevated levels of the following in adolescents (ages 12 to 17) with acne vulgaris:296

  • Hyperactivity
  • Hyperactivity/Impulsivity
  • Inattention
  • Total ADHD score

For both acne vulgaris and ADHD, elevated levels of androgens in the womb are thought to be a contributing factor.

6.24. Gut-Brain Axis, Gut Bacteria, Gut Flora

See the section on Gut-Brain Axis

6.25. Polycystic Ovary Syndrome (PCOS)

Women with polycystic ovary syndrome (PCOS) appear to have an increased risk of mental disorders, primarily anxiety disorders and depression, but also ADHD.297
Adolescents with PCOS also showed an increased risk of ADHD.298

6.26. Anabolic-Androgenic Steroids (AAS)

Strength athletes who take anabolic-androgenic steroids are significantly more likely to have ADHD than strength athletes who do not take them.299

6.27. Glucose-6-phosphate dehydrogenase deficiency (G6PD)

Glucose-6-phosphate dehydrogenase (G6PD) deficiency increased the risk of ADHD by 16%.300

G6PD deficiency is an X-linked genetic disorder that affects about 4.9% of the population.
The enzyme glucose-6-phosphate dehydrogenase (G6PD) facilitates the synthesis of nicotinamide adenine dinucleotide phosphate (NADPH) and glutathione (GSH), which are involved in regulating the redox balance. G6PD deficiency leads to reduced GSH levels and, consequently, increased oxidative stress.

G6PD deficiency is usually food-related (favism; a hemolytic reaction to the consumption of fava beans) and is sometimes genetic (more common in the Mediterranean region and the Middle East, and to some extent in Asia and Africa).
G6PD deficiency can cause (especially in children):

  • severe hemolysis
  • Hyperbilirubinemia
  • Jaundice
  • Hearing impairments
  • Behavioral disorders
  • lead to long-term neurological damage
  • increased production of reactive oxygen species (ROS)
    • resulting in the activation of astrocytes and microglia, increased levels of proinflammatory chemokines and cytokines, neuroinflammation, and impaired brain development
  • Imbalance in the antioxidant system
    • which leads to damage to astrocytes, neuronal death, and DNA damage
    • oxidative cell death of leukocytes, myocytes, and other immune cells.

6.28. Lipodystrophy (lack of adipose tissue)

A study found evidence of a significantly increased prevalence of ADHD in patients with lipodystrophy.301

6.29. Lipid Metabolism, Fatty Acids

To avoid repetition, we have included this section under “Fatty Acids, Probiotics, and More for ADHD“ In the chapter “ Treatment: Medications for ADHD, in the section “ : Vitamins, Minerals, and Dietary Supplements for ADHD.

6.30. Gender Diversity

A multinational study found evidence that the frequency and severity of ADHD symptoms were particularly high among individuals with gender-specific differences.302

6.31. Mitochondrial disorder

Mitochondrial dysfunction or mitochondrial disorders are being discussed as a possible cause of ADHD.303304 305 To date, no concrete findings have emerged on this topic.

6.32. Diaphragmatic hernia

Among children with a congenital defect in the diaphragm (diaphragmatic hernia), 26.3%306 to 39%307 of the survivors had problems with sustained attention. 51.9% had a formal diagnosis of ADHD, a specific learning disability, or a developmental disorder.306
If there is a hole in the diaphragm, organs from the abdominal cavity can enter the area around the lungs and interfere with lung development and breathing.
The mechanism underlying ADHD is therefore hypoxia.

6.33. Factors Not Associated with an Increased Risk of ADHD

  • Children with ADHD were found to have a 14% lower prevalence of microcytic anemia (OR: 0.86).308
  • Growing up bilingual did not increase the risk of ADHD309
  • Autoimmune diseases showed no evidence of a causal link between autoimmune diseases and ADHD. The following were examined:230
    • Lupus erythematosus
      • In contrast, a retrospective matched-cohort study (n = 11,144) that a lupus diagnosis 15 years or more after the onset of psychiatric disorders was associated with a 61% higher likelihood of such disorders, and that psychiatric disorders were associated with a 120% increased risk of lupus 10 years or more after their onset. A lupus diagnosis was associated with an increased prescription of, among other things, ADHD medications 10 years prior.310
    • Crohn’s disease
    • Ulcerative colitis
    • Type 1 diabetes (contradictory study: see above)
    • rheumatoid arthritis
    • Psoriasis
    • Ankylosing spondylitis
    • Multiple sclerosis
  • High blood pressure
    • A study found no statistically significant genetic link between high blood pressure and ADHD.311 This finding is contradicted, at least, by the primary ADHD animal model, the SHR, which develops high blood pressure with age.
  • COVID-19 Genetic Testing
    • A genetic predisposition that increases susceptibility to COVID-19 showed no signs of an increased risk of ADHD. Conversely, however, ADHD and Tourette syndrome are associated with an increased risk of COVID-19 and a more severe course of the disease.312
  • T1-weighted/T2-weighted ratio
    • The T1w/T2w ratio is an indicator of intracortical myelin based on magnetic resonance imaging (MRI). No differences in the T1w/T2w ratio were found between the ADHD and ASD groups and the control group.313
  • Obesity
    • After adjusting for confounding factors, no significant causal effect of obesity on ADHD was observed314
  • Platinum- and taxane-based chemotherapy in children315
  • Congenital abdominal wall defect316
    • ADHD risk remains unchanged
    • 3.51-fold increased risk of ASD

6.34. Factors Associated with a Reduced Risk of ADHD

  • The parents’ immigrant status is associated with a reduced risk of ADHD317 within the first two generations.318
  • Lyme disease was associated with a 10% reduction in ADHD prevalence319

  1. DocCheck Flexikon: Infektion

  2. Nudel R, Hougaard DM, Werge T, Benros ME (2023): Genetic and epidemiological analyses of infection load and its relationship with psychiatric disorders. Epidemiol Infect. 2023 May 18;151:e93. doi: 10.1017/S0950268823000687. PMID: 37197974; PMCID: PMC10311684.

  3. Lin MC, Pan YJ, Wu CS, Liu CL, Chen PC, Thompson WK, Fan CC, Wang SH (2025): Prenatal and early childhood infections requiring hospitalization and risk of neurodevelopmental disorders in offspring: a population-based birth cohort study in Taiwan. Mol Psychiatry. 2025 May;30(5):1791-1800. doi: 10.1038/s41380-024-02787-z. PMID: 39390224.

  4. Andersen M, Matthiesen NB, Murra M, Nielsen SY, Henriksen TB (2025): Early-Onset Neonatal Infection and Attention Deficit Hyperactivity and Autism Spectrum Disorder: A Nationwide Cohort Study. Paediatr Perinat Epidemiol. 2025 Sep;39(7):588-597. doi: 10.1111/ppe.70036. PMID: 40528692; PMCID: PMC12574489. n = 981.869

  5. Hsu TW, Chu CS, Tsai SJ, Bai YM, Su TP, Chen TJ, Chen MH, Liang CS (2022): Risk of Major Mental Disorder after Severe Bacterial Infections in Children and Adolescents: A Nationwide Longitudinal Study. Neuropsychobiology. 2022;81(6):539-549. doi: 10.1159/000526984. PMID: 36404700. n = 14.024

  6. Feigenson KA, Kusnecov AW, Silverstein SM (2014): Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehav Rev. 2014 Jan;38:72-93. doi: 10.1016/j.neubiorev.2013.11.006. PMID: 24247023; PMCID: PMC3896922. REVIEW

  7. Graham EE, Tetens MM, Bodilsen J, Dessau R, Ellermann-Eriksen S, Andersen NS, Jørgensen CS, Pedersen M, Søgaard KK, Bangsborg J, Nielsen AC, Møller JK, Obel D, Lebech AM, Nygaard U, Omland LH, Obel N (2024): Risk of psychiatric neurodevelopmental disorders after meningitis in childhood: a nationwide, population-based cohort study. Infect Dis (Lond). 2024 Sep 4:1-11. doi: 10.1080/23744235.2024.2399101. PMID: 39230517. n = 20.300

  8. Wait JW, Stanton L, Schoeman JF (2002): Tuberculosis meningitis and attention deficit hyperactivity disorder in children. J Trop Pediatr. 2002 Oct;48(5):294-9. doi: 10.1093/tropej/48.5.294. PMID: 12405172. n = 42

  9. Wait JW, Schoeman JF (2010): Behaviour profiles after tuberculous meningitis. J Trop Pediatr. 2010 Jun;56(3):166-71. doi: 10.1093/tropej/fmp080. PMID: 19710247.

  10. Mynarek M, Vik T, Andersen GL, Brigtsen AK, Hollung SJ, Larose TL, Lydersen S, Olsen LC, Strøm MS, Afset JE (2023): Mortality and neurodevelopmental outcome after invasive group B streptococcal infection in infants. Dev Med Child Neurol. 2023 Jun 12. doi: 10.1111/dmcn.15643. Epub ahead of print. PMID: 37306102.

  11. Wilson, Thomas (2022): Peridontitis as a Risk Factor for Attention Deficit Hyperactivity Disorder: Possible Neuro-inflammatory Mechanisms. Neurochem Res. 2022 Jun 28. doi: 10.1007/s11064-022-03650-9. PMID: 35764847.

  12. Lavebratt, Yang, Giacobini, Forsell, Schalling, Partonen, Gissler (2019): Early exposure to antibiotic drugs and risk for psychiatric disorders: a population-based study. Transl Psychiatry. 2019 Nov 26;9(1):317. doi: 10.1038/s41398-019-0653-9. n = 1 Mio.

  13. Oh J, Woo HG, Kim HJ, Park J, Lee M, Rahmati M, Rhee SY, Min C, Koyanagi A, Smith L, Fond G, Boyer L, Kim MS, Shin JI, Lee SW, Yon DK (2024): Prenatal and infant exposure to antibiotics and subsequent risk of neuropsychiatric disorders in children: A nationwide birth cohort study in South Korea. Psychiatry Res. 2024 Oct;340:116117. doi: 10.1016/j.psychres.2024.116117. PMID: 39128166. n = 3,2 Mio infants, 2,3 Mio mothers

  14. Li Lin CY, Huang YJ, Lin HC, Tsai ML, Ku JT, Lee FC, Chang H (2025): Increased incidence of attention-deficit/hyperactivity disorder is associated with early and prolonged exposure to antibiotics: A population-based retrospective cohort study. Pediatr Neonatol. 2025 Jun 5:S1875-9572(25)00101-9. doi: 10.1016/j.pedneo.2025.03.008. PMID: 40527658. n = 195.890

  15. Slykerman, Thompson, Waldie, Murphy, Wall, Mitchell (2017): Antibiotics in the first year of life and subsequent neurocognitive outcomes. Acta Paediatr. 2017 Jan;106(1):87-94. doi: 10.1111/apa.13613. n = 526

  16. Hamad, Alessi-Severini, Mahmud, Brownell, Kuo (2019): Antibiotic Exposure in the First Year of Life and the Risk of Attention-Deficit/Hyperactivity Disorder: A Population-based Cohort Study. Am J Epidemiol. 2019 Sep 5. pii: kwz178. doi: 10.1093/aje/kwz178.

  17. Axelsson, Clausen, Petersen, Hageman, Pinborg, Kessing, Bergholt, Rasmussen, Keiding, Løkkegaard (2018): Investigating the effects of cesarean delivery and antibiotic use in early childhood on risk of later attention deficit hyperactivity disorder. J Child Psychol Psychiatry. 2018 Aug 23. doi: 10.1111/jcpp.12961. n = 671.592 Geburten

  18. Beier MA, Setoguchi S, Gerhard T, Roy J, Koffman D, Mendhe D, Madej J, Strom BL, Blaser MJ, Horton DB (2025): Early childhood antibiotics and chronic pediatric conditions: a retrospective cohort study. J Infect Dis. 2025 Apr 16:jiaf191. doi: 10.1093/infdis/jiaf191. PMID: 40237450.

  19. Borrego-Ruiz A, Borrego JJ (2024): Neurodevelopmental Disorders Associated with Gut Microbiome Dysbiosis in Children. Children (Basel). 2024 Jun 28;11(7):796. doi: 10.3390/children11070796. PMID: 39062245; PMCID: PMC11275248. REVIEW

  20. Green JE, Wrobel A, Todd E, Marx W, Berk M, Lotfaliany M, Castle D, Cryan JF, Athan E, Hair C, Nierenberg AA, Jacka FN, Dawson S (2025): Early antibiotic exposure and risk of psychiatric and neurocognitive outcomes: systematic review and meta-analysis. Br J Psychiatry. 2025 Mar;226(3):171-183. doi: 10.1192/bjp.2024.121. PMID: 39658347. REVIEW

  21. Yang KL, Yen TA, Lin FJ, Hsu CN, Wang CC (2024): Antibiotic use and risk of autism spectrum disorder and attention-deficit/hyperactivity disorder: a population-based cohort study. Child Adolesc Psychiatry Ment Health. 2024 Jul 11;18(1):82. doi: 10.1186/s13034-024-00774-4. PMID: 38992772; PMCID: PMC11241894. n = 2.441.886

  22. Greenlaw C, MacRae R, Wilson-Murphy M (2025): Powassan Virus Encephalitis in Pediatric Patients. J Child Neurol. 2025 Apr 27:8830738251333465. doi: 10.1177/08830738251333465. PMID: 40289568.

  23. Michos AG, Syriopoulou VP, Hadjichristodoulou C, Daikos GL, Lagona E, Douridas P, Mostrou G, Theodoridou M. (2007): Aseptic meningitis in children: analysis of 506 cases. PLoS One. 2007 Aug 1;2(7):e674. doi: 10.1371/journal.pone.0000674. PMID: 17668054; PMCID: PMC1933255.

  24. Fowlkes AL, Honarmand S, Glaser C, Yagi S, Schnurr D, Oberste MS, Anderson L, Pallansch MA, Khetsuriani N. (2008): Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005. J Infect Dis. 2008 Dec 1;198(11):1685-91. doi: 10.1086/592988. PMID: 18959496.

  25. Balestrieri E, Matteucci C, Cipriani C, Grelli S, Ricceri L, Calamandrei G, Vallebona PS (2019): Endogenous Retroviruses Activity as a Molecular Signature of Neurodevelopmental Disorders. Int J Mol Sci. 2019 Nov 30;20(23):6050. doi: 10.3390/ijms20236050. PMID: 31801288; PMCID: PMC6928979. REVIEW

  26. (Chou IC, Lin CC, Kao CH (2015): Enterovirus Encephalitis Increases the Risk of Attention Deficit Hyperactivity Disorder: A Taiwanese Population-based Case-control Study. Medicine (Baltimore). 2015 Apr;94(16):e707. doi: 10.1097/MD.0000000000000707. PMID: 25906098; PMCID: PMC4602682.

  27. Lin HY, Chen YL, Chou PH, Gau SS, Chang LY (2022): Long-term psychiatric outcomes in youth with enterovirus A71 central nervous system involvement. Brain Behav Immun Health. 2022 Jun 1;23:100479. doi: 10.1016/j.bbih.2022.100479. PMID: 35694176; PMCID: PMC9184869.

  28. Goh M, Joy C, Gillespie AN, Soh QR, He F, Sung V (2023): Asymptomatic viruses detectable in saliva in the first year of life: a narrative review. Pediatr Res. 2023 Dec 22. doi: 10.1038/s41390-023-02952-0. PMID: 38135726. REVIEW

  29. Chang LY, Huang LM, Gau SS, Wu YY, Hsia SH, Fan TY, Lin KL, Huang YC, Lu CY, Lin TY (2007): Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med. 2007 Mar 22;356(12):1226-34. doi: 10.1056/NEJMoa065954. PMID: 17377160.

  30. Nozyce, Lee SS, Wiznia, Nachman, Mofenson, Smith, Yogev, McIntosh, Stanley, Pelton (2006): A behavioral and cognitive profile of clinically stable HIV-infected children. Pediatrics. 2006 Mar;117(3):763-70. doi: 10.1542/peds.2005-0451. PMID: 16510656. n = 274

  31. Zeegers I, Rabie H, Swanevelder S, Edson C, Cotton M, van Toorn R (2010): Attention deficit hyperactivity and oppositional defiance disorder in HIV-infected South African children. J Trop Pediatr. 2010 Apr;56(2):97-102. doi: 10.1093/tropej/fmp072. PMID: 19656842.

  32. Dale, Church, Heyman (2003): Striatal encephalitis after varicella zoster infection complicated by Tourettism. Mov Disord. 2003 Dec;18(12):1554-6. doi: 10.1002/mds.10610. PMID: 14673900.

  33. Elmehy DA, Elmansory BM, Gamea GA, Abdelhai DI, Abd-Elsalam SM, Salamah AM, Ata DS, Mahmoud EF, Ibrahim HA, Salama AM (2023): Parasitic infections as potential risk factors for attention deficit hyperactivity disorder (ADHD) in children. J Parasit Dis. 2023 Mar;47(1):82-92. doi: 10.1007/s12639-022-01542-x. PMID: 36910322; PMCID: PMC9998788.

  34. Ogonah MGT, Botchway S, Yu R, Schofield PW, Fazel S (2025): An umbrella review of health outcomes following traumatic brain injury. Nat Ment Health. 2025;3(1):83-91. doi: 10.1038/s44220-024-00356-5. PMID: 39802934; PMCID: PMC11717692. UMBRELLASTUDY

  35. Ornstein TJ, Sagar S, Schachar RJ, Ewing-Cobbs L, Chapman SB, Dennis M, Saunders AE, Yang TT, Levin HS, Max JE (2014): Neuropsychological performance of youth with secondary attention-deficit/hyperactivity disorder 6- and 12-months after traumatic brain injury. J Int Neuropsychol Soc. 2014 Nov;20(10):971-81. doi: 10.1017/S1355617714000903. PMID: 25489810; PMCID: PMC5010863.

  36. Ryan, Catroppa, Ward, Yeates, Crossley, Hollenkamp, Hearps, Beauchamp, Anderson (2022): Association of neurostructural biomarkers with secondary attention-deficit/hyperactivity disorder (ADHD) symptom severity in children with traumatic brain injury: a prospective cohort study. Psychol Med. 2022 Aug 25:1-10. doi: 10.1017/S0033291722002598. PMID: 36004807.

  37. Kaldoja ML, Nadendla KD, Ploetz D, Caldwell CT, Suskauer SJ, Svingos A, Busch TA, Slomine BS (2025): Exploring sex differences in pediatric mild traumatic brain injury: clinical characteristics and recovery patterns of pediatric mTBI patients with non-credible effort. Child Neuropsychol. 2025 Apr 15:1-17. doi: 10.1080/09297049.2025.2492134. PMID: 40235056.

  38. Chang, Hsu, Wu, Huang, Chang, Bai, Chen, Chen (2018): Traumatic Brain Injury in Early Childhood and Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder: A Nationwide Longitudinal Study.; J Clin Psychiatry. 2018 Oct 16;79(6). pii: 17m11857. doi: 10.4088/JCP.17m11857.

  39. Vrijsen JN, Tendolkar I, Onnink M, Hoogman M, Schene AH, Fernández G, van Oostrom I, Franke B (2018): ADHD symptoms in healthy adults are associated with stressful life events and negative memory bias. Atten Defic Hyperact Disord. 2018 Jun;10(2):151-160. doi: 10.1007/s12402-017-0241-x. Epub 2017 Oct 28. PMID: 29081022; PMCID: PMC5973996.

  40. Sanchez EO, Bangasser DA (2022): The effects of early life stress on impulsivity. Neurosci Biobehav Rev. 2022 Jun;137:104638. doi: 10.1016/j.neubiorev.2022.104638. PMID: 35341796; PMCID: PMC9119952. REVIEW

  41. Karayağmurlu, Aytaç, Gülşen (2019): Relationship between otorhinologic trauma and Attention Deficit Hyperactivity Disorder symptoms in children. Int J Pediatr Otorhinolaryngol. 2019 Feb 8;120:89-92. doi: 10.1016/j.ijporl.2019.02.016.

  42. Brown AW, Esterov D, Zielinski MD, Weaver AL, Mara KC, Ferrara MJ, Immermann JM, Moir C (2023): Incidence and risk of attention-deficit/hyperactivity disorder and learning disability by adulthood after traumatic brain injury in childhood: a population-based birth cohort study. Child Neuropsychol. 2022 Oct 24:1-17. doi: 10.1080/09297049.2022.2136645. PMID: 36278854.

  43. Gerschman T, Brooks BL, Mrazik M, Eliason PH, Bonfield S, Yeates KO, Emery CA, Schneider KJ (2023): Are Self-Reported and Parent-Reported Attention Problems and Hyperactivity Associated With Higher Rates of Concussion in Youth Ice Hockey Players? Clin J Sport Med. 2022 Oct 5. doi: 10.1097/JSM.0000000000001080. PMID: 36731042.

  44. Laaksonen J, Ponkilainen V, Möttönen J, Mattila VM, Kuitunen I (2024): Paediatric traumatic brain injury and attention-deficit/hyperactivity disorder medication in Finland: a nationwide register-based cohort study. BMJ Ment Health. 2024 May 30;27(1):e301083. doi: 10.1136/bmjment-2024-301083. PMID: 39093719; PMCID: PMC11141179. n = 128.006

  45. Cortese S, Moreno C (2025): Advancing the evidence base for child and adolescent psychopharmacology. BMJ Ment Health. 2025 Mar 3;28(1):e301634. doi: 10.1136/bmjment-2025-301634. PMID: 40032555; PMCID: PMC11877239.

  46. Almeida MN, Alper DP, Barrero C, Parikh N, Hauc SC, Moscarelli J, Golinko M, Persing J, Swanson J, Alperovich M (2024): Radiographic severity is associated with worse executive function in metopic craniosynostosis. Childs Nerv Syst. 2024 Jun 21. doi: 10.1007/s00381-024-06493-7. PMID: 38904768.

  47. Almeida MN, Alper DP, Long AS, Barrero C, Williams MC, Boroumand S, Glahn J, Shah J, Swanson J, Alperovich M (2023): Risk of ADHD, Autism Spectrum Disorder, and Executive Function Impairment in Metopic Craniosynostosis. Plast Reconstr Surg. 2023 Dec 19. doi: 10.1097/PRS.0000000000011249. PMID: 38113367. n = 60

  48. Ihnat J, Hu KG, Goss J, Allam O, Parikh N, Vassallo M, Mayes L, Persing J, Alperovich M (2025): Long-term neurocognitive and behavioral outcomes in patients with non-syndromic craniosynostosis. Childs Nerv Syst. 2025 Jul 14;41(1):233. doi: 10.1007/s00381-025-06888-0. PMID: 40659876. n = 54

  49. Parikh N, Hu KG, Lewis K, Kauke-Navarro M, Allam O, Goss JA, Ihnat JM, Persing JA, Golinko MS, Alperovich M (2025): Comparison of behavioral outcomes following cranial vault remodeling versus strip craniectomy for non-syndromic sagittal craniosynostosis. Childs Nerv Syst. 2025 Jul 28;41(1):248. doi: 10.1007/s00381-025-06900-7. PMID: 40719882.

  50. Vanderwiel SL, Jones B, Nickels KC, Wong-Kisiel LC, Fine A, Mandrekar J, Wirrell EC (2024): Risk of ADHD in children with childhood absence epilepsy versus controls: A population-based study. Epilepsy Behav. 2024 Dec;161:110143. doi: 10.1016/j.yebeh.2024.110143. PMID: 39515005.

  51. Brabcová DB, Otáhalová A, Kohout J, Suleková M, Mašková I, Bělohlávková A, Kršek P (2025): Quality of life, academic self-concept, and mental health in children with epilepsy: The possible role of epilepsy comorbidities. Epilepsy Behav. 2025 Sep;170:110471. doi: 10.1016/j.yebeh.2025.110471. PMID: 40383004.

  52. Wiesmüller L, Strauch D, Schönberger J, San Antonio-Arce V, Bast T, Schubert-Bast S, Syrbe S, Jacobs J, Klotz KA (2025): Sleep disturbances and health-related quality of life in children with epilepsy: A caregiver survey. Epilepsy Behav. 2025 Oct;171:110613. doi: 10.1016/j.yebeh.2025.110613. PMID: 40768929. n = 304

  53. Teo JH, Lim WC, Wong MS, Lin JB, Han VX, Ng ZM, Thomas T (2025): Comparative clinical outcomes in children with Febrile Infection-Related Epilepsy Syndrome (FIRES). Epilepsy Behav. 2025 Sep;170:110467. doi: 10.1016/j.yebeh.2025.110467. PMID: 40382999.

  54. Perti A, Chaudhury S, Javadekar A, Mishra SR (2025): ADHD in West syndrome. Ind Psychiatry J. 2025 May-Aug;34(2):366-367. doi: 10.4103/ipj.ipj_153_24. PMID: 40861152; PMCID: PMC12373351.

  55. Silvestri R, Gagliano A, Aricò I, Calarese T, Cedro C, Bruni O, Condurso R, Germanò E, Gervasi G, Siracusano R, Vita G, Bramanti P (2009): Sleep disorders in children with Attention-Deficit/Hyperactivity Disorder (ADHD) recorded overnight by video-polysomnography. Sleep Med. 2009 Dec;10(10):1132-8. doi: 10.1016/j.sleep.2009.04.003. PMID: 19527942.

  56. Guilleminault C, Khramtsov A (2001): Upper airway resistance syndrome in children: a clinical review. Semin Pediatr Neurol. 2001 Dec;8(4):207-15. doi: 10.1053/spen.2001.29045. PMID: 11768783. REVIEW

  57. Perez A, Hunter K (2020): Adenotonsillectomy as a treatment for sleep-disordered breathing in children with ADHD. JAAPA. 2020 Oct;33(10):34-39. doi: 10.1097/01.JAA.0000697248.35685.c6. PMID: 32976233. REVIEW

  58. Abtahi S, Witmans M, Alsufyani NA, Major MP, Major PW (2020): Pediatric sleep-disordered breathing in the orthodontic population: Prevalence of positive risk and associations. Am J Orthod Dentofacial Orthop. 2020 Apr;157(4):466-473.e1. doi: 10.1016/j.ajodo.2019.05.015. PMID: 32241353.

  59. Blumer S, Eli I, Kaminsky-Kurtz S, Shreiber-Fridman Y, Dolev E, Emodi-Perlman A (2022): Sleep-Related Breathing Disorders in Children-Red Flags in Pediatric Care. J Clin Med. 2022 Sep 22;11(19):5570. doi: 10.3390/jcm11195570. PMID: 36233440; PMCID: PMC9573712. n = 227

  60. Scalzitti NJ, Sarber KM (2018): Diagnosis and perioperative management in pediatric sleep-disordered breathing. Paediatr Anaesth. 2018 Nov;28(11):940-946. doi: 10.1111/pan.13506. PMID: 30281185. REVIEW

  61. Goodwin JL, Vasquez MM, Silva GE, Quan SF (2010): Incidence and remission of sleep-disordered breathing and related symptoms in 6- to 17-year old children–the Tucson Children’s Assessment of Sleep Apnea Study. J Pediatr. 2010 Jul;157(1):57-61. doi: 10.1016/j.jpeds.2010.01.033. PMID: 20304429; PMCID: PMC2886190.

  62. Fraire JA, Deltetto NM, Catalani F, Beneitez A, Martín L, Fischman D, Orden AB, Mayer M (2021): Prevalence of sleep-disordered breathing among adolescents and its association with the presence of obesity and hypertension. Arch Argent Pediatr. 2021 Aug;119(4):245-250. English, Spanish. doi: 10.5546/aap.2021.eng.245. PMID: 34309300.

  63. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993): The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993 Apr 29;328(17):1230-5. doi: 10.1056/NEJM199304293281704. PMID: 8464434.

  64. Jennum P, Riha RL (2009): Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. Eur Respir J. 2009 Apr;33(4):907-14. doi: 10.1183/09031936.00180108. PMID: 19336593. REVIEW

  65. Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J (2015): Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015 Apr;3(4):310-8. doi: 10.1016/S2213-2600(15)00043-0. PMID: 25682233; PMCID: PMC4404207. n = 3.043

  66. Matsumoto T, Chin K (2019): Prevalence of sleep disturbances: Sleep disordered breathing, short sleep duration, and non-restorative sleep. Respir Investig. 2019 May;57(3):227-237. doi: 10.1016/j.resinv.2019.01.008. PMID: 30827934. REVIEW

  67. Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pépin JL, Peppard PE, Sinha S, Tufik S, Valentine K, Malhotra A (2019): Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019 Aug;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5. PMID: 31300334; PMCID: PMC7007763. METASTUDY

  68. Behr,M, Acker J, Cohrs S. et al. (2018):Prävalenz schlafbezogener Atmungsstörungen bei stationären Patienten mit psychischen Erkrankungen. Nervenarzt 89, 807–813 (2018). https://doi.org/10.1007/s00115-018-0545-x

  69. Gozal D, Kheirandish-Gozal L, Capdevila OS, Dayyat E, Kheirandish E (2008): Prevalence of recurrent otitis media in habitually snoring school-aged children. Sleep Med. 2008 Jul;9(5):549-54. doi: 10.1016/j.sleep.2007.08.002. PMID: 17921061; PMCID: PMC2527176. n = 1.844

  70. Zhang QQ, Guo RX, Xie M, Qiang Y, Shi Y, Liu XH, Cheng L, Liu HQ, Luo HN (2022): Hypoxia in non-rapid eye movement sleep in children with otitis media with effusion. J Int Med Res. 2022 Oct;50(10):3000605221133659. doi: 10.1177/03000605221133659. PMID: 36310499; PMCID: PMC9619286.

  71. Huang CC, Wu PW, Chiu CH, Lee TJ, Chen CL (2022): Assessment of sleep-disordered breathing in pediatric otitis media with effusion. Pediatr Neonatol. 2022 Jan;63(1):25-32. doi: 10.1016/j.pedneo.2021.06.013. PMID: 34391662.

  72. Portier F, van den Abbeele T, Lecain E, Sauvaget E, Escoubet B, Huy PT, Herman P (1999): Oxygen modulates Na+ absorption in middle ear epithelium. Am J Physiol. 1999 Feb;276(2):C312-7. doi: 10.1152/ajpcell.1999.276.2.C312. PMID: 9950758.

  73. Bhutta MF, Cheeseman MT, Brown SD (2014): Myringotomy in the Junbo mouse model of chronic otitis media alleviates inflammation and cellular hypoxia. Laryngoscope. 2014 Sep;124(9):E377-83. doi: 10.1002/lary.24698. PMID: 24706577.

  74. Shupak A, Tabari R, Swarts JD, Bluestone CD, Doyle WJ (1996): Effects of middle ear oxygen and carbon dioxide tensions on eustachian tube ventilatory function. Laryngoscope. 1996 Feb;106(2 Pt 1):221-4. doi: 10.1097/00005537-199602000-00022. PMID: 8583858.

  75. Alshukry A, Lagier C, Della Vedova C, Salburgo F, Lavieille JP, Montava M (2020): The Effects of Hypoxia on Middle Ear Pressure Regulation. High Alt Med Biol. 2020 Mar;21(1):99-104. doi: 10.1089/ham.2019.0043. PMID: 31985271.

  76. Koyama S (1989): [Partial oxygen tension of middle ear cavity in a normobaric environment]. Nihon Jibiinkoka Gakkai Kaiho. 1989 Jan;92(1):68-77. Japanese. doi: 10.3950/jibiinkoka.92.68. PMID: 2723886.

  77. Marcus CL, Moore RH, Rosen CL, Giordani B, Garetz SL, Taylor HG, Mitchell RB, Amin R, Katz ES, Arens R, Paruthi S, Muzumdar H, Gozal D, Thomas NH, Ware J, Beebe D, Snyder K, Elden L, Sprecher RC, Willging P, Jones D, Bent JP, Hoban T, Chervin RD, Ellenberg SS, Redline S; Childhood Adenotonsillectomy Trial (CHAT). A randomized trial of adenotonsillectomy for childhood sleep apnea (2013): N Engl J Med. 2013 Jun 20;368(25):2366-76. doi: 10.1056/NEJMoa1215881. PMID: 23692173; PMCID: PMC3756808. n = 464

  78. Bixler EO, Fernandez-Mendoza J, Liao D, Calhoun S, Rodriguez-Colon SM, Gaines J, He F, Vgontzas AN (2016): Natural history of sleep disordered breathing in prepubertal children transitioning to adolescence. Eur Respir J. 2016 May;47(5):1402-9. doi: 10.1183/13993003.01771-2015. PMID: 26846837; PMCID: PMC7085278.

  79. Tan HL, Alonso Alvarez ML, Tsaoussoglou M, Weber S, Kaditis AG (2017): When and why to treat the child who snores? Pediatr Pulmonol. 2017 Mar;52(3):399-412. doi: 10.1002/ppul.23658. PMID: 28029756. REVIEW

  80. Tabone L, Khirani S, Amaddeo A, Emeriaud G, Fauroux B (2020): Cerebral oxygenation in children with sleep-disordered breathing. Paediatr Respir Rev. 2020 Apr;34:18-23. doi: 10.1016/j.prrv.2019.10.002. PMID: 31753753. REVIEW

  81. Tabone L, Khirani S, Olmo Arroyo J, Amaddeo A, Sabil A, Fauroux B (2019): Cerebral Oxygenation During Respiratory Events in Children with Sleep-Disordered Breathing and Associated Disorders. J Pediatr. 2019 Nov;214:134-140.e7. doi: 10.1016/j.jpeds.2019.07.040. PMID: 31540763. n = 65

  82. Tamanyan K, Weichard A, Biggs SN, Davey MJ, Nixon GM, Walter LM, Horne RSC (2019): The impact of central and obstructive respiratory events on cerebral oxygenation in children with sleep disordered breathing. Sleep. 2019 May 1;42(5):zsz044. doi: 10.1093/sleep/zsz044. PMID: 30958878. n = 60

  83. Khadra MA, McConnell K, VanDyke R, Somers V, Fenchel M, Quadri S, Jefferies J, Cohen AP, Rutter M, Amin R (2008): Determinants of regional cerebral oxygenation in children with sleep-disordered breathing. Am J Respir Crit Care Med. 2008 Oct 15;178(8):870-5. doi: 10.1164/rccm.200802-321OC. PMID: 18658114; PMCID: PMC2566795. n = 93

  84. Tamanyan K, Walter LM, Weichard A, Davey MJ, Nixon GM, Biggs SN, Horne RSC (2018): Age Effects on Cerebral Oxygenation and Behavior in Children with Sleep-disordered Breathing. Am J Respir Crit Care Med. 2018 Jun 1;197(11):1468-1477. doi: 10.1164/rccm.201709-1825OC. PMID: 29351000. n = 157

  85. Pizza F, Biallas M, Wolf M, Werth E, Bassetti CL (2010): Nocturnal cerebral hemodynamics in snorers and in patients with obstructive sleep apnea: a near-infrared spectroscopy study. Sleep. 2010 Feb;33(2):205-10. doi: 10.1093/sleep/33.2.205. PMID: 20175404; PMCID: PMC2817907. n = 19

  86. Zaffanello M, Pietrobelli A, Nosetti L, Ferrante G, Rigotti E, Ganzarolli S, Piacentini G (2025): Sleep-Disordered Breathing and Central Respiratory Control in Children: A Comprehensive Review. Children (Basel). 2025 Feb 25;12(3):279. doi: 10.3390/children12030279. PMID: 40150562; PMCID: PMC11940935. REVIEW

  87. Miano S, Paolino MC, Urbano A, Parisi P, Massolo AC, Castaldo R, Villa MP (2011): Neurocognitive assessment and sleep analysis in children with sleep-disordered breathing. Clin Neurophysiol. 2011 Feb;122(2):311-9. doi: 10.1016/j.clinph.2010.06.019. PMID: 20637692. n = 104

  88. Smith TF, Schmidt-Kastner R, McGeary JE, Kaczorowski JA, Knopik VS (2016): Pre- and Perinatal Ischemia-Hypoxia, the Ischemia-Hypoxia Response Pathway, and ADHD Risk. Behav Genet. 2016 May;46(3):467-77. doi: 10.1007/s10519-016-9784-4. PMID: 26920003. REVIEW

  89. Ivanov I, Miraglia B, Prodanova D, Newcorn JH (2024): Sleep Disordered Breathing and Risk for ADHD: Review of Supportive Evidence and Proposed Underlying Mechanisms. J Atten Disord. 2024 Mar;28(5):686-698. doi: 10.1177/10870547241232313. PMID: 38353411. REVIEW

  90. Torabi-Nami M, Mehrabi S, Borhani-Haghighi A, Derman S (2015): Withstanding the obstructive sleep apnea syndrome at the expense of arousal instability, altered cerebral autoregulation and neurocognitive decline. J Integr Neurosci. 2015 Jun;14(2):169-93. doi: 10.1142/S0219635215500144. PMID: 25916253. REVIEW

  91. Sedky K, Bennett DS, Carvalho KS (2014): Attention deficit hyperactivity disorder and sleep disordered breathing in pediatric populations: a meta-analysis. Sleep Med Rev. 2014 Aug;18(4):349-56. doi: 10.1016/j.smrv.2013.12.003. PMID: 24581717. METASTUDY

  92. Chen F, Khorshidsavar A, Chen W, Mohtaram S (2025): Enhancing the comprehensive management strategies for attention-deficit/hyperactivity disorder (ADHD) in pediatric patients with concurrent sleep-disordered breathing: Integrating effective therapeutic approaches. Explore (NY). 2025 Nov-Dec;21(6):103241. doi: 10.1016/j.explore.2025.103241. PMID: 40865424.

  93. Hiscock H, Canterford L, Ukoumunne OC, Wake M (2007): Adverse associations of sleep problems in Australian preschoolers: national population study. Pediatrics. 2007 Jan;119(1):86-93. doi: 10.1542/peds.2006-1757. PMID: 17200274. n = 4.983

  94. Chang SJ, Chae KY (2010): Obstructive sleep apnea syndrome in children: Epidemiology, pathophysiology, diagnosis and sequelae. Korean J Pediatr. 2010 Oct;53(10):863-71. doi: 10.3345/kjp.2010.53.10.863. PMID: 21189956; PMCID: PMC3004499.

  95. Johnson EO, Roth T (2006): An epidemiologic study of sleep-disordered breathing symptoms among adolescents. Sleep. 2006 Sep;29(9):1135-42. doi: 10.1093/sleep/29.9.1135. PMID: 17040001.

  96. Csábi E, Gaál V, Hallgató E, Schulcz RA, Katona G, Benedek P (2022): Increased behavioral problems in children with sleep-disordered breathing. Ital J Pediatr. 2022 Sep 15;48(1):173. doi: 10.1186/s13052-022-01364-w. PMID: 36109824; PMCID: PMC9479439.

  97. Melendres MC, Lutz JM, Rubin ED, Marcus CL (2004): Daytime sleepiness and hyperactivity in children with suspected sleep-disordered breathing. Pediatrics. 2004 Sep;114(3):768-75. doi: 10.1542/peds.2004-0730. PMID: 15342852. n = 180

  98. de Carlos Villafranca F, Cobo Plana J, Díaz-Esnal B, Fernández-Mondragón P, Macías Escalada E, Puente Rodríguez M (2003): Ronchopathie chronique et syndrome de l’apnée-hypopnée obstructive du sommeil chez l’enfant [Chronic snoring and obstructive sleep apnea-hypopnea syndrome in children]. Orthod Fr. 2003 Sep;74(3):431-57. French. PMID: 15301372.

  99. Fidan T, Fidan V (2008): The impact of adenotonsillectomy on attention-deficit hyperactivity and disruptive behavioral symptoms. Eurasian J Med. 2008 Apr;40(1):14-7. PMID: 25610016; PMCID: PMC4261322. n = 30

  100. Gottlieb DJ, Vezina RM, Chase C, Lesko SM, Heeren TC, Weese-Mayer DE, Auerbach SH, Corwin MJ (2003): Symptoms of sleep-disordered breathing in 5-year-old children are associated with sleepiness and problem behaviors. Pediatrics. 2003 Oct;112(4):870-7. doi: 10.1542/peds.112.4.870. PMID: 14523179. n = 3.019

  101. Ali NJ, Pitson D, Stradling JR (1996): Sleep disordered breathing: effects of adenotonsillectomy on behaviour and psychological functioning. Eur J Pediatr. 1996 Jan;155(1):56-62. doi: 10.1007/BF02115629. PMID: 8750813. n = 23

  102. Perfect MM, Archbold K, Goodwin JL, Levine-Donnerstein D, Quan SF (2013): Risk of behavioral and adaptive functioning difficulties in youth with previous and current sleep disordered breathing. Sleep. 2013 Apr 1;36(4):517-525B. doi: 10.5665/sleep.2536. PMID: 23543901; PMCID: PMC3595180. n = 263

  103. O’Brien LM, Mervis CB, Holbrook CR, Bruner JL, Smith NH, McNally N, McClimment MC, Gozal D (2004): Neurobehavioral correlates of sleep-disordered breathing in children. J Sleep Res. 2004 Jun;13(2):165-72. doi: 10.1111/j.1365-2869.2004.00395.x. PMID: 15175097. n = 70

  104. Gottlieb DJ, Chase C, Vezina RM, Heeren TC, Corwin MJ, Auerbach SH, Weese-Mayer DE, Lesko SM (2004): Sleep-disordered breathing symptoms are associated with poorer cognitive function in 5-year-old children. J Pediatr. 2004 Oct;145(4):458-64. doi: 10.1016/j.jpeds.2004.05.039. PMID: 15480367. n = 205

  105. Bourke RS, Anderson V, Yang JS, Jackman AR, Killedar A, Nixon GM, Davey MJ, Walker AM, Trinder J, Horne RS (2011): Neurobehavioral function is impaired in children with all severities of sleep disordered breathing. Sleep Med. 2011 Mar;12(3):222-9. doi: 10.1016/j.sleep.2010.08.011. PMID: 21324739. n = 136

  106. Jackman AR, Biggs SN, Walter LM, Embuldeniya US, Davey MJ, Nixon GM, Anderson V, Trinder J, Horne RS (2012): Sleep-disordered breathing in preschool children is associated with behavioral, but not cognitive, impairments. Sleep Med. 2012 Jun;13(6):621-31. doi: 10.1016/j.sleep.2012.01.013. PMID: 22503657. n = 153

  107. Martins JG, Ladeia PO, Zechi-Ceide RM, Ribas MDC, Zimmermann N, Maximino LP (2025): Cognitive and Behavioral Characteristics of Children with Robin Sequence Associated with Stickler Syndrome: A Case Series. Cleft Palate Craniofac J. 2025 Sep 1:10556656251372323. doi: 10.1177/10556656251372323. PMID: 40888621.

  108. Wu Y, Wang C, Jiang Y, Zhang Y, Zheng L, Ning XL, Xu Z (2024): Impaired Attention in Children with Obstructive Sleep Apnea: A Preliminary Study of Behavior Combined with Neuroelectrophysiology. Nat Sci Sleep. 2024 Dec 11;16:1995-2007. doi: 10.2147/NSS.S484458. PMID: 39677824; PMCID: PMC11646427. n = 87

  109. Koutsoklenis A, Honkasilta J (2023): ADHD in the DSM-5-TR: What has changed and what has not. Front Psychiatry. 2023 Jan 10;13:1064141. doi: 10.3389/fpsyt.2022.1064141. PMID: 36704731; PMCID: PMC9871920.

  110. Biggs SN, Nixon GM, Horne RS (2014): The conundrum of primary snoring in children: what are we missing in regards to cognitive and behavioural morbidity? Sleep Med Rev. 2014 Dec;18(6):463-75. doi: 10.1016/j.smrv.2014.06.009. PMID: 25060969. REVIEW

  111. Sadeh A, Pergamin L, Bar-Haim Y (2006): Sleep in children with attention-deficit hyperactivity disorder: a meta-analysis of polysomnographic studies. Sleep Med Rev. 2006 Dec;10(6):381-98. doi: 10.1016/j.smrv.2006.03.004. PMID: 16846743. REVIEW

  112. Konofal E, Lecendreux M, Bouvard MP, Mouren-Simeoni MC (2001): High levels of nocturnal activity in children with attention-deficit hyperactivity disorder: a video analysis. Psychiatry Clin Neurosci. 2001 Apr;55(2):97-103. doi: 10.1046/j.1440-1819.2001.00808.x. PMID: 11285086. n = 49

  113. Carskadon MA, Pueschel SM, Millman RP (1993): Sleep-disordered breathing and behavior in three risk groups: preliminary findings from parental reports. Childs Nerv Syst. 1993 Dec;9(8):452-7. doi: 10.1007/BF00393547. PMID: 8124671.

  114. Carpena MX, Bonilla C, Matijasevich A, Martins-Silva T, Genro JP, Hutz MH, Rohde LA, Tovo-Rodrigues L (2021): Sleep-related traits and attention-deficit/hyperactivity disorder comorbidity: Shared genetic risk factors, molecular mechanisms, and causal effects. World J Biol Psychiatry. 2021 Dec;22(10):778-791. doi: 10.1080/15622975.2021.1907719. PMID: 33821771.

  115. Tomás Vila M, Miralles Torres A, Beseler Soto B, Revert Gomar M, Sala Langa MJ, Uribelarrea Sierra AI (2008): Relación entre el trastorno por déficit de atención e hiperactividad y los trastornos del sueño. Resultados de un estudio epidemiológico en la población escolar de la ciudad de Gandía [Attention-deficit/hyperactivity disorder and sleep disturbances. Results of an epidemiological study in schoolchildren in Gandia, Spain]. An Pediatr (Barc). 2008 Sep;69(3):251-7. Spanish. doi: 10.1157/13125820. PMID: 18775271. n = 877

  116. Mir E, Kumar R, Suri TM, Suri JC, Venkatachalam VP, Sen MK, Chakrabarti S (2019): Neurocognitive and behavioral abnormalities in Indian children with sleep-disordered breathing before and after adenotonsillectomy. Lung India. 2019 Jul-Aug;36(4):304-312. doi: 10.4103/lungindia.lungindia_398_18. PMID: 31290415; PMCID: PMC6625250.

  117. Chervin RD, Ruzicka DL, Giordani BJ, Weatherly RA, Dillon JE, Hodges EK, Marcus CL, Guire KE (2006): Sleep-disordered breathing, behavior, and cognition in children before and after adenotonsillectomy. Pediatrics. 2006 Apr;117(4):e769-78. doi: 10.1542/peds.2005-1837. PMID: 16585288; PMCID: PMC1434467. n = 105

  118. Lushington K, Kennedy D, Martin J, Kohler M (2021): Quality-of-life but not behavior improves 48-months post-adenotonsillectomy in children with SDB. Sleep Med. 2021 May;81:418-429. doi: 10.1016/j.sleep.2021.02.057. PMID: 33831667. n = 64

  119. Song IS, Hong SN, Joo JW, Han MS, Hwang SJ, Seo MY, Lee SH (2020): Long-term results of sleep-related quality-of-life and behavioral problems after adenotonsillectomy. Laryngoscope. 2020 Feb;130(2):546-550. doi: 10.1002/lary.27951. PMID: 30950515. n = 20

  120. Gozal D (1998): Sleep-disordered breathing and school performance in children. Pediatrics. 1998 Sep;102(3 Pt 1):616-20. doi: 10.1542/peds.102.3.616. PMID: 9738185. n = 54

  121. Mitchell RB, Kelly J (2007): Behavioral changes in children with mild sleep-disordered breathing or obstructive sleep apnea after adenotonsillectomy. Laryngoscope. 2007 Sep;117(9):1685-8. doi: 10.1097/MLG.0b013e318093edd7. PMID: 17667138. n = 40

  122. Mietchen JJ, Bennett DP, Huff T, Hedges DW, Gale SD (2016): Executive Function in Pediatric Sleep-Disordered Breathing: A Meta-analysis. J Int Neuropsychol Soc. 2016 Sep;22(8):839-50. doi: 10.1017/S1355617716000643. PMID: 27481012. METASTUDY

  123. Biggs SN, Bourke R, Anderson V, Jackman AR, Killedar A, Nixon GM, Davey MJ, Walker AM, Trinder J, Horne RS (2011): Working memory in children with sleep-disordered breathing: objective versus subjective measures. Sleep Med. 2011 Oct;12(9):887-91. doi: 10.1016/j.sleep.2011.07.003. PMID: 21924953. n = 127

  124. Chervin RD, Ellenberg SS, Hou X, Marcus CL, Garetz SL, Katz ES, Hodges EK, Mitchell RB, Jones DT, Arens R, Amin R, Redline S, Rosen CL; Childhood Adenotonsillectomy Trial (2015): Prognosis for Spontaneous Resolution of OSA in Children. Chest. 2015 Nov;148(5):1204-1213. doi: 10.1378/chest.14-2873. PMID: 25811889; PMCID: PMC4631037. n = 194

  125. Biggs SN, Walter LM, Jackman AR, Nisbet LC, Weichard AJ, Hollis SL, Davey MJ, Anderson V, Nixon GM, Horne RS (2015): Long-Term Cognitive and Behavioral Outcomes following Resolution of Sleep Disordered Breathing in Preschool Children. PLoS One. 2015 Sep 29;10(9):e0139142. doi: 10.1371/journal.pone.0139142. PMID: 26418065; PMCID: PMC4587807. n = 35

  126. Schöbel (2026): Schlafapnoe; Vortrag medLIVE.

  127. Zhang G, Spickett J, Rumchev K, Lee AH, Stick S (2004): Snoring in primary school children and domestic environment: a Perth school based study. Respir Res. 2004 Nov 4;5(1):19. doi: 10.1186/1465-9921-5-19. PMID: 15527500; PMCID: PMC535337. n = 88

  128. Smedje H, Broman JE, Hetta J (1999): Parents’ reports of disturbed sleep in 5-7-year-old Swedish children. Acta Paediatr. 1999 Aug;88(8):858-65. doi: 10.1080/08035259950168793. PMID: 10503686. n = 1.844

  129. Gozal D, O’Brien LM (2004): Snoring and obstructive sleep apnoea in children: why should we treat? Paediatr Respir Rev. 2004;5 Suppl A:S371-6. doi: 10.1016/s1526-0542(04)90066-8. PMID: 14980299. REVIEW

  130. Türkoğlu, Tahsin Somuk, Sapmaz, Bilgiç (2019): Effect of adenotonsillectomy on sleep problems, attention deficit hyperactivity disorder symptoms, and quality of life of children with adenotonsillar hypertrophy and sleep-disordered breathing. Int J Psychiatry Med. 2019 Mar 1:91217419829988. doi: 10.1177/0091217419829988. n = 1.736

  131. Sahin U, Ozturk O, Ozturk M, Songur N, Bircan A, Akkaya A (2009): Habitual snoring in primary school children: prevalence and association with sleep-related disorders and school performance. Med Princ Pract. 2009;18(6):458-65. doi: 10.1159/000235895. PMID: 19797922. n = 1.164

  132. Chervin RD, Archbold KH, Dillon JE, Panahi P, Pituch KJ, Dahl RE, Guilleminault C (2002): Inattention, hyperactivity, and symptoms of sleep-disordered breathing. Pediatrics. 2002 Mar;109(3):449-56. doi: 10.1542/peds.109.3.449. PMID: 11875140.

  133. Fatima Y, Cairns A, Skinner I, Doi SAR, Mamun AA (2018): Prenatal and early life origins of adolescence sleep problems: evidence from a birth cohort. Int J Adolesc Med Health. 2018 Oct 20;33(1). doi: 10.1515/ijamh-2018-0048. PMID: 30352032. n = 5.081

  134. Constantin E, Low NC, Dugas E, Karp I, O’Loughlin J (2015): Association Between Childhood Sleep-Disordered Breathing and Disruptive Behavior Disorders in Childhood and Adolescence. Behav Sleep Med. 2015;13(6):442-54. doi: 10.1080/15402002.2014.940106. PMID: 25102357. n = 605

  135. Chervin RD, Dillon JE, Bassetti C, Ganoczy DA, Pituch KJ (1997): Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep. 1997 Dec;20(12):1185-92. doi: 10.1093/sleep/20.12.1185. PMID: 9493930. n = 143

  136. Lumeng JC, Chervin RD (2008): Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc. 2008 Feb 15;5(2):242-52. doi: 10.1513/pats.200708-135MG. PMID: 18250218; PMCID: PMC2645255. REVIEW

  137. Chervin RD, Ruzicka DL, Archbold KH, Dillon JE (2005): Snoring predicts hyperactivity four years later. Sleep. 2005 Jul;28(7):885-90. doi: 10.1093/sleep/28.7.885. PMID: 16124670. n = 229

  138. Joseph M, Lajili M, Dudoignon B, Delclaux C, Bokov P (2025): Loudness of snoring, not apnea-hypopnea index, is associated with hyperactivity behavior in snoring children and adolescents. Sleep Med. 2025 Mar;127:43-48. doi: 10.1016/j.sleep.2025.01.006. PMID: 39787820.

  139. Kim KM, Kim JH, Kim D, Lim MH, Joo H, Yoo SJ, Kim E, Ha M, Paik KC, Kwon HJ (2020): Associations among High Risk for Sleep-disordered Breathing, Related Risk Factors, and Attention Deficit/Hyperactivity Symptoms in Elementary School Children. Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):553-561. doi: 10.9758/cpn.2020.18.4.553. PMID: 33124587; PMCID: PMC7609213. n = 13.560

  140. O’Brien LM, Mervis CB, Holbrook CR, Bruner JL, Klaus CJ, Rutherford J, Raffield TJ, Gozal D (2004): Neurobehavioral implications of habitual snoring in children. Pediatrics. 2004 Jul;114(1):44-9. doi: 10.1542/peds.114.1.44. PMID: 15231906.

  141. Wu Y, Wang Y, Wang C, Zhao F, Ma D, Xu Z, Ni X (2023): Characteristics of the Attentional Network in Children with Sleep-Disordered Breathing. Nat Sci Sleep. 2023 Sep 20;15:719-727. doi: 10.2147/NSS.S413330. PMID: 37750168; PMCID: PMC10518154. n = 95

  142. Smith DL, Gozal D, Hunter SJ, Kheirandish-Gozal L (2017): Frequency of snoring, rather than apnea-hypopnea index, predicts both cognitive and behavioral problems in young children. Sleep Med. 2017 Jun;34:170-178. doi: 10.1016/j.sleep.2017.02.028. PMID: 28522088; PMCID: PMC5532874. n = 631

  143. Hunter SJ, Gozal D, Smith DL, Philby MF, Kaylegian J, Kheirandish-Gozal L (2016): Effect of Sleep-disordered Breathing Severity on Cognitive Performance Measures in a Large Community Cohort of Young School-aged Children. Am J Respir Crit Care Med. 2016 Sep 15;194(6):739-47. doi: 10.1164/rccm.201510-2099OC. PMID: 26930303; PMCID: PMC5027230. n = 1.010

  144. Brockmann PE, Bertrand P, Pardo T, Cerda J, Reyes B, Holmgren NL (2012): Prevalence of habitual snoring and associated neurocognitive consequences among Chilean school aged children. Int J Pediatr Otorhinolaryngol. 2012 Sep;76(9):1327-31. doi: 10.1016/j.ijporl.2012.05.028. PMID: 22748305. n = 523

  145. Arman AR, Ersu R, Save D, Karadag B, Karaman G, Karabekiroglu K, Karakoc F, Dagli E, Berkem M (2005): Symptoms of inattention and hyperactivity in children with habitual snoring: evidence from a community-based study in Istanbul. Child Care Health Dev. 2005 Nov;31(6):707-17. doi: 10.1111/j.1365-2214.2005.00561.x. PMID: 16207229. n = 286

  146. Brockmann PE, Urschitz MS, Schlaud M, Poets CF (2012): Primary snoring in school children: prevalence and neurocognitive impairments. Sleep Breath. 2012 Mar;16(1):23-9. doi: 10.1007/s11325-011-0480-6. PMID: 21240656. n = 92

  147. Urschitz MS, Eitner S, Guenther A, Eggebrecht E, Wolff J, Urschitz-Duprat PM, Schlaud M, Poets CF (2004): Habitual snoring, intermittent hypoxia, and impaired behavior in primary school children. Pediatrics. 2004 Oct;114(4):1041-8. doi: 10.1542/peds.2003-1145-L. PMID: 15466103. n = 1.144

  148. Liu, Liu, Liu, Sun, Jia (2019): Associations of sleep problems with ADHD symptoms: Findings from the Shandong Adolescent Behavior and Health Cohort (SABHC). Sleep. 2019 Dec 2. pii: zsz294. doi: 10.1093/sleep/zsz294. n = 7.072

  149. Chen P, Qin J, Wang Y, Yuan J, Pan Y, Zhu B (2024): The causal relationship between sleep and risk of psychiatric disorders: A two-sample mendelian randomization study. Front Genet. 2024 Jun 17;15:1380544. doi: 10.3389/fgene.2024.1380544. PMID: 38952712; PMCID: PMC11215123.

  150. Andersson, Sonnesen (2018): Sleepiness, occlusion, dental arch and palatal dimensions in children attention deficit hyperactivity disorder (ADHD).Eur Arch Paediatr Dent. 2018 Mar 14. doi: 10.1007/s40368-018-0330-3.

  151. Chiang HL, Gau SS, Ni HC, Chiu YN, Shang CY, Wu YY, Lin LY, Tai YM, Soong WT (2010): Association between symptoms and subtypes of attention-deficit hyperactivity disorder and sleep problems/disorders. J Sleep Res. 2010 Dec;19(4):535-45. doi: 10.1111/j.1365-2869.2010.00832.x. PMID: 20408926.

  152. Rodopman-Arman A, Perdahli-Fiş N, Ekinci O, Berkem M (2011): Sleep habits, parasomnias and associated behaviors in school children with attention deficit hyperactivity disorder (ADHD). Turk J Pediatr. 2011 Jul-Aug;53(4):397-403. PMID: 21980842.

  153. Lin CH, Wu PY, Hong SY, Chang YT, Lin SS, Chou IC (2025): The Role of Polysomnography for Children with Attention-Deficit/Hyperactivity Disorder. Life (Basel). 2025 Apr 21;15(4):678. doi: 10.3390/life15040678. PMID: 40283232; PMCID: PMC12029080. n = 36

  154. Galland BC, Tripp EG, Gray A, Taylor BJ (2011): Apnea-hypopnea indices and snoring in children diagnosed with ADHD: a matched case-control study. Sleep Breath. 2011 Sep;15(3):455-62. doi: 10.1007/s11325-010-0357-0. PMID: 20440568.

  155. Gomes AA, Parchão C, Almeida A, Clemente V, Pinto de Azevedo MH (2014): Sleep-wake patterns reported by parents in hyperactive children diagnosed according to ICD-10, as compared to paired controls. Child Psychiatry Hum Dev. 2014 Oct;45(5):533-43. doi: 10.1007/s10578-013-0422-6. PMID: 24276394. n = 30

  156. Silvestri R, Gagliano A, Aricò I, Calarese T, Cedro C, Bruni O, Condurso R, Germanò E, Gervasi G, Siracusano R, Vita G, Bramanti P (2009): Sleep disorders in children with Attention-Deficit/Hyperactivity Disorder (ADHD) recorded overnight by video-polysomnography. Sleep Med. 2009 Dec;10(10):1132-8. doi: 10.1016/j.sleep.2009.04.003. PMID: 19527942. n = 55

  157. Gau SS, Chiang HL (2009): Sleep problems and disorders among adolescents with persistent and subthreshold attention-deficit/hyperactivity disorders. Sleep. 2009 May;32(5):671-9. doi: 10.1093/sleep/32.5.671. PMID: 19480234; PMCID: PMC2675902. n = 466

  158. Fatima Y, Cairns A, Skinner I, Doi SAR, Mamun AA (2018): Prenatal and early life origins of adolescence sleep problems: evidence from a birth cohort. Int J Adolesc Med Health. 2018 Oct 20;33(1). doi: 10.1515/ijamh-2018-0048. PMID: 30352032.

  159. Chiang HL, Gau SS, Ni HC, Chiu YN, Shang CY, Wu YY, Lin LY, Tai YM, Soong WT (2010): Association between symptoms and subtypes of attention-deficit hyperactivity disorder and sleep problems/disorders. J Sleep Res. 2010 Dec;19(4):535-45. doi: 10.1111/j.1365-2869.2010.00832.x. PMID: 20408926. n = 561

  160. LeBourgeois MK, Avis K, Mixon M, Olmi J, Harsh J (2004): Snoring, sleep quality, and sleepiness across attention-deficit/hyperactivity disorder subtypes. Sleep. 2004 May 1;27(3):520-5. PMID: 15164909. n = 74

  161. Barnes ME, Huss EA, Garrod KN, Van Raay E, Dayyat E, Gozal D, Molfese DL (2009): Impairments in attention in occasionally snoring children: an event-related potential study. Dev Neuropsychol. 2009;34(5):629-49. doi: 10.1080/87565640903133632. PMID: 20183724; PMCID: PMC3468947. n = 22

  162. Chin WC, Huang YS, Chou YH, Wang CH, Chen KT, Hsu JF, Hsu SC (2018): Subjective and objective assessments of sleep problems in children with attention deficit/hyperactivity disorder and the effects of methylphenidate treatment. Biomed J. 2018 Dec;41(6):356-363. doi: 10.1016/j.bj.2018.10.004. PMID: 30709577; PMCID: PMC6362263. n = 101

  163. Al-Zaabi K, Al-Adawi S, Jaju S, Jeyaseelan L, Al-Sibani N, Al-Alawi M, Al-Abri M, Al-Abri R (2018): Effects of an Adenotonsillectomy on the Cognitive and Behavioural Function of Children Who Snore: A naturalistic observational study. Sultan Qaboos Univ Med J. 2018 Nov;18(4):e455-e460. doi: 10.18295/squmj.2018.18.04.005. Epub 2019 Mar 28. PMID: 30988963; PMCID: PMC6443270. n = 37

  164. Kohler MJ, Lushington K, van den Heuvel CJ, Martin J, Pamula Y, Kennedy D (2009): Adenotonsillectomy and neurocognitive deficits in children with Sleep Disordered Breathing. PLoS One. 2009 Oct 6;4(10):e7343. doi: 10.1371/journal.pone.0007343. PMID: 19806214; PMCID: PMC2752197. n = 92

  165. El-Anwar MW, Hamed AA, Abdulmonaem G, Elnashar I, Elfiki IM (2017): Computed Tomography Measurement of Inferior Turbinate in Asymptomatic Adult. Int Arch Otorhinolaryngol. 2017 Oct;21(4):366-370. doi: 10.1055/s-0037-1598649. PMID: 29018500; PMCID: PMC5629090.

  166. Seeger J, Zenev E, Gundlach P, Stein T, Müller G (2003): Bipolar radiofrequency-induced thermotherapy of turbinate hypertrophy: pilot study and 20 months’ follow-up. Laryngoscope. 2003 Jan;113(1):130-5. doi: 10.1097/00005537-200301000-00024. PMID: 12514396.

  167. Ali AH, Digoy GP (2025): Exploring the Role of Turbinate Reduction in Alleviating Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms in Pediatric Patients. Cureus. 2025 Jul 26;17(7):e88807. doi: 10.7759/cureus.88807. PMID: 40861614; PMCID: PMC12377240.

  168. Deveci I, Onder S, Surmeli M, Sahin S, Kipoglu BA, Karabulut B, Eser BC (2018): Impact of Nasal Septal Surgery on Sleep Quality and Attention-Deficit/Hyperactivity Disorder. J Craniofac Surg. 2018 Oct;29(7):e632-e635. doi: 10.1097/SCS.0000000000004541. PMID: 29608471. n = 49

  169. Benninger M, Walner D (2007): Obstructive sleep-disordered breathing in children. Clin Cornerstone. 2007;9 Suppl 1:S6-12. doi: 10.1016/s1098-3597(07)80004-4. PMID: 17584620. REVIEW

  170. Türkoğlu, Tahsin Somuk, Sapmaz, Bilgiç (2019): Effect of adenotonsillectomy on sleep problems, attention deficit hyperactivity disorder symptoms, and quality of life of children with adenotonsillar hypertrophy and sleep-disordered breathing. Int J Psychiatry Med. 2019 Mar 1:91217419829988. doi: 10.1177/0091217419829988.

  171. Kim HY, Dhong HJ, Lee JK, Chung SK, Jung SC (2011): Sleep quality and effects of position on sleep apnea in East Asian children. Auris Nasus Larynx. 2011 Apr;38(2):228-32. doi: 10.1016/j.anl.2010.07.005. PMID: 20800981.

  172. Geiger Z, Gupta N (2023): Adenoid Hypertrophy. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30725669.

  173. Pereira L, Monyror J, Almeida FT, Almeida FR, Guerra E, Flores-Mir C, Pachêco-Pereira C (2018): Prevalence of adenoid hypertrophy: A systematic review and meta-analysis. Sleep Med Rev. 2018 Apr;38:101-112. doi: 10.1016/j.smrv.2017.06.001. PMID: 29153763. METASTUDY

  174. Kapusuz Z, Ozkırış M, Okur A, Saydam L (2012): The prevalence of adenoid hypertrophy in adults in a rural area of Turkey. Kulak Burun Bogaz Ihtis Derg. 2012 Jul-Aug;22(4):225-7. doi: 10.5606/kbbihtisas.2012.043. PMID: 22770258.

  175. Nguyen-Thi-Phuong M, Nguyen-Thi-Thanh M, Goldberg RJ, Nguyen HL, Dao-Thi-Minh A, Duong-Quy S (2025): Obstructive Sleep Apnea and Sleep Disorders in Children with Attention Deficit Hyperactivity Disorder. Pulm Ther. 2025 Sep;11(3):423-441. doi: 10.1007/s41030-025-00299-x. PMID: 40622461; PMCID: PMC12373571. n = 629

  176. Soylu E, Soylu N, Yıldırım YS, Sakallıoğlu Ö, Polat C, Orhan I (2013): Psychiatric disorders and symptoms severity in patients with adenotonsillar hypertrophy before and after adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 2013 Oct;77(10):1775-81. doi: 10.1016/j.ijporl.2013.08.020. PMID: 24011939. n = 75

  177. Fallah R, Arabi Mianroodi A, Eslami M, Khanjani N (2020): Does Adenotonsillectomy alter Symptoms of Attention Deficit Hyperactivity Disorder in Children? Iran J Otorhinolaryngol. 2020 Nov;32(113):359-364. doi: 10.22038/ijorl.2020.43987.2456. PMID: 33282783; PMCID: PMC7701482. n = 100

  178. Soylu E, Soylu N, Yıldırım YS, Polat C, Sakallıoğlu O (2013): The prevelance of psichiatric symptoms in preschool children with adenotonsillar hypertrophy. Int J Pediatr Otorhinolaryngol. 2013 Jul;77(7):1094-8. doi: 10.1016/j.ijporl.2013.04.005. PMID: 23643332. n = 88

  179. Aksu H, Günel C, Özgür BG, Toka A, Başak S (2015): Effects of adenoidectomy/adenotonsillectomy on ADHD symptoms and behavioral problems in children. Int J Pediatr Otorhinolaryngol. 2015 Jul;79(7):1030-3. doi: 10.1016/j.ijporl.2015.04.018. PMID: 25933698. n = 41

  180. Dadgarnia MH, Baradaranfar MH, Fallah R, Atighechi S, Ahsani AH, Baradaranfar A (2012): Effect of adenotonsillectomy on ADHD symptoms of children with adenotonsillar hypertrophy. Acta Med Iran. 2012;50(8):547-51. PMID: 23109027.

  181. Suratt PM, Peruggia M, D’Andrea L, Diamond R, Barth JT, Nikova M, Perriello VA Jr, Johnson ML (2006): Cognitive function and behavior of children with adenotonsillar hypertrophy suspected of having obstructive sleep-disordered breathing. Pediatrics. 2006 Sep;118(3):e771-81. doi: 10.1542/peds.2006-0173. PMID: 16894010. n = 114

  182. Fallah R, Arabi Mianroodi A, Eslami M, Khanjani N (2020): Does Adenotonsillectomy alter Symptoms of Attention Deficit Hyperactivity Disorder in Children? Iran J Otorhinolaryngol. 2020 Nov;32(113):359-364. doi: 10.22038/ijorl.2020.43987.2456. PMID: 33282783; PMCID: PMC7701482.

  183. Amiri S, AbdollahiFakhim S, Lotfi A, Bayazian G, Sohrabpour M, Hemmatjoo T (2015): Effect of adenotonsillectomy on ADHD symptoms of children with adenotonsillar hypertrophy and sleep disordered breathing. Int J Pediatr Otorhinolaryngol. 2015 Aug;79(8):1213-7. doi: 10.1016/j.ijporl.2015.05.015. PMID: 26066853. n = 53

  184. Wei JL, Mayo MS, Smith HJ, Reese M, Weatherly RA (2007): Improved behavior and sleep after adenotonsillectomy in children with sleep-disordered breathing. Arch Otolaryngol Head Neck Surg. 2007 Oct;133(10):974-9. doi: 10.1001/archotol.133.10.974. PMID: 17938319. n = 117

  185. Wei JL, Bond J, Mayo MS, Smith HJ, Reese M, Weatherly RA (2009): Improved behavior and sleep after adenotonsillectomy in children with sleep-disordered breathing: long-term follow-up. Arch Otolaryngol Head Neck Surg. 2009 Jul;135(7):642-6. doi: 10.1001/archoto.2009.74. PMID: 19620583.

  186. Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, Chen NH (2007): Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study. Sleep Med. 2007 Jan;8(1):18-30. doi: 10.1016/j.sleep.2006.05.016. PMID: 17157069.

  187. Ahmadi MS, Poorolajal J, Masoomi FS, Haghighi M (2016): Effect of adenotonsillectomy on attention deficit-hyperactivity disorder in children with adenotonsillar hypertrophy: A prospective cohort study. Int J Pediatr Otorhinolaryngol. 2016 Jul;86:193-5. doi: 10.1016/j.ijporl.2016.05.012. PMID: 27260606. n = 59

  188. Somuk BT, Bozkurt H, Göktaş G, Demir O, Gürbüzler L, Eyibilen A (2016): Impact of adenotonsillectomy on ADHD and nocturnal enuresis in children with chronic adenotonsillar hypertrophy. Am J Otolaryngol. 2016 Jan-Feb;37(1):27-30. doi: 10.1016/j.amjoto.2015.08.003. PMID: 26700255. n = 75

  189. Ayral M, Baylan MY, Kinis V, Bez Y, Bakir S, Ozbay M, Yorgancilar E, Gun R, Topcu I (2013): Evaluation of hyperactivity, attention deficit, and impulsivity before and after adenoidectomy/adenotonsillectomy surgery. J Craniofac Surg. 2013 May;24(3):731-4. doi: 10.1097/SCS.0b013e31828011ea. PMID: 23714868. n = 63

  190. Won DC, Guilleminault C, Koltai PJ, Quo SD, Stein MT, Loe IM (2017): It Is Just Attention-Deficit Hyperactivity Disorder…or Is It? J Dev Behav Pediatr. 2017 Feb/Mar;38(2):169-172. doi: 10.1097/DBP.0000000000000386. PMID: 28079611; PMCID: PMC5401711. n = 1

  191. Esteller Moré E, Santos Acosta P, Segarra Isern F, Lopez Diu R, Matiño Soler E, Ademà Alcover JM, Estivill Sancho E (2012): Persistencia a largo plazo del síndrome de la apnea-hipopnea obstructiva del sueño infantil tratada con adenoamigdalectomía. Análisis de factores pronósticos [Long-term persistence of obstructive sleep apnoea-hypopnoea syndrome in children treated with adenotonsillectomy. Analysis of prognostic factors]. Acta Otorrinolaringol Esp. 2012 Mar-Apr;63(2):85-92. Spanish. doi: 10.1016/j.otorri.2011.08.004. PMID: 22342641. n = 80

  192. DocCheck Flexikon: Apnoe-Hypopnoe-Index german

  193. DelRosso LM (2016): Epidemiology and Diagnosis of Pediatric Obstructive Sleep Apnea. Curr Probl Pediatr Adolesc Health Care. 2016 Jan;46(1):2-6. doi: 10.1016/j.cppeds.2015.10.009. PMID: 26573241. REVIEW

  194. Marcus CL (2001): Sleep-disordered breathing in children. Am J Respir Crit Care Med. 2001 Jul 1;164(1):16-30. doi: 10.1164/ajrccm.164.1.2008171. PMID: 11435234. REVIEW

  195. Akashiba T, Inoue Y, Uchimura N, Ohi M, Kasai T, Kawana F, Sakurai S, Takegami M, Tachikawa R, Tanigawa T, Chiba S, Chin K, Tsuiki S, Tonogi M, Nakamura H, Nakayama T, Narui K, Yagi T, Yamauchi M, Yamashiro Y, Yoshida M, Oga T, Tomita Y, Hamada S, Murase K, Mori H, Wada H, Uchiyama M, Ogawa H, Sato K, Nakata S, Mishima K, Momomura SI (2022): Sleep Apnea Syndrome (SAS) Clinical Practice Guidelines 2020. Respir Investig. 2022 Jan;60(1):3-32. doi: 10.1016/j.resinv.2021.08.010. PMID: 34986992.

  196. Maris M, Verhulst S, Wojciechowski M, Van de Heyning P, Boudewyns A (2016): Prevalence of Obstructive Sleep Apnea in Children with Down Syndrome. Sleep. 2016 Mar 1;39(3):699-704. doi: 10.5665/sleep.5554. PMID: 26612391; PMCID: PMC4763351.

  197. Breslin J, Spanò G, Bootzin R, Anand P, Nadel L, Edgin J (2014): Obstructive sleep apnea syndrome and cognition in Down syndrome. Dev Med Child Neurol. 2014 Jul;56(7):657-64. doi: 10.1111/dmcn.12376. PMID: 24471822.

  198. Smith, Gozal, Hunter, Kheirandish-Gozal (2017): Parent-Reported Behavioral and Psychiatric Problems Mediate the Relationship between Sleep-Disordered Breathing and Cognitive Deficits in School-Aged Children. Front Neurol. 2017 Aug 11;8:410. doi: 10.3389/fneur.2017.00410. eCollection 2017.

  199. Wu Y, Wang Y, Wang C, Zhao F, Ma D, Xu Z, Ni X (2023): Characteristics of the Attentional Network in Children with Sleep-Disordered Breathing. Nat Sci Sleep. 2023 Sep 20;15:719-727. doi: 10.2147/NSS.S413330. PMID: 37750168; PMCID: PMC10518154. n = 161

  200. Ren Z, Qiu A (2014): Sleep-related breathing disorder is associated with hyperactivity in preschoolers. Singapore Med J. 2014 May;55(5):257-60. doi: 10.11622/smedj.2014068. PMID: 24862749; PMCID: PMC4291982. n = 110

  201. Zhao J, Han S, Zhang J, Wang G, Wang H, Xu Z, Tai J, Peng X, Guo Y, Liu H, Tian J, Jin X, Zheng L, Zhang J, Ni X (2018): Association between mild or moderate obstructive sleep apnea-hypopnea syndrome and cognitive dysfunction in children. Sleep Med. 2018 Oct;50:132-136. doi: 10.1016/j.sleep.2018.04.009. PMID: 30036785.

  202. Cortese S, Faraone SV, Konofal E, Lecendreux M (2009): Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies. J Am Acad Child Adolesc Psychiatry. 2009 Sep;48(9):894-908. doi: 10.1097/CHI.0b013e3181ac09c9. PMID: 19625983. METASTUDY

  203. Naseem S, Chaudhary B, Collop N (2001): Attention deficit hyperactivity disorder in adults and obstructive sleep apnea. Chest. 2001 Jan;119(1):294-6. doi: 10.1378/chest.119.1.294. PMID: 11157621.

  204. Sangal RB, Owens JA, Sangal J (2005): Patients with attention-deficit/hyperactivity disorder without observed apneic episodes in sleep or daytime sleepiness have normal sleep on polysomnography. Sleep. 2005 Sep;28(9):1143-8. PMID: 16268384. n = 60

  205. Luo G, Long F, Yi C, Zhu S, Tian Y, Li C, Long Y, Liu Z, Luo Q (2025): Changes in attention deficit and adipokine levels in children with sleep-disordered breathing. Sleep Med. 2025 Oct;134:106661. doi: 10.1016/j.sleep.2025.106661. PMID: 40752314. n = 111

  206. Eldin MS, Alahmer M, Alkashlan E, Zahran M, Eltonsy M, Zewail A, Kasem A, Abdelaal K, Seddeek M, Ahmed Z (2023): Alterations in Inflammatory Markers and Cognitive Ability after Treatment of Pediatric Obstructive Sleep Apnea. Medicina (Kaunas). 2023 Jan 19;59(2):204. doi: 10.3390/medicina59020204. PMID: 36837406; PMCID: PMC9968190. n = 181

  207. Taylor HG, Bowen SR, Beebe DW, Hodges E, Amin R, Arens R, Chervin RD, Garetz SL, Katz ES, Moore RH, Morales KH, Muzumdar H, Paruthi S, Rosen CL, Sadhwani A, Thomas NH, Ware J, Marcus CL, Ellenberg SS, Redline S, Giordani B (2016): Cognitive Effects of Adenotonsillectomy for Obstructive Sleep Apnea. Pediatrics. 2016 Aug;138(2):e20154458. doi: 10.1542/peds.2015-4458. PMID: 27464674; PMCID: PMC4960728. n = 453

  208. Montgomery-Downs HE, Crabtree VM, Gozal D (2005): Cognition, sleep and respiration in at-risk children treated for obstructive sleep apnoea. Eur Respir J. 2005 Feb;25(2):336-42. doi: 10.1183/09031936.05.00082904. PMID: 15684300. n = 38

  209. Wu D, Au VH, Yang B, Horne SJ, Weedon J, Bernstein MJ, Goldstein NA (2022): Impact of Adenotonsillectomy on Homework Performance in Children With Obstructive Sleep-Disordered Breathing. Ann Otol Rhinol Laryngol. 2022 Nov;131(11):1231-1240. doi: 10.1177/00034894211062543. PMID: 34872386. n = 163

  210. Owens J, Spirito A, Marcotte A, McGuinn M, Berkelhammer L (2000): Neuropsychological and Behavioral Correlates of Obstructive Sleep Apnea Syndrome in Children: A Preliminary Study. Sleep Breath. 2000;4(2):67-78. doi: 10.1007/BF03045026. PMID: 11868122. n = 18

  211. Mitchell RB, Kelly J (2005): Child behavior after adenotonsillectomy for obstructive sleep apnea syndrome. Laryngoscope. 2005 Nov;115(11):2051-5. doi: 10.1097/01.MLG.0000181516.65577.94. PMID: 16319623.

  212. Bhatt SP, Guleria R, Kabra SK (2021): Metabolic alterations and systemic inflammation in overweight/obese children with obstructive sleep apnea. PLoS One. 2021 Jun 4;16(6):e0252353. doi: 10.1371/journal.pone.0252353. PMID: 34086720; PMCID: PMC8177414.

  213. Calhoun SL, Mayes SD, Vgontzas AN, Tsaoussoglou M, Shifflett LJ, Bixler EO (2009): No relationship between neurocognitive functioning and mild sleep disordered breathing in a community sample of children. J Clin Sleep Med. 2009 Jun 15;5(3):228-34. PMID: 19960643; PMCID: PMC2699167. n = 571

  214. Malhotra A, Grunstein RR, Fietze I, Weaver TE, Redline S, Azarbarzin A, Sands SA, Schwab RJ, Dunn JP, Chakladar S, Bunck MC, Bednarik J; SURMOUNT-OSA Investigators (2024): Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024 Oct 3;391(13):1193-1205. doi: 10.1056/NEJMoa2404881. PMID: 38912654; PMCID: PMC11598664.

  215. Gurgel W, Garcia-Argibay M, D’Onofrio BM, Larsson H, Polanczyk GV (2025): Predictors of preschool attention-deficit/hyperactivity disorder diagnosis: a population-based study using national registers. J Child Psychol Psychiatry. 2025 Jun;66(6):834-845. doi: 10.1111/jcpp.14093. PMID: 39676220. n = 631.695

  216. Zhou Z, Shen G, Zhou W, Gong J, Hu B (2025): Causal Relationships Between Modifiable Risk Factors and Gastroesophageal Reflux Disease: A Two-Sample Mendelian Randomization Study. Curr Med Chem. 2025 Aug 1. doi: 10.2174/0109298673372983250710031732. PMID: 40760758. n = 602.604

  217. Bevilacqua F, Iacusso C, Aite L, Valfrè L, D’Astore M, Dotta A, Vicari S, Braguglia A, Menghini D, Conforti A, Fusaro F, Iacobelli BD (2025): Integrating psychological support in the care of children and adolescents with anorectal malformation or Hirschsprung disease: a ten-year experience. Pediatr Surg Int. 2025 Jun 24;41(1):191. doi: 10.1007/s00383-025-06073-z. PMID: 40553209.

  218. Wester T, Gunnarsdottir A, Skoglund C, Svenningsson A (2021): Attention deficit hyperactivity and autism spectrum disorders in patients with anorectal malformations. Acta Paediatr. 2021 Nov;110(11):3131-3136. doi: 10.1111/apa.16100. PMID: 34498328. n = 3.075

  219. Yi Y, Zhong C, Wei-Wei H (2023): The long-term neurodevelopmental outcomes of febrile seizures and underlying mechanisms. Front Cell Dev Biol. 2023 May 25;11:1186050. doi: 10.3389/fcell.2023.1186050. PMID: 37305674; PMCID: PMC10248510. REVIEW

  220. Woo H, Lee SU, Yun D, Jeong S, Cho H, Kim YS (2025): Attention-deficit/hyperactivity disorder in children with a history of febrile seizures: a systematic review and meta-analysis. Eur J Pediatr. 2025 Jun 25;184(7):442. doi: 10.1007/s00431-025-06285-4. PMID: 40555878; PMCID: PMC12187803. METASTUDY

  221. Ku YC, Muo CH, Ku CS, Chen CH, Lee WY, Shen EY, Chang YJ, Kao CH (2014): Risk of subsequent attention deficit-hyperactivity disorder in children with febrile seizures. Arch Dis Child. 2014 Apr;99(4):322-6. doi: 10.1136/archdischild-2013-304647. PMID: 24307684.

  222. Bertelsen EN, Larsen JT, Petersen L, Christensen J, Dalsgaard S (2016): Childhood Epilepsy, Febrile Seizures, and Subsequent Risk of ADHD. Pediatrics. 2016 Aug;138(2):e20154654. doi: 10.1542/peds.2015-4654. PMID: 27412639.

  223. Khoshbakht Y, Bidaki R, Salehi-Abargouei A. Vitamin D Status and Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Observational Studies. Adv Nutr. 2018 Jan 1;9(1):9-20. doi: 10.1093/advances/nmx002. PMID: 29438455; PMCID: PMC6333940. METASTUDY

  224. Lancrei HM, Yeshayahu Y, Grossman ES, Berger I (2022): Sweet but sour: Impaired attention functioning in children with type 1 diabetes mellitus. Front Hum Neurosci. 2022 Sep 8;16:895835. doi: 10.3389/fnhum.2022.895835. PMID: 36158626; PMCID: PMC9495930.

  225. Chen MH, Tsai SJ, Bai YM, Huang KL, Su TP, Chen TJ, Hsu JW (2022): Type 1 diabetes mellitus and risks of major psychiatric disorders: A nationwide population-based cohort study. Diabetes Metab. 2022 Jan;48(1):101319. doi: 10.1016/j.diabet.2022.101319. PMID: 35026379. n = 68.486

  226. Merzon, Grossman, Vinker, Merhasin, Levit, Golan-Cohen (2020): Factors associated with withdrawal from insulin pump therapy: a large-population-based study. Diabetes Metab Res Rev. 2020 Jan 10. doi: 10.1002/dmrr.3288. n = 707

  227. Kapellen, Reimann Kiess, Kostev (2016): Prevalence of medically treated children with ADHD and type 1 diabetes in Germany – Analysis of two representative databases; J Pediatr Endocrinol Metab. 2016 Oct 18. pii: /j/jpem.ahead-of-print/jpem-2016-0171/jpem-2016-0171.xml. doi: 10.1515/jpem-2016-0171.

  228. Zhang-James Y, Draytsel D, Carguello B, Faraone SV, Weinstock RS (2025): Attention-Deficit/Hyperactivity Disorder Symptoms Are Common and Associated with Worse Glycemic Control in Adults with Type 1 Diabetes. J Clin Med. 2025 May 21;14(10):3606. doi: 10.3390/jcm14103606. PMID: 40429601; PMCID: PMC12112195.

  229. Świątek Ł, Jeske J, Miedziaszczyk M, Idasiak-Piechocka I, Wais P (2025): The effect of insulin on the central nervous system: insights into neurological complications and management of type 1 diabetes in the pediatric population. Pediatr Endocrinol Diabetes Metab. 2025;31(2):68-74. doi: 10.5114/pedm.2025.152597. PMID: 40755345; PMCID: PMC12302944. REVIEW

  230. Zhou Y, Jin B, Qiao K (2025): Investigating the causal relationships between attention-deficit/hyperactivity disorder and autoimmune diseases: Evidence from Mendelian randomization study. Medicine (Baltimore). 2025 Jan 3;104(1):e41157. doi: 10.1097/MD.0000000000041157. PMID: 40184135; PMCID: PMC11709194.

  231. Chiu SL, Cline HT (2010): Insulin receptor signaling in the development of neuronal structure and function. Neural Dev. 2010 Mar 15;5:7. doi: 10.1186/1749-8104-5-7. PMID: 20230616; PMCID: PMC2843688. REVIEW

  232. Carvelli L, Morón JA, Kahlig KM, Ferrer JV, Sen N, Lechleiter JD, Leeb-Lundberg LM, Merrill G, Lafer EM, Ballou LM, Shippenberg TS, Javitch JA, Lin RZ, Galli A (2002): PI 3-kinase regulation of dopamine uptake. J Neurochem. 2002 May;81(4):859-69. doi: 10.1046/j.1471-4159.2002.00892.x. PMID: 12065645.

  233. Kondo C, Ihara H, Ogata H, Saima S, Nakane E (2025): Association between premenstrual syndrome or premenstrual dysphoric disorder and presence of ASD or ADHD among adolescent females: a retrospective study. Arch Womens Ment Health. 2025 Jul 23. doi: 10.1007/s00737-025-01602-0. PMID: 40699321.

  234. Huang H, Zhang KP, Sun KK, Yu G (2024): Association between type 2 inflammatory diseases and neurodevelopmental disorders in low-birth-weight children and adolescents. Front Psychol. 2024 Feb 22;15:1292071. doi: 10.3389/fpsyg.2024.1292071. PMID: 38455122; PMCID: PMC10918750. n = 11.260

  235. Chuang YC, Wang CY, Huang WL, Wang LJ, Kuo HC, Chen YC, Huang YJ (2022): Two meta-analyses of the association between atopic diseases and core symptoms of attention deficit hyperactivity disorder. Sci Rep. 2022 Mar 1;12(1):3377. doi: 10.1038/s41598-022-07232-1. PMID: 35232975; PMCID: PMC8888762. METASTUDY

  236. Xu G, Liu B, Yang W, Snetselaar LG, Chen M, Bao W, Strathearn L (2022): Association of Food Allergy, Respiratory Allergy, and Skin Allergy with Attention Deficit/Hyperactivity Disorder among Children. Nutrients. 2022 Jan 21;14(3):474. doi: 10.3390/nu14030474. PMID: 35276830; PMCID: PMC8838767. n = 192.573

  237. Wang Q, Wang R, Li M, Liang J, Zhan X, Lu Y, Huang G, Gu Q (2024): The relationship between allergic rhinitis and attention deficit hyperactivity disorder: a systematic review and meta-analysis. PeerJ. 2024 Oct 18;12:e18287. doi: 10.7717/peerj.18287. PMID: 39434793; PMCID: PMC11493030. METASTUDY

  238. Wang LJ, Yu YH, Fu ML, Yeh WT, Hsu JL, Yang YH, Chen WJ, Chiang BL, Pan WH (2018): Attention deficit-hyperactivity disorder is associated with allergic symptoms and low levels of hemoglobin and serotonin. Sci Rep. 2018 Jul 6;8(1):10229. doi: 10.1038/s41598-018-28702-5. PMID: 29980754; PMCID: PMC6035203.

  239. Wei J, Li Y, Wu Q, Lei B, Gui X (2025): Bidirectional association between allergic rhinitis and attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. J Affect Disord. 2025 Jan 15;369:499-507. doi: 10.1016/j.jad.2024.10.032. PMID: 39389122. METASTUDY

  240. Jiang Z, Long X, Die X, Hou J, Wang Y, Wang Y, Feng W (2025): Causal effects of pediatric asthma on psychiatric disorders: a bidirectional Mendelian randomization study. J Asthma. 2025 Mar;62(3):445-455. doi: 10.1080/02770903.2024.2409418. PMID: 39320275.

  241. Xu X, Li S, Chen Y, Deng X, Li J, Xiong D, Xie H (2025): Association between allergic diseases and mental health conditions: An umbrella review. J Allergy Clin Immunol. 2025 Mar;155(3):701-713. doi: 10.1016/j.jaci.2024.10.030. PMID: 39521284. REVIEW

  242. DocCheck Flexikon: Atopie

  243. Hu S, Li L, Zhou C, Zhang Y, Yu X (2025): Multi-Strain Probiotics Alleviate Food Allergy-Induced Neurobehavioral Abnormalities by Regulating Gut Microbiota and Metabolites. Nutrients. 2025 Jun 8;17(12):1955. doi: 10.3390/nu17121955. PMID: 40573066; PMCID: PMC12196041.

  244. Bunyavanich S, Berin MC (2019): Food allergy and the microbiome: Current understandings and future directions. J Allergy Clin Immunol. 2019 Dec;144(6):1468-1477. doi: 10.1016/j.jaci.2019.10.019. PMID: 31812181; PMCID: PMC6905201. REVIEW

  245. Maniscalco I, Bartochowski P, Priori V, Iancau SP, De Francesco M, Innamorati M, Jagodzinska N, Giupponi G, Masucci L, Conca A, Mroczek M (2025): The Effects of Fecal Microbial Transplantation on the Symptoms in Autism Spectrum Disorder, Gut Microbiota and Metabolites: A Scoping Review. Microorganisms. 2025 May 31;13(6):1290. doi: 10.3390/microorganisms13061290. PMID: 40572178; PMCID: PMC12195398. REVIEW

  246. Sharon G, Cruz NJ, Kang DW, Gandal MJ, Wang B, Kim YM, Zink EM, Casey CP, Taylor BC, Lane CJ, Bramer LM, Isern NG, Hoyt DW, Noecker C, Sweredoski MJ, Moradian A, Borenstein E, Jansson JK, Knight R, Metz TO, Lois C, Geschwind DH, Krajmalnik-Brown R, Mazmanian SK (2019): Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice. Cell. 2019 May 30;177(6):1600-1618.e17. doi: 10.1016/j.cell.2019.05.004. PMID: 31150625; PMCID: PMC6993574.

  247. Zhuoran Z, Xiaoman W, Rui Y, Qingjiu C (2025): Association Between ADHD and Pediatric Asthma: Results From a Large-Sample Cross-Sectional Study of National Surveys and Mendelian Randomization Analyses. J Atten Disord. 2025 Oct;29(12):1092-1106. doi: 10.1177/10870547251349252. PMID: 40576263.

  248. Penchev P, Milanova-Ilieva D, Gaydarski L, Petrov PP, Ketev K, Stanchev P, Husain N, Ramadanov N (2025): Attention Deficit and Memory Function in Children with Bronchial Asthma: A Systematic Review and Meta-Analysis of 104,975 Patients with Trial Sequential Analysis. Children (Basel). 2025 Jul 31;12(8):1013. doi: 10.3390/children12081013. PMID: 40868465; PMCID: PMC12384668. METASTUDY

  249. Buske-Kirschbaum, Schmitt, Plessow, Romanos, Weidinger, Roessner (2012): Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology. 2013 Jan;38(1):12-23. doi: 10.1016/j.psyneuen.2012.09.017. PMID: 23141851. REVIEW

  250. Molla A, Jannadi R, Hafez D, Alrohaily L, Abdullah E, Azouni D, Albadrani M (2025): Exploring Attention-Deficit/Hyperactivity Disorder Symptoms in Patients With Atopic Dermatitis by Disease Severity: Cross-Sectional Analysis. JMIR Dermatol. 2025 Jul 15;8:e74126. doi: 10.2196/74126. PMID: 40663791; PMCID: PMC12283059. n = 419

  251. Cao S, Zhang Z, Liu L, Li Y, Li W, Li Y, Wu D (2024): Causal relationships between atopic dermatitis and psychiatric disorders: a bidirectional two-sample Mendelian randomization study. BMC Psychiatry. 2024 Jan 3;24(1):16. doi: 10.1186/s12888-023-05478-1. PMID: 38172785; PMCID: PMC10763185.

  252. Liu Z, Wang Y, Wang S, Wu J, Jia C, Tan X, Liu X, Huang X, Zhang L (2024): Unraveling the causative connection between urticaria, inflammatory cytokines, and mental disorders: Perspectives from genetic evidence. Skin Res Technol. 2024 Sep;30(9):e13906. doi: 10.1111/srt.13906. PMID: 39300828; PMCID: PMC11413335.

  253. Wang HF, Liu S, Cao Y, Li QS (2025): Bidirectional association between atopic dermatitis and attention deficit hyperactivity disorder: a systematic review and meta-analysis. Ann Med. 2025 Dec;57(1):2483370. doi: 10.1080/07853890.2025.2483370. PMID: 40159827; PMCID: PMC11960313. METASTUDY

  254. Wan J, Shin DB, Syed MN, Abuabara, Lemeshow, Gelfand (2022): Atopic dermatitis and risk of major neuropsychiatric disorders in children: a population-based cohort study. J Eur Acad Dermatol Venereol. 2022 Aug 26. doi: 10.1111/jdv.18564. PMID: 36018560. n = 2,4 Mio

  255. Ma EZ, Chang HR, Radtke S, Wan J (2024): Symptoms of Cognitive Impairment Among Children With Atopic Dermatitis. JAMA Dermatol. 2024 Mar 6:e240015. doi: 10.1001/jamadermatol.2024.0015. PMID: 38446433; PMCID: PMC10918570.

  256. Zader SJ, Williams E, Buryk MA (2019); Mental Health Conditions and Hyperthyroidism. Pediatrics. 2019 Nov;144(5):e20182874. doi: 10.1542/peds.2018-2874. PMID: 31582535. n = 2.479

  257. Ozturk Y, Hangül Z, Demir N, Tufan AE (2024): THE RELATIONS BETWEEN THYROID HORMONES AND CLINICAL FEATURES OF TURKISH CHILDREN AND ADOLESCENTS WITH ADHD AND ADHD-NOS: A PRELIMINARY STUDY. Psychiatr Danub. 2024 Dec;36(3-4):333-339. doi: 10.24869/psyd.2024.333. PMID: 39724120. n = 81

  258. Meng H, Bigambo FM, Gu W, Wang X, Li Y (2024): Evaluation of thyroid function tests among children with neurological disorders. Front Endocrinol (Lausanne). 2024 Dec 9;15:1498788. doi: 10.3389/fendo.2024.1498788. PMID: 39717108; PMCID: PMC11663650. METASTUDY

  259. Chen G, Gao W, Xu Y, Chen H, Cai H (2023): Serum TSH Levels are Associated with Hyperactivity Behaviors in Children with Attention Deficit/Hyperactivity Disorder. Neuropsychiatr Dis Treat. 2023 Mar 7;19:557-564. doi: 10.2147/NDT.S402530. PMID: 36915908; PMCID: PMC10007977.

  260. Göbel A, Heldmann M, Göttlich M, Dirk AL, Brabant G, Münte TF (2016): Effect of Mild Thyrotoxicosis on Performance and Brain Activations in a Working Memory Task. PLoS One. 2016 Aug 18;11(8):e0161552. doi: 10.1371/journal.pone.0161552. PMID: 27536945; PMCID: PMC4990413.

  261. Bauer M, Goetz T, Glenn T, Whybrow PC (2008): The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol. 2008 Oct;20(10):1101-14. doi: 10.1111/j.1365-2826.2008.01774.x. PMID: 18673409. REVIEW

  262. Göttlich M, Chatterjee K, Moran C, Heldmann M, Rogge B, Cirkel A, Brabant G, Münte TF (2024): Altered brain functional connectivity in patients with resistance to thyroid hormone ß. PLoS One. 2024 Aug 22;19(8):e0306538. doi: 10.1371/journal.pone.0306538. PMID: 39172991; PMCID: PMC11341041.

  263. Eberle AJ (1995): Hyperactivity and Graves’ disease. J Am Acad Child Adolesc Psychiatry. 1995 Aug;34(8):973-4. doi: 10.1097/00004583-199508000-00003. PMID: 7665452.

  264. Losada-Del Pozo R, Soto-Insuga V, Martínez González M, Soriano Guillén L (2017): Neuropsychiatric manifestations of Graves’ disease in paediatric patients. Neurologia. 2017 Apr;32(3):196-197. English, Spanish. doi: 10.1016/j.nrl.2015.05.001. PMID: 26096670.

  265. Kuge R, Muroya K, Mochizuki H, Nagasaki K, Hasegawa Y (2025): Psychiatric symptoms in children and adolescents with Graves’ disease: A retrospective study and a prospective study. Pediatr Int. 2025 Jan-Dec;67(1):e70134. doi: 10.1111/ped.70134. PMID: 40599034.

  266. Bossowski AT, Reddy V, Perry LA, Johnston LB, Banerjee K, Blair JC, Savage MO (2007): Clinical and endocrine features and long-term outcome of Graves’ disease in early childhood. J Endocrinol Invest. 2007 May;30(5):388-92. doi: 10.1007/BF03346315. PMID: 17598970.

  267. Woolston JL, Caracansi A (1999): Case study: missed diagnosis and mistreatment of unrecognized comorbid Graves disease. J Am Acad Child Adolesc Psychiatry. 1999 Jul;38(7):861-4. doi: 10.1097/00004583-199907000-00016. PMID: 10405504.

  268. Sims EK, Eugster EA, Nebesio TD (2012): Detours on the road to diagnosis of Graves disease. Clin Pediatr (Phila). 2012 Feb;51(2):160-4. doi: 10.1177/0009922811418823. PMID: 21868592; PMCID: PMC4094030.

  269. Del-Ponte B, Quinte GC, Cruz S, Grellert M, Santos IS (2019): Dietary patterns and attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis. J Affect Disord. 2019 Jun 1;252:160-173. doi: 10.1016/j.jad.2019.04.061. PMID: 30986731. METASTUDY

  270. Voltas N, Jardí C, Hernández-Martínez C, Arija V, Canals J (2022): Association between free sugars intake and early psychopathological problems. J Child Health Care. 2022 Oct 25:13674935221135106. doi: 10.1177/13674935221135106. PMID: 36282888. n = 86

  271. Hussein RA, Refai RH, El-Zoka AH, Azouz HG, Hussein MF (2025): Association between some environmental risk factors and attention-deficit hyperactivity disorder among children in Egypt: a case-control study. Ital J Pediatr. 2025 Jan 29;51(1):19. doi: 10.1186/s13052-025-01843-w. PMID: 39875928; PMCID: PMC11776284. n = 252

  272. Ferreira RC, Marin AH, Vitolo MR, Campagnolo PDB (2024): Early ultra-processed foods consumption and hyperactivity/inattention in adolescence. Rev Saude Publica. 2024 Oct 18;58:46. doi: 10.11606/s1518-8787.2024058005636. Erratum in: Rev Saude Publica. 2025 Jan 17;58:46err. doi: 10.11606/s1518-8787.2024058005636err. PMID: 39442121; PMCID: PMC11548911.

  273. Niederhofer (2011): Association of Attention-Deficit/Hyperactivity Disorder and Celiac Disease: A Brief Report; Prim Care Companion CNS Disord. 2011; 13(3): PCC.10br01104; doi: 10.4088/PCC.10br01104; PMCID: PMC3184556, n = 67

  274. ähnlich: Okusaga, Yolken, Langenberg, Sleemi, Kelly, Vaswani, Giegling, Hartmann, Konte, Friedl, Mohyuddin, Groer, Rujescu, Postolache (2013): Elevated gliadin antibody levels in individuals with schizophrenia. World J Biol Psychiatry. 2013 Sep;14(7):509-15. doi: 10.3109/15622975.2012.747699.

  275. Lachance, McKenzie (2013): Biomarkers of gluten sensitivity in patients with non-affective psychosis: a meta-analysis. Schizophr Res. 2014 Feb;152(2-3):521-7. doi: 10.1016/j.schres.2013.12.001.

  276. Stevenson J, Sonuga-Barke E, McCann D, Grimshaw K, Parker KM, Rose-Zerilli MJ, Holloway JW, Warner JO (2010): The role of histamine degradation gene polymorphisms in moderating the effects of food additives on children’s ADHD symptoms. Am J Psychiatry. 2010 Sep;167(9):1108-15. doi: 10.1176/appi.ajp.2010.09101529. PMID: 20551163. RCT

  277. Lee J, Lee SI, Lee YM, Hong YH (2023): Prevalence of Attention Deficit Hyperactivity Disorder in Girls With Central Precocious Puberty. J Atten Disord. 2023 Jul 14:10870547231180116. doi: 10.1177/10870547231180116. PMID: 37449382.

  278. Xu J, Wang F, Gao Y, Qi C, Chen T, Yan J (2024): The Relationship between Early Exposure to General Anesthesia and Neurobehavioral Deficits. Dev Neurosci. 2024 Oct 14:1-17. doi: 10.1159/000542005. PMID: 39401493. REVIEW

  279. Ing, Ma, Sun, Lu, Wall, Olfson, Li (2020): Exposure to Surgery and Anesthesia in Early Childhood and Subsequent Use of Attention Deficit Hyperactivity Disorder Medications. Anesth Analg. 2020 Jan 8. doi: 10.1213/ANE.0000000000004619. n = 256.122

  280. Song JY, Cha HR, Lee SW, Ha EK, Kim JH, Han MY (2023): Association Between Receipt of General Anesthesia During Childhood and Attention Deficit Hyperactive Disorder and Neurodevelopment. J Korean Med Sci. 2023 Feb 13;38(6):e42. doi: 10.3346/jkms.2023.38.e42. PMID: 36786086; PMCID: PMC9925326. n = 93.717

  281. Shi, Dykhoff, Guevara, Sangaralingham, Schroeder, Flick, Zaccariello, Warner (2021): Moderators of the association between attention-deficit/hyperactivity disorder and exposure to anaesthesia and surgery in children. Br J Anaesth. 2021 Sep 6:S0007-0912(21)00497-9. doi: 10.1016/j.bja.2021.07.025. PMID: 34503832. n = 185.002

  282. Sun M, Chen WM, Fu S, Wu SY (2023): Zhang J. Early childhood general anesthesia and risk of Attention Deficit Hyperactivity Disorder. J Child Psychol Psychiatry. 2023 Aug 3. doi: 10.1111/jcpp.13871. PMID: 37537781.

  283. Ing, Bellinger (2022): Long-term cognitive and behavioral outcomes following early exposure to general anesthetics. Curr Opin Anaesthesiol. 2022 Jul 6. doi: 10.1097/ACO.0000000000001155. PMID: 35788121.

  284. Holst, Kronborg, Jepsen, Christensen, Vejlstrup, Juul, Bjerre, Bilenberg, Ravn (2020): Transposition of the Great Arteries, and Tetralogy of Fallot. Attention-deficit/hyperactivity disorder symptoms in children with surgically corrected Ventricular Septal Defect, Cardiol Young. 2020 Jan 13:1-8. doi: 10.1017/S1047951119003184.

  285. Zhou H, Sun W, Ning L, Kang J, Jin Y, Dong C (2024): Early exposure to general anesthesia may contribute to later attention-deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis of cohort studies. J Clin Anesth. 2024 Nov;98:111585. doi: 10.1016/j.jclinane.2024.111585. PMID: 39153353. METASTUDY

  286. Yang, Wang, Chang, Ho, Kuo (2021): A National Population Cohort Study Showed That Exposure to General Anesthesia in Early Childhood Is Associated with an Increase in the Risk of Developmental Delay. Children (Basel). 2021 Sep 24;8(10):840. doi: 10.3390/children8100840. PMID: 34682104; PMCID: PMC8534755.

  287. Hou Y, Li S, Hou Q, Wang R, Xu X, Li Z, Ma L, Liu Q, Shen Y, Zheng H (2025): Vitamin K2 mitigates cognitive, and motor impairments induced by multiple surgery with anesthesia and analgesia in neonatal stage. Biochem Biophys Res Commun. 2025 Jun 8;765:151784. doi: 10.1016/j.bbrc.2025.151784. PMID: 40273626.

  288. Merzon E, Farag R, Ashkenazi S, Magen E, Manor I, Weizman A, Green I, Golan-Cohen A, Genshin A, Vinker S, Israel A (2024): Increased Prevalence of Attention Deficit Hyperactivity Disorder in Individuals with Selective Immunoglobulin A Deficiency: A Nationwide Case-Control Study. J Clin Med. 2024 Oct 12;13(20):6075. doi: 10.3390/jcm13206075. PMID: 39458025; PMCID: PMC11508521. n = 4.632

  289. Nadeem A, Donohue S, Shah FZ, Perez JA, Harper E, Sinh P, Padival R, Cooper G, Katz J, Cominelli F, Regueiro M, Mansoor E (2024): Early Onset Active Inflammatory Bowel Disease Is Associated With Psychiatric Comorbidities: A Multi-Network Propensity-Matched Cohort Study. Crohns Colitis 360. 2024 Dec 20;7(1):otae066. doi: 10.1093/crocol/otae066. PMID: 39749210; PMCID: PMC11694680.

  290. Butwicka A, Olén O, Larsson H, Halfvarson J, Almqvist C, Lichtenstein P, Serlachius E, Frisén L, Ludvigsson JF (2019): Association of Childhood-Onset Inflammatory Bowel Disease With Risk of Psychiatric Disorders and Suicide Attempt. JAMA Pediatr. 2019 Oct 1;173(10):969-978. doi: 10.1001/jamapediatrics.2019.2662. PMID: 31424531; PMCID: PMC6704748.

  291. Yang X, Yang L, Zhang T, Zhang H, Chen H, Zuo X (2023): Causal atlas between inflammatory bowel disease and mental disorders: a bi-directional 2-sample Mendelian randomization study. Front Immunol. 2023 Oct 13;14:1267834. doi: 10.3389/fimmu.2023.1267834. PMID: 37901213; PMCID: PMC10611497.

  292. Kappel RK, Bisgaard TH, Poulsen G, Jess T (2024): Risk of Anxiety, Depression, and Attention-Deficit/Hyperactivity Disorder in Pediatric Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study. Clin Transl Gastroenterol. 2024 Apr 1;15(4):e00657. doi: 10.14309/ctg.0000000000000657. PMID: 37934192; PMCID: PMC11042764.

  293. Shero N, Pandeya DR (2022): Impact of Crohn’s disease during pregnancy on children with attention deficit hyperactivity disorder: A review. Ann Med Surg (Lond). 2022 Feb 11;75:103369. doi: 10.1016/j.amsu.2022.103369. PMID: 35198194; PMCID: PMC8851270. REVIEW

  294. Fuhrmann, Tesch, Romanos, Abraham, Schmitt (2020): ADHD in school-age children is related to infant exposure to systemic H1-antihistamines. Allergy. 2020 Nov;75(11):2956-2957. doi: 10.1111/all.14411. PMID: 32441335. n = 41.484

  295. Muller D, Signal TL, Shanthakumar M, Paine SJ (2023): Sleep inequities and associations between poor sleep and mental health for school-aged children: findings from the New Zealand Health Survey. Sleep Adv. 2023 Nov 18;4(1):zpad049. doi: 10.1093/sleepadvances/zpad049. PMID: 38084299; PMCID: PMC10710543.

  296. Koç HA, Önal BS (2024): Relationship between acne vulgaris and attention deficit hyperactivity disorder in adolescent: A cross-sectional study. J Dermatol. 2024 Aug 30. doi: 10.1111/1346-8138.17435. PMID: 39212308. n = 194

  297. Rodriguez-Paris, Remlinger-Molenda, Kurzawa, Głowińska, Spaczyński, Rybakowski, Pawełczyk, Banaszewska (2019): Psychiatric disorders in women with polycystic ovary syndrome. Psychiatr Pol. 2019 Aug 31;53(4):955-966. doi: 10.12740/PP/OnlineFirst/93105.

  298. Trivedi C, Rizvi A, Ashraf S, Husain K, Yadav G, Adams E, Perugula M, Nabi S, Mansuri Z, Jain S (2024): Psychiatric Comorbidities in Hospitalized Adolescents With Polycystic Ovary Syndrome: A Cross-Sectional Study Using the National Inpatient Sample. Prim Care Companion CNS Disord. 2024 Nov 7;26(6):24m03760. doi: 10.4088/PCC.24m03760. PMID: 39546358.

  299. Kildal, Hassel, Bjørnebekk (2022): ADHD symptoms and use of anabolic androgenic steroids among male weightlifters. Sci Rep. 2022 Jun 8;12(1):9479. doi: 10.1038/s41598-022-12977-w. PMID: 35676515; PMCID: PMC9178025.

  300. Merzon E, Magen E, Ashkenazi S, Weizman A, Manor I, Krone B, Green I, Golan-Cohen A, Vinker S, Faraone SV, Israel A (2023): The Association between Glucose 6-Phosphate Dehydrogenase Deficiency and Attention Deficit/Hyperactivity Disorder. Nutrients. 2023 Nov 29;15(23):4948. doi: 10.3390/nu15234948. PMID: 38068806; PMCID: PMC10708268.

  301. Demir T, Simsir IY, Tuncel OK, Ozbaran B, Yildirim I, Pirildar S, Ozen S, Akinci B (2024): Impact of lipodystrophy on health-related quality of life: the QuaLip study. Orphanet J Rare Dis. 2024 Jan 5;19(1):10. doi: 10.1186/s13023-023-03004-w. PMID: 38183080; PMCID: PMC10768358.

  302. Lewczuk K, Marcowski P, Wizła M, Gola M, Nagy L, Koós M, Kraus SW, Demetrovics Z, Potenza MN, Ballester-Arnal R, Batthyány D, Bergeron S, Billieux J, Briken P, Burkauskas J, Cárdenas-López G, Carvalho J, Castro-Calvo J, Chen L, Ciocca G, Corazza O, Csako RI, Fernandez DP, Fujiwara H, Fernandez EF, Fuss J, Gabrhelík R, Gewirtz-Meydan A, Gjoneska B, Grubbs JB, Hashim HT, Islam MS, Ismail M, Jiménez-Martínez MC, Jurin T, Kalina O, Klein V, Költő A, Lee SK, Lin CY, Lin YC, Lochner C, López-Alvarado S, Lukavská K, Mayta-Tristán P, Miller DJ, Orosová O, Orosz G; Sungkyunkwan University’s research team; Ponce FP, Quintana GR, Quintero Garzola GC, Ramos-Diaz J, Rigaud K, Rousseau A, Tubino Scanavino M, Schulmeyer MK, Sharan P, Shibata M, Shoib S, Sigre-Leirós V, Sniewski L, Spasovski O, Steibliene V, Stein DJ, Ünsal BC, Vaillancourt-Morel MP, Claire Van Hout M, Bőthe B (2024): Cross-Cultural Adult ADHD Assessment in 42 Countries Using the Adult ADHD Self-Report Scale Screener. J Atten Disord. 2024 Feb;28(4):512-530. doi: 10.1177/10870547231215518. PMID: 38180045.

  303. Pinto Payares DV, Spooner L, Vosters J, Dominguez S, Patrick L, Harris A, Kanungo S (2024): A systematic review on the role of mitochondrial dysfunction/disorders in neurodevelopmental disorders and psychiatric/behavioral disorders. Front Psychiatry. 2024 Jun 28;15:1389093. doi: 10.3389/fpsyt.2024.1389093. PMID: 39006821; PMCID: PMC11239503.

  304. Zayats T, Johansson S, Haavik J (2015): Expanding the toolbox of ADHD genetics. How can we make sense of parent of origin effects in ADHD and related behavioral phenotypes? Behav Brain Funct. 2015 Oct 16;11(1):33. doi: 10.1186/s12993-015-0078-4. PMID: 26475699; PMCID: PMC4609130. REVIEW

  305. Yang Z, Luo Y, Yang Z, Liu Z, Li M, Wu X, Chen L, Xin W (2026): Mitochondrial dynamics dysfunction and neurodevelopmental disorders: From pathological mechanisms to clinical translation. Neural Regen Res. 2026 May 1;21(5):1926-1946. doi: 10.4103/NRR.NRR-D-24-01422. PMID: 40537021.

  306. Frisk V, Jakobson LS, Unger S, Trachsel D, O’Brien K (2011): Long-term neurodevelopmental outcomes of congenital diaphragmatic hernia survivors not treated with extracorporeal membrane oxygenation. J Pediatr Surg. 2011 Jul;46(7):1309-18. doi: 10.1016/j.jpedsurg.2010.12.023. PMID: 21763827.

  307. PEETSOLD, M., HUISMAN, J., HOFMAN, V., HEIJ, H., RAAT, H., & GEMKE, R. (2009): Psychological outcome and quality of life in children born with congenital diaphragmatic hernia. Archives of disease in childhood, 94(11), 834-840.

  308. Yackobovitch-Gavan M, Ben-Hefer D, Feldhamer I, Meyerovitch J (2024): The association between infantile microcytic anemia and attention deficit hyperactivity disorder, a case-control study. Heliyon. 2024 Jun 22;10(12):e33430. doi: 10.1016/j.heliyon.2024.e33430. PMID: 39015811; PMCID: PMC11250855.

  309. Köder F, Sharma C, Cameron S, Garraffa M (2022):The effects of bilingualism on cognition and behaviour in individuals with attention deficits: A scoping review. Front Psychol. 2022 Dec 23;13:1057501. doi: 10.3389/fpsyg.2022.1057501. PMID: 36619112; PMCID: PMC9816333. METASTUDIE

  310. Blasbalg U, Paz Toren (2024): The association between systemic lupus erythematosus (SLE) and early psychiatric background. J Psychiatr Res. 2024 Dec;180:349-354. doi: 10.1016/j.jpsychires.2024.10.029. PMID: 39520766.

  311. Huangfu N, Lu Y, Ma H, Hu Z, Cui H, Yang F (2023): Genetic liability to mental disorders in relation to the risk of hypertension. Front Cardiovasc Med. 2023 Feb 27;10:1087251. doi: 10.3389/fcvm.2023.1087251. PMID: 36923957; PMCID: PMC10008891.

  312. Chen F, Cao H, Baranova A, Zhao Q, Zhang F (2023): Causal associations between COVID-19 and childhood mental disorders. BMC Psychiatry. 2023 Dec 8;23(1):922. doi: 10.1186/s12888-023-05433-0. PMID: 38066446; PMCID: PMC10704772.

  313. Norbom LB, Syed B, Kjelkenes R, Rokicki J, Beauchamp A, Nerland S, Kushki A, Anagnostou E, Arnold P, Crosbie J, Kelley E, Nicolson R, Schachar R, Taylor MJ, Westlye LT, Tamnes CK, Lerch JP (2025): Probing Autism and ADHD subtypes using cortical signatures of the T1w/T2w-ratio and morphometry. Neuroimage Clin. 2025;45:103736. doi: 10.1016/j.nicl.2025.103736. PMID: 39837011; PMCID: PMC11788868.

  314. Zhang YX, Yang H, Guo Q, Zhang RF (2024): Investigating the causal relationship between childhood obesity and attention deficit hyperactivity disorder: A Mendelian randomization study. Asian J Surg. 2024 Dec 2:S1015-9584(24)02614-9. doi: 10.1016/j.asjsur.2024.11.012. PMID: 39627048.

  315. Van Assche IA, Van Calsteren K, Huis In ’t Veld EA, van Gerwen M, Heylen L, LeJeune CL, Cardonick E, Halaska MJ, Fruscio R, Fumagalli M, van Dijk-Lokkart EM, Lemiere J, van Grotel M, Lagae L, van den Heuvel-Eibrink MM, Amant F (2024): Child outcomes after prenatal exposure to platinum and taxane-based chemotherapy: an unplanned interim analysis of the international network on cancer, infertility, and pregnancy study. EClinicalMedicine. 2024 Nov 11;78:102922. doi: 10.1016/j.eclinm.2024.102922. PMID: 39588212; PMCID: PMC11585789.

  316. Fogelström A, Skoglund C, Hagel E, Wester T, Löf Granström A, Mesas-Burgos C (2025): Neurodevelopmental disorders in children with congenital abdominal wall defects: a national population-based study. Pediatr Surg Int. 2025 Sep 22;41(1):303. doi: 10.1007/s00383-025-06201-9. PMID: 40983721; PMCID: PMC12454545. N = 5.439, n = 496

  317. Hansen, Qureshi, Gele, Hauge, Biele, Surén, Kjøllesdal (2023): Developmental disorders among Norwegian-born children with immigrant parents. Child Adolesc Psychiatry Ment Health. 2023 Jan 6;17(1):3. doi: 10.1186/s13034-022-00547-x. PMID: 36609392; PMCID: PMC9825022.

  318. Chang J, Lee YJ, Lex H, Kerns C, Lugar K, Wright M (2023): Attention-Deficit Hyperactivity Disorder among children of immigrants: immigrant generation and family poverty. Ethn Health. 2023 Dec 17:1-13. doi: 10.1080/13557858.2023.2293657. PMID: 38105627. n = 83.362

  319. Tetens MM, Graham EE, Andersen NS, Bangsborg J, Bodilsen J, Dessau RB, Ellermann-Eriksen S, Jørgensen CS, Møller JK, Nielsen ACY, Pedersen M, Søgaard KK, Obel D, Nygaard U, Obel N, Lebech AM, Omland LH (2025): No associations between neuroborreliosis in children and psychiatric neurodevelopmental disorders: a nationwide, population-based, matched cohort study. J Child Psychol Psychiatry. 2025 May;66(5):716-724. doi: 10.1111/jcpp.14079. PMID: 39618006. n = 12.452